Medications for human use with a single active ingredient starting with the letter O-R.

Médicaments à usage humain contenant un seul ingrédient actif commençant par la lettre O-R.

Last Update: 2021-05-03
Product Name;
DIN;
Active ingredient(s) and concentration;
Number of active ingredients: Number of active ingredients;
Original market date;
Route(s) of administration;
Dosage form(s);
AHFS;
Schedule;
Company
Monograph
OCALIVA;
02463148;
obeticholic acid 10 mg;
2017-05-26;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
INTERCEPT PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95105
OCALIVA;
02463121;
obeticholic acid 5 mg;
2017-05-26;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
INTERCEPT PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95104
GAZYVA;
02434806;
obinutuzumab 25 mg / ml;
2014-11-28;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91910
OCREVUS;
02467224;
ocrelizumab 30 mg / ml;
2017-09-21;
Intravenous;
Solution;
92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95561
TEINT IDOLE ULTRA WEAR;
02379228;
octinoxate 3 % / w/w;
2012-04-13;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86510
CLE DE PEAU BEAUTE TEINT STICK ECLAT;
02453746;
octinoxate 3.4 % / w/w;
2016-12-09;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94028
TEINT LIFT ANTI-RIDES FPS 20 SPF 20;
02259338;
octinoxate 4 % / w/w;
2005-01-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74459
PROTECTIVE LIP CONDITIONER;
02430762;
octinoxate 4.9 % / w/w;
2015-11-09;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91520
TRUE MATCH LUMI;
02387018;
octinoxate 7 % / w/w;
2012-05-30;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
L’ OREAL CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87257
OCTINOXATE LOTION SPF 18;
02407191;
octinoxate 7 % / w/w;
2014-07-20;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAYBELLINE CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89191
MARCELLE/BB/CREAM/CRÈME/ANTI-AGING/ANTI-ÂGE/SPF 20 FPS;
02382741;
octinoxate 7.5 % / w/w;
2012-07-10;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86856
BEYOND COLOR LIPSTICK SPF 15;
02435020;
octinoxate 7.5 % / w/w;
2015-07-30;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91931
BEYOND COLOR LIP CONDITIONER SPF 15;
02435039;
octinoxate 7.5 % / w/w;
2015-07-30;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91932
LISE WATIER CC CREME FPS 25 SPF;
02457458;
octinoxate 7.5 % / w/w;
2017-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94450
MARCELLE CITY TINTED CREAM CRÈME TINTÉE MULTI-PROTECTION SPF 25 FPS;
02457466;
octinoxate 7.5 % / w/w;
2016-12-05;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94451
SANDOSTATIN LAR 10MG;
02239323;
octreotide (octreotide acetate) 10 mg / vial;
1999-01-27;
Intramuscular;
Powder For Suspension, Sustained-Release;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62792
SANDOSTATIN 100MCG/ML;
00839205;
octreotide (octreotide acetate) 100 mcg / ml;
1989-12-31;
Intravenous , Subcutaneous;
Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9916
OCTREOTIDE ACETATE OMEGA;
02248640;
octreotide (octreotide acetate) 100 mcg / ml;
2004-02-26;
Intravenous , Subcutaneous;
Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72997
SANDOSTATIN LAR 20MG;
02239324;
octreotide (octreotide acetate) 20 mg / vial;
1999-01-27;
Intramuscular;
Powder For Suspension, Sustained-Release;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62793
SANDOSTATIN 200MCG/ML;
02049392;
octreotide (octreotide acetate) 200 mcg / ml;
1996-12-31;
Intravenous , Subcutaneous;
Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19627
OCTREOTIDE ACETATE OMEGA;
02248642;
octreotide (octreotide acetate) 200 mcg / ml;
2004-03-11;
Intravenous , Subcutaneous;
Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72999
SANDOSTATIN LAR 30MG;
02239325;
octreotide (octreotide acetate) 30 mg / vial;
1999-01-27;
Intramuscular;
Powder For Suspension, Sustained-Release;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62794
SANDOSTATIN 50MCG/ML;
00839191;
octreotide (octreotide acetate) 50 mcg / ml;
1989-12-31;
Intravenous , Subcutaneous;
Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9915
OCTREOTIDE ACETATE OMEGA;
02248639;
octreotide (octreotide acetate) 50 mcg / ml;
2004-02-26;
Intravenous , Subcutaneous;
Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72996
OCTREOTIDE ACETATE OMEGA;
02248641;
octreotide (octreotide acetate) 500 mcg / ml;
2004-02-26;
Intravenous , Subcutaneous;
Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72998
KESIMPTA;
02511355;
ofatumumab 20 mg / 0.4 ml;
2021-04-08;
Subcutaneous;
Solution;
92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100057
OCUFLOX;
02143291;
ofloxacin 0.3 %;
1995-12-31;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18491
ZYPREXA INTRAMUSCULAR;
02247099;
olanzapine (olanzapine tartrate) 10 mg / vial;
2004-01-12;
Intramuscular;
Powder For Solution;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71336
OLANZAPINE FOR INJECTION;
02416522;
olanzapine (olanzapine tartrate) 10 mg / vial;
2014-07-22;
Intramuscular;
Powder For Solution;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90112
ZYPREXA – 10MG;
02229285;
olanzapine 10 mg;
1996-11-14;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43533
ZYPREXA ZYDIS;
02243087;
olanzapine 10 mg;
2001-03-15;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66954
TEVA-OLANZAPINE;
02276747;
olanzapine 10 mg;
2007-06-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76242
APO-OLANZAPINE;
02281821;
olanzapine 10 mg;
2009-10-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76748
PMS-OLANZAPINE;
02303175;
olanzapine 10 mg;
2008-04-02;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78850
PMS-OLANZAPINE ODT;
02303205;
olanzapine 10 mg;
2009-10-15;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78853
OLANZAPINE;
02311992;
olanzapine 10 mg;
2010-02-01;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79752
SANDOZ OLANZAPINE ODT;
02327783;
olanzapine 10 mg;
2010-02-26;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81319
RIVA-OLANZAPINE;
02337150;
olanzapine 10 mg;
2010-02-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82276
OLANZAPINE ODT;
02338653;
olanzapine 10 mg;
2010-02-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82432
OLANZAPINE ODT;
02343673;
olanzapine 10 mg;
2012-04-24;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82911
APO-OLANZAPINE ODT;
02360624;
olanzapine 10 mg;
2011-08-08;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84559
OLANZAPINE;
02372843;
olanzapine 10 mg;
2011-10-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85793
OLANZAPINE;
02385899;
olanzapine 10 mg;
2012-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87150
JAMP OLANZAPINE ODT;
02406632;
olanzapine 10 mg;
2014-08-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89132
MINT-OLANZAPINE;
02410184;
olanzapine 10 mg;
2019-09-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89484
RAN-OLANZAPINE ODT;
02414104;
olanzapine 10 mg;
2013-10-17;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89877
JAMP OLANZAPINE FC;
02417286;
olanzapine 10 mg;
2015-06-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90191
MINT-OLANZAPINE ODT;
02436973;
olanzapine 10 mg;
2015-03-18;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92129
AURO-OLANZAPINE ODT;
02448734;
olanzapine 10 mg;
2015-12-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93445
AG-OLANZAPINE FC;
02487632;
olanzapine 10 mg;
2020-01-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97778
SANDOZ OLANZAPINE;
02310384;
olanzapine 10.0 mg;
2009-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79602
ZYPREXA 15MG;
02238850;
olanzapine 15 mg;
2002-06-24;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62290
ZYPREXA ZYDIS;
02243088;
olanzapine 15 mg;
2004-01-09;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66955
TEVA-OLANZAPINE;
02276755;
olanzapine 15 mg;
2007-06-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76243
APO-OLANZAPINE;
02281848;
olanzapine 15 mg;
2009-10-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76749
PMS-OLANZAPINE;
02303183;
olanzapine 15 mg;
2008-04-02;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78851
PMS-OLANZAPINE ODT;
02303213;
olanzapine 15 mg;
2009-10-15;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78854
OLANZAPINE;
02312018;
olanzapine 15 mg;
2010-02-01;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79753
SANDOZ OLANZAPINE ODT;
02327791;
olanzapine 15 mg;
2010-02-26;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81320
RIVA-OLANZAPINE;
02337169;
olanzapine 15 mg;
2010-02-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82277
OLANZAPINE ODT;
02338661;
olanzapine 15 mg;
2010-02-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82433
OLANZAPINE ODT;
02343681;
olanzapine 15 mg;
2012-04-24;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82912
OLANZAPINE ODT;
02352990;
olanzapine 15 mg;
2011-10-07;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83822
APO-OLANZAPINE ODT;
02360632;
olanzapine 15 mg;
2011-08-08;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84560
OLANZAPINE;
02372851;
olanzapine 15 mg;
2011-10-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85794
OLANZAPINE;
02385902;
olanzapine 15 mg;
2012-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87151
JAMP OLANZAPINE ODT;
02406640;
olanzapine 15 mg;
2014-08-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89133
MINT-OLANZAPINE;
02410192;
olanzapine 15 mg;
2019-09-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89485
RAN-OLANZAPINE ODT;
02414112;
olanzapine 15 mg;
2013-10-17;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89878
JAMP OLANZAPINE FC;
02417294;
olanzapine 15 mg;
2015-06-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90192
MINT-OLANZAPINE ODT;
02436981;
olanzapine 15 mg;
2015-03-18;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92130
AURO-OLANZAPINE ODT;
02448742;
olanzapine 15 mg;
2015-12-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93446
SANDOZ OLANZAPINE;
02310392;
olanzapine 15.0 mg;
2009-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79603
ZYPREXA;
02229250;
olanzapine 2.5 mg;
1997-12-08;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43530
TEVA-OLANZAPINE;
02276712;
olanzapine 2.5 mg;
2007-06-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76239
APO-OLANZAPINE;
02281791;
olanzapine 2.5 mg;
2009-10-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76745
PMS-OLANZAPINE;
02303116;
olanzapine 2.5 mg;
2008-04-02;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78844
SANDOZ OLANZAPINE;
02310341;
olanzapine 2.5 mg;
2009-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79599
OLANZAPINE;
02311968;
olanzapine 2.5 mg;
2010-02-01;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79749
RIVA-OLANZAPINE;
02337126;
olanzapine 2.5 mg;
2010-02-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82273
OLANZAPINE;
02372819;
olanzapine 2.5 mg;
2011-10-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85790
OLANZAPINE;
02385864;
olanzapine 2.5 mg;
2012-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87147
MINT-OLANZAPINE;
02410141;
olanzapine 2.5 mg;
2019-09-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89481
JAMP OLANZAPINE FC;
02417243;
olanzapine 2.5 mg;
2015-06-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90188
AG-OLANZAPINE FC;
02487608;
olanzapine 2.5 mg;
2020-01-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97775
ZYPREXA 20MG;
02238851;
olanzapine 20 mg;
2007-04-30;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62291
ZYPREXA ZYDIS;
02243089;
olanzapine 20 mg;
2007-01-02;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66956
SANDOZ OLANZAPINE ODT;
02327805;
olanzapine 20 mg;
2010-02-26;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81321
APO-OLANZAPINE;
02333015;
olanzapine 20 mg;
2009-10-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81866
OLANZAPINE ODT;
02343703;
olanzapine 20 mg;
2012-04-24;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82913
TEVA-OLANZAPINE;
02359707;
olanzapine 20 mg;
2011-04-28;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84470
APO-OLANZAPINE ODT;
02360640;
olanzapine 20 mg;
2011-08-08;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84561
JAMP OLANZAPINE ODT;
02406659;
olanzapine 20 mg;
2014-08-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89134
RAN-OLANZAPINE ODT;
02414120;
olanzapine 20 mg;
2013-10-17;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89879
JAMP OLANZAPINE FC;
02417308;
olanzapine 20 mg;
2015-06-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90193
OLANZAPINE;
02421704;
olanzapine 20 mg;
2014-06-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90636
OLANZAPINE ODT;
02425114;
olanzapine 20 mg;
2014-06-10;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90977
AURO-OLANZAPINE ODT;
02448750;
olanzapine 20 mg;
2015-12-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93447
ZYPREXA – 5MG;
02229269;
olanzapine 5 mg;
1996-11-14;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43531
ZYPREXA ZYDIS;
02243086;
olanzapine 5 mg;
2001-03-06;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66953
TEVA-OLANZAPINE;
02276720;
olanzapine 5 mg;
2007-06-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76240
APO-OLANZAPINE;
02281805;
olanzapine 5 mg;
2009-10-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76746
PMS-OLANZAPINE;
02303159;
olanzapine 5 mg;
2008-04-02;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78848
PMS-OLANZAPINE ODT;
02303191;
olanzapine 5 mg;
2009-10-15;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78852
OLANZAPINE;
02311976;
olanzapine 5 mg;
2010-02-01;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79750
SANDOZ OLANZAPINE ODT;
02327775;
olanzapine 5 mg;
2010-02-26;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81318
RIVA-OLANZAPINE;
02337134;
olanzapine 5 mg;
2010-02-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82274
OLANZAPINE ODT;
02338645;
olanzapine 5 mg;
2010-02-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82431
OLANZAPINE ODT;
02343665;
olanzapine 5 mg;
2012-04-24;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82910
APO-OLANZAPINE ODT;
02360616;
olanzapine 5 mg;
2011-11-16;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84558
OLANZAPINE;
02372827;
olanzapine 5 mg;
2011-10-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85791
OLANZAPINE;
02385872;
olanzapine 5 mg;
2012-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87148
JAMP OLANZAPINE ODT;
02406624;
olanzapine 5 mg;
2014-08-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89131
MINT-OLANZAPINE;
02410168;
olanzapine 5 mg;
2019-09-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89482
RAN-OLANZAPINE ODT;
02414090;
olanzapine 5 mg;
2013-10-17;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89876
JAMP OLANZAPINE FC;
02417251;
olanzapine 5 mg;
2015-06-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90189
MINT-OLANZAPINE ODT;
02436965;
olanzapine 5 mg;
2015-03-18;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92128
AURO-OLANZAPINE ODT;
02448726;
olanzapine 5 mg;
2015-12-01;
Oral;
Tablet (Orally Disintegrating);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93444
AG-OLANZAPINE FC;
02487616;
olanzapine 5 mg;
2020-01-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97776
SANDOZ OLANZAPINE;
02310368;
olanzapine 5.0 mg;
2009-12-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79600
ZYPREXA;
02229277;
olanzapine 7.5 mg;
1996-11-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43532
TEVA-OLANZAPINE;
02276739;
olanzapine 7.5 mg;
2007-06-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76241
APO-OLANZAPINE;
02281813;
olanzapine 7.5 mg;
2009-10-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76747
PMS-OLANZAPINE;
02303167;
olanzapine 7.5 mg;
2008-04-02;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78849
SANDOZ OLANZAPINE;
02310376;
olanzapine 7.5 mg;
2009-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79601
OLANZAPINE;
02311984;
olanzapine 7.5 mg;
2010-02-01;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79751
RIVA-OLANZAPINE;
02337142;
olanzapine 7.5 mg;
2010-02-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82275
OLANZAPINE;
02372835;
olanzapine 7.5 mg;
2011-10-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85792
OLANZAPINE;
02385880;
olanzapine 7.5 mg;
2012-06-12;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87149
MINT-OLANZAPINE;
02410176;
olanzapine 7.5 mg;
2019-09-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89483
JAMP OLANZAPINE FC;
02417278;
olanzapine 7.5 mg;
2015-06-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90190
LYNPARZA;
02475200;
olaparib 100 mg;
2018-05-23;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96554
LYNPARZA;
02475219;
olaparib 150 mg;
2018-05-23;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96555
OLMETEC;
02318660;
olmesartan medoxomil 20 mg;
2008-12-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80414
ACT OLMESARTAN;
02442191;
olmesartan medoxomil 20 mg;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92655
SANDOZ OLMESARTAN;
02443414;
olmesartan medoxomil 20 mg;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92810
AURO-OLMESARTAN;
02443864;
olmesartan medoxomil 20 mg;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92863
APO-OLMESARTAN;
02453452;
olmesartan medoxomil 20 mg;
2017-05-31;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94000
ACH-OLMESARTAN;
02456311;
olmesartan medoxomil 20 mg;
2020-05-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94319
PMS-OLMESARTAN;
02461307;
olmesartan medoxomil 20 mg;
2017-06-02;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94881
JAMP-OLMESARTAN;
02461641;
olmesartan medoxomil 20 mg;
2017-05-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94931
GLN-OLMESARTAN;
02469812;
olmesartan medoxomil 20 mg;
2019-03-05;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95870
OLMESARTAN;
02481057;
olmesartan medoxomil 20 mg;
2020-02-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97140
OLMESARTAN;
02488744;
olmesartan medoxomil 20 mg;
2019-07-09;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97883
NRA-OLMESARTAN;
02499258;
olmesartan medoxomil 20 mg;
2020-11-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98899
OLMETEC;
02318679;
olmesartan medoxomil 40 mg;
2008-12-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80415
ACT OLMESARTAN;
02442205;
olmesartan medoxomil 40 mg;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92656
SANDOZ OLMESARTAN;
02443422;
olmesartan medoxomil 40 mg;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92811
AURO-OLMESARTAN;
02443872;
olmesartan medoxomil 40 mg;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92864
APO-OLMESARTAN;
02453460;
olmesartan medoxomil 40 mg;
2017-05-30;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94001
ACH-OLMESARTAN;
02456338;
olmesartan medoxomil 40 mg;
2020-05-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94320
PMS-OLMESARTAN;
02461315;
olmesartan medoxomil 40 mg;
2017-06-02;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94882
JAMP-OLMESARTAN;
02461668;
olmesartan medoxomil 40 mg;
2017-05-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94932
GLN-OLMESARTAN;
02469820;
olmesartan medoxomil 40 mg;
2019-03-05;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95871
OLMESARTAN;
02481065;
olmesartan medoxomil 40 mg;
2020-02-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97141
OLMESARTAN;
02488752;
olmesartan medoxomil 40 mg;
2019-07-09;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97884
NRA-OLMESARTAN;
02499266;
olmesartan medoxomil 40 mg;
2020-11-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98900
APO-OLOPATADINE;
02305054;
olopatadine (olopatadine hydrochloride) 0.1 %;
2013-07-26;
Ophthalmic;
Solution;
04:00.00 – ANTIHISTAMINE DRUGS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79042
PATANOL;
02233143;
olopatadine (olopatadine hydrochloride) 0.1 % / w/v;
1998-02-09;
Ophthalmic;
Liquid;
04:00.00 – ANTIHISTAMINE DRUGS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=53275
SANDOZ OLOPATADINE;
02358913;
olopatadine (olopatadine hydrochloride) 0.1 % / w/v;
2013-02-04;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84395
ACT OLOPATADINE 0.1%;
02403986;
olopatadine (olopatadine hydrochloride) 0.1 % / w/v;
2013-12-06;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88874
MINT-OLOPATADINE;
02422727;
olopatadine (olopatadine hydrochloride) 0.1 % / w/v;
2014-07-29;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90739
JAMP-OLOPATADINE;
02458411;
olopatadine (olopatadine hydrochloride) 0.1 % / w/v;
2017-10-06;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94555
PATADAY;
02362171;
olopatadine (olopatadine hydrochloride) 0.2 % / w/v;
2011-04-14;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84721
SANDOZ OLOPATADINE 0.2%;
02420171;
olopatadine (olopatadine hydrochloride) 0.2 % / w/v;
2014-02-24;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90478
PAZEO;
02458551;
olopatadine (olopatadine hydrochloride) 0.7 % / w/v;
2018-03-12;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94571
DIPENTUM;
02063808;
olsalazine sodium 250 mg;
1995-12-31;
Oral;
Capsule;
56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ATNAHS PHARMA UK LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17893
XOLAIR;
02459795;
omalizumab 150 mg / ml;
2017-07-06;
Subcutaneous;
Solution;
48:92.00 – RESPIRATORY AGENTS, MISCELLANEOUS;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94712
XOLAIR;
02260565;
omalizumab 150 mg / vial;
2005-02-03;
Subcutaneous;
Powder For Solution;
48:92.00 – RESPIRATORY AGENTS, MISCELLANEOUS;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74602
XOLAIR;
02459787;
omalizumab 75 mg / 0.5 ml;
2017-06-28;
Subcutaneous;
Solution;
48:92.00 – RESPIRATORY AGENTS, MISCELLANEOUS;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94711
TEVA-OMEPRAZOLE;
02295407;
omeprazole (omeprazole magnesium) 10 mg;
2008-09-02;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78071
LOSEC;
02190915;
omeprazole (omeprazole magnesium) 20 mg;
1996-12-31;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19716
TEVA-OMEPRAZOLE;
02295415;
omeprazole (omeprazole magnesium) 20 mg;
2008-09-02;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78072
RIVA-OMEPRAZOLE DR;
02402416;
omeprazole (omeprazole magnesium) 20 mg;
2013-07-25;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88725
OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS;
02416549;
omeprazole (omeprazole magnesium) 20 mg;
2013-12-05;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90114
JAMP-OMEPRAZOLE DR;
02420198;
omeprazole (omeprazole magnesium) 20 mg;
2014-02-11;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90479
OMEPRAZOLE;
02439018;
omeprazole (omeprazole magnesium) 20 mg;
2015-11-16;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92337
NAT-OMEPRAZOLE DR;
02439549;
omeprazole (omeprazole magnesium) 20 mg;
2015-07-22;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92395
PRIVA-OMEPRAZOLE;
02449919;
omeprazole (omeprazole magnesium) 20 mg;
2016-09-07;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93578
BIO-OMEPRAZOLE;
02449927;
omeprazole (omeprazole magnesium) 20 mg;
2016-09-07;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93579
OMEPRAZOLE;
02490692;
omeprazole (omeprazole magnesium) 20 mg;
2020-03-12;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98075
NRA-OMEPRAZOLE;
02501880;
omeprazole (omeprazole magnesium) 20 mg;
2020-12-02;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99149
OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS;
02504294;
omeprazole (omeprazole magnesium) 20 mg;
2021-03-16;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99372
SANDOZ OMEPRAZOLE;
02296438;
omeprazole 10 mg;
2007-09-14;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78175
LOSEC;
00846503;
omeprazole 20 mg;
1989-12-31;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9823
APO-OMEPRAZOLE;
02245058;
omeprazole 20 mg;
2004-01-28;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69062
SANDOZ OMEPRAZOLE;
02296446;
omeprazole 20 mg;
2007-09-14;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78176
PMS-OMEPRAZOLE;
02320851;
omeprazole 20 mg;
2009-03-13;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80626
OMEPRAZOLE;
02339927;
omeprazole 20 mg;
2010-02-05;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82550
OMEPRAZOLE;
02348691;
omeprazole 20 mg;
2010-06-16;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83404
OMEPRAZOLE-20;
02411857;
omeprazole 20 mg;
2013-10-23;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89644
HEARTBURN CONTROL;
02435683;
omeprazole 20 mg;
2015-03-12;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92002
BOTOX;
01981501;
onabotulinumtoxina 100 unit / vial;
1992-12-31;
Intramuscular;
Powder For Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription , Schedule D;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13476
BOTOX COSMETIC;
02243721;
onabotulinumtoxina 100 unit / vial;
2001-05-07;
Intramuscular;
Powder For Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription , Schedule D;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67653
ZOLGENSMA;
02509695;
onasemnogene abeparvovec 20000000000000 vg / ml;
2021-02-04;
Intravenous;
Solution;
26:00.00 – CELLULAR AND GENE THERAPY;
Prescription Recommended , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99897
ZOFRAN;
02213745;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
1999-08-01;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43137
ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION;
02274418;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2012-06-28;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75986
ONDANSETRON INJECTION USP -(PRESERVATIVE FREE);
02279428;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2006-04-19;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76501
ONDANSETRON INJECTION USP -(WITH PRESERVATIVE);
02279436;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2006-04-19;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76502
ONDANSETRON INJECTION, USP;
02390019;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2013-05-09;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87549
ONDANSETRON INJECTION, USP;
02390051;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2013-05-09;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87552
JAMP-ONDANSETRON;
02420414;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2014-03-14;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90500
JAMP-ONDANSETRON;
02420422;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2014-03-14;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90501
ONDANSETRON INJECTION USP;
02464578;
ondansetron (ondansetron hydrochloride dihydrate) 2 mg / ml;
2018-05-22;
Intravenous;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95270
ZOFRAN;
02213567;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
1998-03-30;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43116
PMS-ONDANSETRON;
02258188;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2006-04-19;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74341
SANDOZ ONDANSETRON;
02274310;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2006-04-19;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75976
APO-ONDANSETRON;
02288184;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2006-11-16;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77362
ACT ONDANSETRON;
02296349;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2009-06-29;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78168
MYLAN-ONDANSETRON;
02297868;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2007-07-20;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78319
NAT-ONDANSETRON;
02417839;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2015-03-18;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90245
ONDANSETRON;
02421402;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2014-03-18;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90603
CCP-ONDANSETRON;
02458810;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2017-07-24;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94596
ACCEL-ONDANSETRON;
02478927;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg;
2019-09-19;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
ACCEL PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96963
ZOFRAN;
02229639;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg / 5 ml;
1996-11-13;
Oral;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47565
APO-ONDANSETRON;
02291967;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg / 5 ml;
2008-03-04;
Oral;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77733
JAMP ONDANSETRON;
02490617;
ondansetron (ondansetron hydrochloride dihydrate) 4 mg / 5 ml;
2020-04-22;
Oral;
Solution;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98068
ZOFRAN;
02213575;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
1997-04-14;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43117
PMS-ONDANSETRON;
02258196;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2006-04-19;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74342
SANDOZ ONDANSETRON;
02274329;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2006-04-19;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75977
APO-ONDANSETRON;
02288192;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2006-11-16;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77363
ACT ONDANSETRON;
02296357;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2009-06-29;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78169
MYLAN-ONDANSETRON;
02297876;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2007-07-20;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78320
ONDANSETRON;
02325160;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2009-06-25;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81057
NAT-ONDANSETRON;
02417847;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2015-03-18;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90246
ONDANSETRON;
02421410;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2014-03-18;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90604
CCP-ONDANSETRON;
02458802;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2017-07-24;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94595
ACCEL-ONDANSETRON;
02478935;
ondansetron (ondansetron hydrochloride dihydrate) 8 mg;
2019-09-19;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
ACCEL PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96964
MINT-ONDANSETRON;
02305259;
ondansetron (ondansetron hydrochloride) 4 mg;
2008-04-23;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79079
JAMP-ONDANSETRON;
02313685;
ondansetron (ondansetron hydrochloride) 4 mg;
2008-09-26;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79919
MAR-ONDANSETRON;
02371731;
ondansetron (ondansetron hydrochloride) 4 mg;
2012-12-21;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85687
MINT-ONDANSETRON;
02305267;
ondansetron (ondansetron hydrochloride) 8 mg;
2008-04-23;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79080
JAMP-ONDANSETRON;
02313693;
ondansetron (ondansetron hydrochloride) 8 mg;
2008-09-26;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79920
MAR-ONDANSETRON;
02371758;
ondansetron (ondansetron hydrochloride) 8 mg;
2012-12-21;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85688
ZOFRAN ODT;
02239372;
ondansetron 4 mg;
1999-03-31;
Oral;
Tablet (Orally Disintegrating);
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62841
ONDISSOLVE ODF;
02389983;
ondansetron 4 mg;
2013-02-08;
Oral;
Film, Soluble;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87545
VPI-ONDANSETRON ODT;
02444674;
ondansetron 4 mg;
2015-11-23;
Oral;
Tablet (Orally Disintegrating);
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
VPI PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92979
ONDANSETRON ODT;
02481723;
ondansetron 4 mg;
2019-05-15;
Oral;
Tablet (Orally Disintegrating);
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97221
MINT-ONDANSETRON ODT;
02487330;
ondansetron 4 mg;
2019-10-16;
Oral;
Tablet (Orally Disintegrating);
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97750
ZOFRAN ODT;
02239373;
ondansetron 8 mg;
1999-03-31;
Oral;
Tablet (Orally Disintegrating);
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62842
ONDISSOLVE ODF;
02389991;
ondansetron 8 mg;
2013-02-08;
Oral;
Film, Soluble;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87546
VPI-ONDANSETRON ODT;
02444682;
ondansetron 8 mg;
2015-11-23;
Oral;
Tablet (Orally Disintegrating);
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
VPI PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92980
ONDANSETRON ODT;
02481731;
ondansetron 8 mg;
2019-05-15;
Oral;
Tablet (Orally Disintegrating);
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97222
MINT-ONDANSETRON ODT;
02487349;
ondansetron 8 mg;
2019-10-16;
Oral;
Tablet (Orally Disintegrating);
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97751
XENICAL;
02240325;
orlistat 120 mg;
1999-06-03;
Oral;
Capsule;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63865
ORFENACE TABLET 100MG;
02047535;
orphenadrine citrate 100 mg;
1994-12-31;
Oral;
Tablet;
12:20.92 – MISCELLANEOUS SKELETAL MUSCLE RELAXANTS;
Otc;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16522
SANDOZ ORPHENADRINE;
02243559;
orphenadrine citrate 100 mg;
2001-02-27;
Oral;
Tablet (Extended-Release);
12:20.92 – MISCELLANEOUS SKELETAL MUSCLE RELAXANTS;
Otc;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67477
TAMIFLU;
02304848;
oseltamivir (oseltamivir phosphate) 30 mg;
2008-12-01;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79011
NAT-OSELTAMIVIR;
02472635;
oseltamivir (oseltamivir phosphate) 30 mg;
2018-02-06;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96194
MAR-OSELTAMIVIR;
02497352;
oseltamivir (oseltamivir phosphate) 30 mg;
2020-09-17;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98718
JAMP OSELTAMIVIR;
02497409;
oseltamivir (oseltamivir phosphate) 30 mg;
2020-09-24;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98723
MINT-OSELTAMIVIR;
02497441;
oseltamivir (oseltamivir phosphate) 30 mg;
2020-06-12;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98727
OSELTAMIVIR PHOSPHATE CAPSULES;
02504006;
oseltamivir (oseltamivir phosphate) 30 mg;
2020-10-02;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
STRIDES PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99346
TAMIFLU;
02304856;
oseltamivir (oseltamivir phosphate) 45 mg;
2008-12-08;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79012
NAT-OSELTAMIVIR;
02472643;
oseltamivir (oseltamivir phosphate) 45 mg;
2018-02-06;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96195
MAR-OSELTAMIVIR;
02497360;
oseltamivir (oseltamivir phosphate) 45 mg;
2020-09-17;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98719
OSELTAMIVIR PHOSPHATE CAPSULES;
02504014;
oseltamivir (oseltamivir phosphate) 45 mg;
2020-10-02;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
STRIDES PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99347
TAMIFLU;
02381842;
oseltamivir (oseltamivir phosphate) 6 mg / ml;
2012-09-10;
Oral;
Powder For Suspension;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86768
NAT-OSELTAMIVIR;
02499894;
oseltamivir (oseltamivir phosphate) 6 mg / ml;
2020-09-29;
Oral;
Powder For Suspension;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98960
TAMIFLU CAPSULE 75MG;
02241472;
oseltamivir (oseltamivir phosphate) 75 mg;
1999-12-23;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65111
NAT-OSELTAMIVIR;
02457989;
oseltamivir (oseltamivir phosphate) 75 mg;
2016-09-29;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94501
MAR-OSELTAMIVIR;
02497379;
oseltamivir (oseltamivir phosphate) 75 mg;
2020-09-17;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98720
JAMP OSELTAMIVIR;
02497425;
oseltamivir (oseltamivir phosphate) 75 mg;
2020-09-24;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98725
MINT-OSELTAMIVIR;
02497476;
oseltamivir (oseltamivir phosphate) 75 mg;
2020-05-29;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98729
OSELTAMIVIR PHOSPHATE CAPSULES;
02504022;
oseltamivir (oseltamivir phosphate) 75 mg;
2020-10-02;
Oral;
Capsule;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
STRIDES PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99348
TAGRISSO;
02456214;
osimertinib (osimertinib mesylate) 40 mg;
2016-07-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94310
TAGRISSO;
02456222;
osimertinib (osimertinib mesylate) 80 mg;
2016-07-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94311
OXALIPLATIN INJECTION;
02435071;
oxaliplatin 5 mg / ml;
2015-12-16;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91937
OXALIPLATIN INJECTION;
02436957;
oxaliplatin 5 mg / ml;
2015-12-17;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92127
OXALIPLATIN;
02444763;
oxaliplatin 5 mg / ml;
2015-12-17;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92996
TARO-OXALIPLATIN;
02449692;
oxaliplatin 5 mg / ml;
2017-02-15;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93552
APO OXAZEPAM TAB 10MG;
00402680;
oxazepam 10 mg;
1979-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3463
OXAZEPAM 10 TAB 10MG;
00497754;
oxazepam 10 mg;
1980-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3806
RIVA OXAZEPAM;
00568392;
oxazepam 10 mg;
1983-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5563
APO OXAZEPAM TAB 15MG;
00402745;
oxazepam 15 mg;
1979-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3465
OXAZEPAM 15 TAB 15MG;
00497762;
oxazepam 15 mg;
1980-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3807
RIVA OXAZEPAM;
00568406;
oxazepam 15 mg;
1983-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5213
APO OXAZEPAM TAB 30MG;
00402737;
oxazepam 30 mg;
1979-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3464
OXAZEPAM 30 TAB 30MG;
00497770;
oxazepam 30 mg;
1980-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3808
RIVA OXAZEPAM;
00568414;
oxazepam 30 mg;
1983-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5214
APO-OXCARBAZEPINE;
02284294;
oxcarbazepine 150 mg;
2006-08-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76987
JAMP-OXCARBAZEPINE;
02440717;
oxcarbazepine 150 mg;
2015-06-08;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92508
TRILEPTAL 300 MG;
02242068;
oxcarbazepine 300 mg;
2002-04-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65741
APO-OXCARBAZEPINE;
02284308;
oxcarbazepine 300 mg;
2006-08-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76988
JAMP-OXCARBAZEPINE;
02440725;
oxcarbazepine 300 mg;
2015-06-08;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92509
TRILEPTAL ORAL SUSPENSION;
02244673;
oxcarbazepine 60 mg / ml;
2002-09-05;
Oral;
Suspension;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68661
TRILEPTAL 600 MG;
02242069;
oxcarbazepine 600 mg;
2002-04-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65742
APO-OXCARBAZEPINE;
02284316;
oxcarbazepine 600 mg;
2006-08-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76989
JAMP-OXCARBAZEPINE;
02440733;
oxcarbazepine 600 mg;
2015-06-08;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92510
OXYTROL;
02254735;
oxybutynin 3.9 mg / 24 hour;
2004-08-12;
Transdermal;
Patch;
86:12.04 – Antimuscarinics;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73990
DITROPAN XL;
02243961;
oxybutynin chloride 10 mg;
2001-06-22;
Oral;
Tablet (Extended-Release);
86:12.04 – Antimuscarinics;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67904
PMS-OXYBUTYNIN;
02240549;
oxybutynin chloride 2.5 mg;
1999-11-22;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64119
APO-OXYBUTYNIN – TAB 5MG;
02163543;
oxybutynin chloride 5 mg;
1995-12-31;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18355
TEVA-OXYBUTYNIN;
02230394;
oxybutynin chloride 5 mg;
1997-02-28;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49219
PMS-OXYBUTYNIN;
02240550;
oxybutynin chloride 5 mg;
1999-11-22;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64120
DITROPAN XL;
02243960;
oxybutynin chloride 5 mg;
2001-06-22;
Oral;
Tablet (Extended-Release);
86:12.04 – Antimuscarinics;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67903
RIVA-OXYBUTYNIN;
02299364;
oxybutynin chloride 5 mg;
2008-06-09;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78474
OXYBUTYNIN;
02350238;
oxybutynin chloride 5 mg;
2010-05-12;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83545
PMS-OXYBUTYNIN;
02223376;
oxybutynin chloride 5 mg / 5 ml;
1996-09-04;
Oral;
Syrup;
86:12.04 – Antimuscarinics;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43358
SUPEUDOL 10;
00392480;
oxycodone hydrochloride 10 mg;
1973-12-31;
Rectal;
Suppository;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3551
SUPEUDOL 10;
00443948;
oxycodone hydrochloride 10 mg;
1980-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3996
OXY.IR;
02240131;
oxycodone hydrochloride 10 mg;
2000-03-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63645
PMS-OXYCODONE CR;
02309882;
oxycodone hydrochloride 10 mg;
2012-11-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79557
PMS-OXYCODONE;
02319985;
oxycodone hydrochloride 10 mg;
2008-12-03;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80543
APO-OXYCODONE CR;
02366754;
oxycodone hydrochloride 10 mg;
2012-11-26;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85158
OXYNEO;
02372525;
oxycodone hydrochloride 10 mg;
2011-09-13;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85760
OXYNEO;
02372533;
oxycodone hydrochloride 15 mg;
2011-09-13;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85765
APO-OXYCODONE CR;
02394766;
oxycodone hydrochloride 15 mg;
2012-11-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87990
SUPEUDOL 20;
00392472;
oxycodone hydrochloride 20 mg;
1973-12-31;
Rectal;
Suppository;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3550
OXY.IR;
02240132;
oxycodone hydrochloride 20 mg;
2000-03-31;
Oral;
Tablet (Immediate Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63646
SUPEUDOL;
02262983;
oxycodone hydrochloride 20 mg;
2005-04-26;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74839
PMS-OXYCODONE CR;
02309890;
oxycodone hydrochloride 20 mg;
2012-11-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79558
PMS-OXYCODONE;
02319993;
oxycodone hydrochloride 20 mg;
2008-12-03;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80544
OXYNEO;
02372797;
oxycodone hydrochloride 20 mg;
2011-09-13;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85788
APO-OXYCODONE CR;
02366762;
oxycodone hydrochloride 20.0 mg;
2012-11-26;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85159
OXYNEO;
02372541;
oxycodone hydrochloride 30 mg;
2011-09-13;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85766
APO-OXYCODONE CR;
02394774;
oxycodone hydrochloride 30 mg;
2012-11-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87991
APO-OXYCODONE CR;
02306530;
oxycodone hydrochloride 40 mg;
2012-11-26;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79224
PMS-OXYCODONE CR;
02309904;
oxycodone hydrochloride 40 mg;
2012-11-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79559
OXYNEO;
02372568;
oxycodone hydrochloride 40 mg;
2011-09-13;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85767
SUPEUDOL 5;
00789739;
oxycodone hydrochloride 5 mg;
1990-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10433
OXY.IR;
02231934;
oxycodone hydrochloride 5 mg;
2000-03-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51386
PMS-OXYCODONE;
02319977;
oxycodone hydrochloride 5 mg;
2008-12-03;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80542
APO-OXYCODONE CR;
02366746;
oxycodone hydrochloride 5.0 mg;
2012-11-26;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85157
OXYNEO;
02372576;
oxycodone hydrochloride 60 mg;
2011-09-13;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85768
APO-OXYCODONE CR;
02394782;
oxycodone hydrochloride 60 mg;
2012-11-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87993
PMS-OXYCODONE CR;
02309912;
oxycodone hydrochloride 80 mg;
2012-11-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79560
OXYNEO;
02372584;
oxycodone hydrochloride 80 mg;
2011-09-13;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85769
APO-OXYCODONE CR;
02366789;
oxycodone hydrochloride 80.0 mg;
2012-11-26;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85161
OXYGEN 100%;
00572810;
oxygen 100 %;
1911-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
AIR LIQUIDE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5682
OXYGENE – GAS INH;
02170175;
oxygen 100 %;
1995-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PREVIMED INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18663
OXYGEN USP – GAS 100%;
02219719;
oxygen 100 %;
1996-07-30;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
LAKERIDGE HEALTH CORPORATION COMMUNITY RESPIRATORY SERVICES
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20349
OXYGEN 99%;
02014408;
oxygen 99 %;
1993-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13886
OXYGEN USP;
02154838;
oxygen 99 %;
1995-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
MESSER CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19299
OXYGEN USP;
02237847;
oxygen 99 %;
1998-05-13;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
INH-ALLAIRE INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61206
OXYGEN (COMPRESSED);
02238428;
oxygen 99 %;
1999-03-01;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
ST. THOMAS ELGIN GENERAL HOSPITAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61847
OXYGEN;
02238755;
oxygen 99 %;
1999-07-01;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
VITALAIRE CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62190
OXYGEN USP;
02240621;
oxygen 99 %;
2005-08-01;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
HURONIA/MED-E-OX LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64194
OXYGEN USP;
02242542;
oxygen 99 %;
2000-07-13;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
ONTARIO HOME OXYGEN AND RESPIRATORY SERVICE INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66284
OXYGEN USP;
02243073;
oxygen 99 %;
2000-12-19;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
RIMER ALCO NORTH AMERICA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66939
OXYGEN USP;
02247852;
oxygen 99 %;
2003-07-03;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
OXYMED, DIV. DE 118303 CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72159
OXYGEN;
02248123;
oxygen 99 %;
2003-11-01;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
RESPIRATORY HOMECARE SOLUTIONS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72450
OXYGEN 99.0%;
00591629;
oxygen 99.0 %;
1986-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
AIR PRODUCTS CANADA LTD/LTÉE.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6826
OXYGEN, COMPRESSED;
02242508;
oxygen 99.2 %;
2000-11-01;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
RESPIRATORY HOMECARE SOLUTIONS (VANCOUVER ISLAND), 0930469 B.C. LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66253
OXYGEN USP;
02052881;
oxygen 99.5 %;
1993-10-21;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
GASPRO, DIVISION OF PRORESP INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27306
OXYGEN;
02474298;
oxygen 99.5 %;
2018-03-26;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
ONTARIO MEDICAL OXYGEN SERVICES INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96434
OXYGEN U.S.P.;
02230956;
oxygen 99.99 %;
1997-03-11;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
MAGGAS MEDICAL INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50235
CLARITIN ALLERGY DECONGESTANT;
02243690;
oxymetazoline hydrochloride 0.05 %;
2001-05-02;
Nasal;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67620
DRIXORAL NASAL CONGESTION;
02380129;
oxymetazoline hydrochloride 0.05 %;
2012-08-15;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86596
EXTRA MOISTURIZING NASAL SPRAY;
02428660;
oxymetazoline hydrochloride 0.05 %;
2015-07-08;
Nasal;
Spray, Metered Dose;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91311
NASAL CONGESTION SPRAY;
02428679;
oxymetazoline hydrochloride 0.05 %;
2015-07-08;
Nasal;
Spray, Metered Dose;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91312
DRIXORAL DECONGESTANT NASAL SPRAY;
00740861;
oxymetazoline hydrochloride 0.05 % / w/v;
1986-12-31;
Nasal;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41903
LONG LASTING DRISTAN NASAL MIST;
01929372;
oxymetazoline hydrochloride 0.05 % / w/v;
1992-12-31;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
FOUNDATION CONSUMER BRANDS, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41954
LONG LASTING DRISTAN MENTHOLATED NASAL SPRAY;
01929380;
oxymetazoline hydrochloride 0.05 % / w/v;
1992-12-31;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
FOUNDATION CONSUMER BRANDS, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41970
DRIXORAL NO DRIP EXTRA MOISTURIZING;
02245575;
oxymetazoline hydrochloride 0.05 % / w/v;
2002-09-28;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69670
DRIXORAL NO DRIP ORIGINAL UNSCENTED;
02245578;
oxymetazoline hydrochloride 0.05 % / w/v;
2002-09-28;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69673
DRIXORAL NO DRIP COOLING MENTHOL;
02245580;
oxymetazoline hydrochloride 0.05 % / w/v;
2002-09-28;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69676
SINUFRIN;
02439484;
oxymetazoline hydrochloride 0.05 % / w/v;
2015-05-10;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
NEILMED PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92387
SINUFRIN PLUS;
02439492;
oxymetazoline hydrochloride 0.05 % / w/v;
2015-05-10;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
NEILMED PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92388
LONG LASTING DECONGESTANT NASAL SPRAY;
02454351;
oxymetazoline hydrochloride 0.05 % / w/v;
2017-05-28;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
CRLS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94094
EXTRA MOISTURIZING NASAL SPRAY;
02460572;
oxymetazoline hydrochloride 0.05 % / w/v;
2018-06-27;
Nasal;
Spray, Metered Dose;
52:32.00 – VASOCONSTRICTORS;
Otc;
JUNO OTC INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94800
NASAL CONGESTION SPRAY;
02460599;
oxymetazoline hydrochloride 0.05 % / w/v;
2018-06-28;
Nasal;
Spray, Metered Dose;
52:32.00 – VASOCONSTRICTORS;
Otc;
JUNO OTC INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94802
DRIXORAL NO DRIP NASAL CONGESTION;
02498294;
oxymetazoline hydrochloride 0.05 % / w/v;
2021-03-08;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98807
DRIXORAL NO DRIP NASAL CONGESTION WITH MENTHOL;
02498308;
oxymetazoline hydrochloride 0.05 % / w/v;
2021-03-08;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98808
OXYTOCIN INJECTION USP;
00497398;
oxytocin 10 unit / ml;
1981-12-31;
Intramuscular , Intravenous;
Solution;
76:00.00 – OXYTOCICS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4293
OXYTOCIN INJECTION, USP;
02139561;
oxytocin 10 unit / ml;
1996-08-14;
Intramuscular , Intravenous;
Solution;
76:00.00 – OXYTOCICS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31361
ZEPOSIA;
02505991;
ozanimod (ozanimod hydrochloride) 0.92 mg;
2020-11-12;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
CELGENE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99535
OZANEX;
02463504;
ozenoxacin 1 % / w/w;
2018-01-04;
Topical;
Cream;
84:04.04 – ANTIBIOTICS;
Prescription;
FERRER INTERNACIONAL, S.A.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95159
ABRAXANE FOR INJECTABLE SUSPENSION;
02281066;
paclitaxel 100 mg / vial;
2006-08-31;
Intravenous;
Powder For Suspension;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76673
PACLITAXEL FOR INJECTION;
02244372;
paclitaxel 6 mg / ml;
2001-10-31;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BIOLYSE PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68340
PACLITAXEL INJECTION USP;
02320150;
paclitaxel 6 mg / ml;
2015-03-31;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80560
PACLITAXEL INJECTION USP;
02391465;
paclitaxel 6 mg / ml;
2014-07-02;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87681
IBRANCE;
02453169;
palbociclib 100 mg;
2016-04-19;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93970
IBRANCE;
02493543;
palbociclib 100 mg;
2020-09-21;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98355
IBRANCE;
02453177;
palbociclib 125 mg;
2016-04-19;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93971
IBRANCE;
02493551;
palbociclib 125 mg;
2020-09-21;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98356
IBRANCE;
02453150;
palbociclib 75 mg;
2016-04-20;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93969
IBRANCE;
02493535;
palbociclib 75 mg;
2020-09-21;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98354
INVEGA SUSTENNA;
02354233;
paliperidone (paliperidone palmitate) 100 mg / 1 ml;
2010-07-21;
Intramuscular;
Suspension (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83943
INVEGA SUSTENNA;
02354241;
paliperidone (paliperidone palmitate) 150 mg / 1.5 ml;
2010-07-21;
Intramuscular;
Suspension (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83944
INVEGA TRINZA;
02455943;
paliperidone (paliperidone palmitate) 175 mg / 0.875 ml;
2016-07-25;
Intramuscular;
Suspension (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94281
INVEGA TRINZA;
02455986;
paliperidone (paliperidone palmitate) 263 mg / 1.315 ml;
2016-07-25;
Intramuscular;
Suspension (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94284
INVEGA TRINZA;
02455994;
paliperidone (paliperidone palmitate) 350 mg / 1.75 ml;
2016-07-25;
Intramuscular;
Suspension (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94285
INVEGA SUSTENNA;
02354217;
paliperidone (paliperidone palmitate) 50 mg / 0.5 ml;
2010-07-21;
Intramuscular;
Suspension (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83941
INVEGA TRINZA;
02456001;
paliperidone (paliperidone palmitate) 525 mg / 2.625 ml;
2016-07-25;
Intramuscular;
Suspension (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94286
INVEGA SUSTENNA;
02354225;
paliperidone (paliperidone palmitate) 75 mg / 0.75 ml;
2010-07-21;
Intramuscular;
Suspension (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83942
INVEGA;
02300273;
paliperidone 3 mg;
2007-10-02;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78559
INVEGA;
02300281;
paliperidone 6 mg;
2007-10-02;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78560
INVEGA;
02300303;
paliperidone 9 mg;
2007-10-02;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78561
SYNAGIS;
02438364;
palivizumab 100 mg / ml;
2016-11-03;
Intramuscular;
Solution;
08:18.24 – MONOCLONAL ANTIBODIES;
Prescription , Schedule D;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92274
SYNAGIS;
02438372;
palivizumab 50 mg / 0.5 ml;
2016-11-03;
Intramuscular;
Solution;
08:18.24 – MONOCLONAL ANTIBODIES;
Prescription , Schedule D;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92275
ALOXI;
02381710;
palonosetron (palonosetron hydrochloride) 0.25 mg / 5 ml;
2012-07-19;
Intravenous;
Solution;
56:22.00 – ANTIEMETICS;
Prescription;
ELVIUM LIFE SCIENCES
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86757
ALOXI;
02381729;
palonosetron (palonosetron hydrochloride) 0.5 mg;
2012-08-07;
Oral;
Capsule;
56:22.00 – ANTIEMETICS;
Prescription;
ELVIUM LIFE SCIENCES
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86758
DIUREX WATER CAPLETS;
02242893;
pamabrom 50 mg;
2001-03-12;
Oral;
Tablet;
40:28.00 – DIURETICS;
Otc;
ALVA-AMCO PHARMACAL COMPANIES, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66725
PAMIDRONATE DISODIUM FOR INJECTION;
02244550;
pamidronate disodium 3 mg / ml;
2001-08-31;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68533
PAMIDRONATE DISODIUM FOR INJECTION;
02246597;
pamidronate disodium 3 mg / ml;
2004-03-01;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70784
PAMIDRONATE DISODIUM FOR INJECTION;
02244551;
pamidronate disodium 6 mg / ml;
2001-08-31;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68534
PAMIDRONATE DISODIUM FOR INJECTION;
02246598;
pamidronate disodium 6 mg / ml;
2004-03-02;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70785
PAMIDRONATE DISODIUM OMEGA 6 MG/ML;
02249677;
pamidronate disodium 6.0 mg / ml;
2006-05-24;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73448
PAMIDRONATE DISODIUM FOR INJECTION;
02244552;
pamidronate disodium 9 mg / ml;
2001-08-31;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68535
PAMIDRONATE DISODIUM FOR INJECTION;
02246599;
pamidronate disodium 9 mg / ml;
2004-03-01;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70786
PAMIDRONATE DISODIUM OMEGA 9 MG/ML;
02249685;
pamidronate disodium 9.0 mg / ml;
2005-07-27;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73449
VECTIBIX;
02308487;
panitumumab 100 mg / 5 ml;
2008-05-27;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79412
VECTIBIX;
02308509;
panitumumab 400 mg / 20 ml;
2017-01-03;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79414
MYLAN-PANTOPRAZOLE T;
02408570;
pantoprazole (pantoprazole magnesium hemipentahydrate) 40 mg;
2015-08-31;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89331
PANTOPRAZOLE T;
02466147;
pantoprazole (pantoprazole magnesium hemipentahydrate) 40 mg;
2017-10-25;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95445
TECTA;
02267233;
pantoprazole (pantoprazole magnesium) 40 mg;
2006-03-15;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75263
TEVA-PANTOPRAZOLE MAGNESIUM;
02440628;
pantoprazole (pantoprazole magnesium) 40 mg;
2015-11-16;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92500
PANTOPRAZOLE MAGNESIUM;
02441853;
pantoprazole (pantoprazole magnesium) 40 mg;
2015-11-25;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ALTIUS HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92624
TEVA-PANTOPRAZOLE;
02285479;
pantoprazole (pantoprazole sodium sesquihydrate) 20 mg;
2008-04-11;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77096
SANDOZ PANTOPRAZOLE;
02301075;
pantoprazole (pantoprazole sodium sesquihydrate) 20 mg;
2008-06-03;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78642
JAMP-PANTOPRAZOLE;
02408414;
pantoprazole (pantoprazole sodium sesquihydrate) 20 mg;
2014-02-11;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89317
PANTOPRAZOLE-20;
02428172;
pantoprazole (pantoprazole sodium sesquihydrate) 20 mg;
2014-07-21;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91265
TEVA-PANTOPRAZOLE;
02285487;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2008-04-11;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77097
SANDOZ PANTOPRAZOLE;
02301083;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2008-06-03;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78643
RIVA-PANTOPRAZOLE;
02316463;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2008-10-27;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80197
JAMP-PANTOPRAZOLE;
02357054;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2014-12-12;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84215
PANTOPRAZOLE;
02370808;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2011-09-13;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85592
JAMP PANTOPRAZOLE SODIUM;
02392623;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2021-03-18;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87788
AURO-PANTOPRAZOLE;
02415208;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2016-02-06;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89982
MAR-PANTOPRAZOLE;
02416565;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2014-07-18;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90116
MINT-PANTOPRAZOLE;
02417448;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2014-01-16;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90206
PRIVA-PANTOPRAZOLE;
02425378;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2015-01-13;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91002
PANTOPRAZOLE-40;
02428180;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2014-07-21;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91266
PANTOPRAZOLE;
02431327;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2014-10-16;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91574
PANTOPRAZOLE;
02437945;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2015-05-20;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92231
BIO-PANTOPRAZOLE;
02445867;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2016-11-24;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93114
M-PANTOPRAZOLE;
02467372;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2017-11-01;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95575
PANTOPRAZOLE;
02469138;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2019-03-08;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95779
NRA-PANTOPRAZOLE;
02471825;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2018-10-06;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96103
AG-PANTOPRAZOLE;
02478781;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2018-07-17;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96927
AG-PANTOPRAZOLE SODIUM;
02481588;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg;
2018-12-27;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97204
PANTOPRAZOLE FOR INJECTION;
02458969;
pantoprazole (pantoprazole sodium sesquihydrate) 40 mg / vial;
2017-10-20;
Intravenous;
Powder For Solution;
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94611
PANTOLOC;
02241804;
pantoprazole (pantoprazole sodium) 20 mg;
2000-05-02;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65469
APO-PANTOPRAZOLE;
02292912;
pantoprazole (pantoprazole sodium) 20 mg;
2008-03-05;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77826
PANTOLOC;
02229453;
pantoprazole (pantoprazole sodium) 40 mg;
1997-03-05;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47339
APO-PANTOPRAZOLE;
02292920;
pantoprazole (pantoprazole sodium) 40 mg;
2008-03-05;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77827
RAN-PANTOPRAZOLE;
02305046;
pantoprazole (pantoprazole sodium) 40 mg;
2008-02-12;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79041
PMS-PANTOPRAZOLE;
02307871;
pantoprazole (pantoprazole sodium) 40 mg;
2008-06-04;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79355
PANTOPRAZOLE;
02318695;
pantoprazole (pantoprazole sodium) 40 mg;
2009-01-29;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80417
PANTOPRAZOLE SODIUM FOR INJECTION;
02306727;
pantoprazole (pantoprazole sodium) 40 mg / vial;
2008-03-11;
Intravenous;
Powder For Solution;
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79242
PANTOPRAZOLE FOR INJECTION;
02352214;
pantoprazole (pantoprazole sodium) 40 mg / vial;
2010-12-14;
Intravenous;
Powder For Solution;
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83745
PANTOPRAZOLE SODIUM FOR INJECTION;
02441527;
pantoprazole (pantoprazole sodium) 40 mg / vial;
2017-11-20;
Intravenous;
Powder For Solution;
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
GENERIC MEDICAL PARTNERS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92591
PAPAVERINE HYDROCHLORIDE INJECTION USP;
00009881;
papaverine hydrochloride 65 mg / 2 ml;
1951-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=160
HUMATIN CAP 250MG;
02078759;
paromomycin (paromomycin sulfate) 250 mg;
1994-12-31;
Oral;
Capsule;
08:30.04 – AMEBICIDES;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16701
TEVA-PAROXETINE;
02248556;
paroxetine (paroxetine hydrochloride acetone solvate) 10 mg;
2004-01-16;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72911
PAROXETINE;
02388227;
paroxetine (paroxetine hydrochloride acetone solvate) 10 mg;
2012-06-26;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87377
TEVA-PAROXETINE;
02248557;
paroxetine (paroxetine hydrochloride acetone solvate) 20 mg;
2004-01-16;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72912
PAROXETINE;
02388235;
paroxetine (paroxetine hydrochloride acetone solvate) 20 mg;
2012-06-26;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87378
TEVA-PAROXETINE;
02248558;
paroxetine (paroxetine hydrochloride acetone solvate) 30 mg;
2004-01-16;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72913
PAROXETINE;
02388243;
paroxetine (paroxetine hydrochloride acetone solvate) 30 mg;
2012-06-26;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87379
RIVA-PAROXETINE;
02248559;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2004-02-16;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72914
AURO-PAROXETINE;
02383276;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2012-07-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86903
MAR-PAROXETINE;
02411946;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2014-06-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89654
MINT-PAROXETINE;
02421372;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2014-03-17;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90600
PRIVA-PAROXETINE;
02444313;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2016-12-21;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92928
BIO-PAROXETINE;
02444909;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2016-12-21;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93013
M-PAROXETINE;
02467402;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2018-03-07;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95578
AG-PAROXETINE;
02475537;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2018-07-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96560
PAROXETINE;
02477823;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2019-03-05;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96844
NRA-PAROXETINE;
02479753;
paroxetine (paroxetine hydrochloride hemihydrate) 10 mg;
2018-12-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97010
RIVA-PAROXETINE;
02248560;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2004-02-16;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72915
AURO-PAROXETINE;
02383284;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2012-07-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86904
MAR-PAROXETINE;
02411954;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2014-06-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89652
MINT-PAROXETINE;
02421380;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2014-03-17;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90601
PRIVA-PAROXETINE;
02444321;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2016-12-21;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92929
BIO-PAROXETINE;
02444917;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2016-12-21;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93014
M-PAROXETINE;
02467410;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2018-03-07;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95579
AG-PAROXETINE;
02475545;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2018-07-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96561
PAROXETINE;
02477831;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2019-03-05;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96845
NRA-PAROXETINE;
02479761;
paroxetine (paroxetine hydrochloride hemihydrate) 20 mg;
2018-12-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97011
RIVA-PAROXETINE;
02248561;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2004-02-16;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72916
AURO-PAROXETINE;
02383292;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2012-07-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86905
MAR-PAROXETINE;
02411962;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2014-06-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89655
MINT-PAROXETINE;
02421399;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2014-03-17;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90602
PRIVA-PAROXETINE;
02444348;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2016-12-21;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92930
BIO-PAROXETINE;
02444925;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2016-12-21;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93015
M-PAROXETINE;
02467429;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2018-07-30;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95580
AG-PAROXETINE;
02475553;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2018-07-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96562
PAROXETINE;
02477858;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2019-03-05;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96846
NRA-PAROXETINE;
02479788;
paroxetine (paroxetine hydrochloride hemihydrate) 30 mg;
2018-12-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97012
PAXIL TAB 10MG;
02027887;
paroxetine (paroxetine hydrochloride) 10 mg;
1997-01-31;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43575
APO-PAROXETINE;
02240907;
paroxetine (paroxetine hydrochloride) 10 mg;
2003-10-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64498
PMS-PAROXETINE;
02247750;
paroxetine (paroxetine hydrochloride) 10 mg;
2003-10-29;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72042
PAROXETINE-10;
02248913;
paroxetine (paroxetine hydrochloride) 10 mg;
2004-03-19;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73287
PAROXETINE;
02282844;
paroxetine (paroxetine hydrochloride) 10 mg;
2009-10-22;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76846
JAMP-PAROXETINE;
02368862;
paroxetine (paroxetine hydrochloride) 10 mg;
2011-10-06;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85383
PAXIL CR;
02248503;
paroxetine (paroxetine hydrochloride) 12.5 mg;
2004-01-05;
Oral;
Tablet (Extended-Release);
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72855
PAXIL TAB 20MG;
01940481;
paroxetine (paroxetine hydrochloride) 20 mg;
1993-12-31;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14007
APO-PAROXETINE;
02240908;
paroxetine (paroxetine hydrochloride) 20 mg;
2003-10-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64499
PMS-PAROXETINE;
02247751;
paroxetine (paroxetine hydrochloride) 20 mg;
2003-10-29;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72043
PAROXETINE-20;
02248914;
paroxetine (paroxetine hydrochloride) 20 mg;
2004-03-19;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73288
PAROXETINE;
02282852;
paroxetine (paroxetine hydrochloride) 20 mg;
2009-10-22;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76847
JAMP-PAROXETINE;
02368870;
paroxetine (paroxetine hydrochloride) 20 mg;
2011-10-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85384
PAXIL CR;
02248504;
paroxetine (paroxetine hydrochloride) 25 mg;
2004-01-05;
Oral;
Tablet (Extended-Release);
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72856
PAXIL TAB 30MG;
01940473;
paroxetine (paroxetine hydrochloride) 30 mg;
1993-12-31;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14006
APO-PAROXETINE;
02240909;
paroxetine (paroxetine hydrochloride) 30 mg;
2003-10-24;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64500
PMS-PAROXETINE;
02247752;
paroxetine (paroxetine hydrochloride) 30 mg;
2003-10-29;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72044
PAROXETINE-30;
02248915;
paroxetine (paroxetine hydrochloride) 30 mg;
2004-03-19;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73289
PAROXETINE;
02282860;
paroxetine (paroxetine hydrochloride) 30 mg;
2009-10-22;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76848
JAMP-PAROXETINE;
02368889;
paroxetine (paroxetine hydrochloride) 30 mg;
2011-10-06;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85385
SIGNIFOR;
02413299;
pasireotide (pasireotide diaspartate) 0.3 mg / ml;
2013-11-26;
Subcutaneous;
Solution;
68:29.04 – Somatostatin Agonists;
Prescription;
RECORDATI RARE DISEASES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89797
SIGNIFOR;
02413302;
pasireotide (pasireotide diaspartate) 0.6 mg / ml;
2013-11-26;
Subcutaneous;
Solution;
68:29.04 – Somatostatin Agonists;
Prescription;
RECORDATI RARE DISEASES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89798
SIGNIFOR;
02413310;
pasireotide (pasireotide diaspartate) 0.9 mg / ml;
2013-11-28;
Subcutaneous;
Solution;
68:29.04 – Somatostatin Agonists;
Prescription;
RECORDATI RARE DISEASES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89799
SIGNIFOR LAR;
02480425;
pasireotide (pasireotide pamoate) 10 mg / vial;
2019-05-30;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
68:29.04 – Somatostatin Agonists;
Prescription;
RECORDATI RARE DISEASES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97095
SIGNIFOR LAR;
02437252;
pasireotide (pasireotide pamoate) 20 mg / vial;
2016-01-28;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
68:29.04 – Somatostatin Agonists;
Prescription;
RECORDATI RARE DISEASES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92155
SIGNIFOR LAR;
02480433;
pasireotide (pasireotide pamoate) 30 mg / vial;
2019-05-30;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
68:29.04 – Somatostatin Agonists;
Prescription;
RECORDATI RARE DISEASES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97096
SIGNIFOR LAR;
02437260;
pasireotide (pasireotide pamoate) 40 mg / vial;
2015-08-04;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
68:29.04 – Somatostatin Agonists;
Prescription;
RECORDATI RARE DISEASES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92157
SIGNIFOR LAR;
02437279;
pasireotide (pasireotide pamoate) 60 mg / vial;
2015-08-04;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
68:29.04 – Somatostatin Agonists;
Prescription;
RECORDATI RARE DISEASES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92156
PATENT BLUE SODIUM INJECTION;
00405396;
patent blue sodium 50 mg / 2 ml;
1979-12-31;
Intravenous , Subcutaneous;
Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Ethical;
GUERBET
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3486
VELTASSA;
02481367;
patiromer (patiromer sorbitex calcium) 16.8 g / sachet;
2019-11-27;
Oral;
Powder For Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97185
VELTASSA;
02481359;
patiromer (patiromer sorbitex calcium) 8.4 g / sachet;
2020-03-09;
Oral;
Powder For Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97184
ONPATTRO;
02489252;
patisiran (patisiran sodium) 2 mg / ml;
2019-07-25;
Intravenous;
Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
ALNYLAM NETHERLANDS B.V.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97933
VOTRIENT;
02352303;
pazopanib (pazopanib hydrochloride) 200 mg;
2010-08-13;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83758
ONCASPAR;
02461900;
pegaspargase 750 unit / ml;
2017-06-01;
Intramuscular , Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
SERVIER CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94965
NEULASTA;
02249790;
pegfilgrastim 10 mg / ml;
2004-03-12;
Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73463
FULPHILA;
02484153;
pegfilgrastim 10 mg / ml;
2020-02-07;
Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97449
LAPELGA;
02474565;
pegfilgrastim 6 mg / 0.6 ml;
2019-02-27;
Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96479
ZIEXTENZO;
02497395;
pegfilgrastim 6 mg / 0.6 ml;
2020-06-15;
Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98722
NYVEPRIA;
02506238;
pegfilgrastim 6 mg / 0.6 ml;
2021-01-18;
Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99556
PEGASYS;
02248077;
peginterferon alfa-2a 180 mcg / 0.5 ml;
2003-08-14;
Subcutaneous;
Solution;
08:18.20 – INTERFERONS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72399
PLEGRIDY;
02444399;
peginterferon beta-1a 125 mcg / 0.5 ml;
2015-09-29;
Subcutaneous;
Liquid;
08:18.20 – INTERFERONS;
Prescription , Schedule D;
BIOGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92943
SOMAVERT;
02272199;
pegvisomant 10 mg / vial;
2006-01-24;
Subcutaneous;
Kit , Powder For Solution;
68:30.08 – SOMATOTROPIN ANTAGONISTS;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75772
SOMAVERT;
02272202;
pegvisomant 15 mg / vial;
2006-01-24;
Subcutaneous;
Kit , Powder For Solution;
68:30.08 – SOMATOTROPIN ANTAGONISTS;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75774
SOMAVERT;
02272210;
pegvisomant 20 mg / vial;
2006-01-24;
Subcutaneous;
Kit , Powder For Solution;
68:30.08 – SOMATOTROPIN ANTAGONISTS;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75775
SOMAVERT;
02448831;
pegvisomant 25 mg / vial;
2016-03-10;
Subcutaneous;
Kit , Powder For Solution;
68:30.08 – SOMATOTROPIN ANTAGONISTS;
Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93460
SOMAVERT;
02448858;
pegvisomant 30 mg / vial;
2016-03-10;
Subcutaneous;
Kit , Powder For Solution;
68:30.08 – SOMATOTROPIN ANTAGONISTS;
Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93461
KEYTRUDA;
02456869;
pembrolizumab 25 mg / ml;
2017-07-13;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94388
PEMETREXED DISODIUM FOR INJECTION;
02438674;
pemetrexed (pemetrexed disodium hemipentahydrate) 100 mg / vial;
2017-05-24;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92306
PEMETREXED DISODIUM FOR INJECTION;
02438682;
pemetrexed (pemetrexed disodium hemipentahydrate) 500 mg / vial;
2017-05-29;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92307
ALIMTA;
02306433;
pemetrexed (pemetrexed disodium) 100 mg / vial;
2009-01-09;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79204
TARO-PEMETREXED;
02429195;
pemetrexed (pemetrexed disodium) 100 mg / vial;
2018-10-18;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91363
PEMETREXED DISODIUM FOR INJECTION;
02459434;
pemetrexed (pemetrexed disodium) 100 mg / vial;
2017-03-31;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94667
ALIMTA;
02253437;
pemetrexed (pemetrexed disodium) 500 mg / vial;
2004-08-03;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73841
PEMETREXED DISODIUM FOR INJECTION;
02394227;
pemetrexed (pemetrexed disodium) 500 mg / vial;
2017-03-31;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87938
TARO-PEMETREXED;
02429209;
pemetrexed (pemetrexed disodium) 500 mg / vial;
2017-02-15;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91364
CUPRIMINE;
00016055;
penicillamine 250 mg;
1964-12-31;
Oral;
Capsule;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=287
PENICILLIN G SODIUM FOR INJECTION, USP;
02220261;
penicillin g (penicillin g sodium) 1000000 unit / vial;
1997-01-23;
Intramuscular , Intravenous;
Powder For Solution;
08:12.16.04 – NATURAL PENICILLINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37244
PENICILLIN G SODIUM FOR INJECTION, USP;
02220296;
penicillin g (penicillin g sodium) 10000000 unit / vial;
1997-01-23;
Intramuscular , Intravenous;
Powder For Solution;
08:12.16.04 – NATURAL PENICILLINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37246
PENICILLIN G SODIUM FOR INJECTION, USP;
02220288;
penicillin g (penicillin g sodium) 5000000 unit / vial;
1997-01-23;
Intramuscular , Intravenous;
Powder For Solution;
08:12.16.04 – NATURAL PENICILLINS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37245
BICILLIN L-A;
02291924;
penicillin g benzathine 1200000 unit / 2 ml;
2008-06-11;
Intramuscular;
Suspension;
08:12.16.04 – NATURAL PENICILLINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77729
PEN-VK;
00642215;
penicillin v potassium 300 mg;
1985-12-31;
Oral;
Tablet;
08:12.16.04 – NATURAL PENICILLINS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6421
PENTAMIDINE ISETIONATE FOR INJECTION BP;
02183080;
pentamidine isetionate 300 mg / vial;
1998-09-10;
Intramuscular , Intravenous;
Powder For Solution;
08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44273
ELMIRON;
02029448;
pentosan polysulfate sodium 100 mg;
1993-12-31;
Oral;
Capsule;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14161
PENTOXIFYLLINE SR;
02230090;
pentoxifylline 400 mg;
1997-01-14;
Oral;
Tablet (Extended-Release);
20:24.00 – HEMORRHEOLOGIC AGENTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48622
FYCOMPA;
02404559;
perampanel 10.0 mg;
2013-06-03;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88932
FYCOMPA;
02404567;
perampanel 12.0 mg;
2013-05-17;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88928
FYCOMPA;
02404516;
perampanel 2.0 mg;
2013-06-19;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88927
FYCOMPA;
02404524;
perampanel 4.0 mg;
2013-06-19;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88929
FYCOMPA;
02404532;
perampanel 6.0 mg;
2013-06-19;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88930
FYCOMPA;
02404540;
perampanel 8.0 mg;
2013-06-19;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88931
DEFINITY;
02243173;
perflutren 150 mcl / ml;
2002-02-16;
Intravenous;
Suspension;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Prescription;
LANTHEUS MI CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67049
NEULEPTIL;
01926772;
periciazine 10 mg;
1969-12-31;
Oral;
Capsule;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12425
NEULEPTIL;
01926756;
periciazine 10 mg / ml;
1976-12-31;
Oral;
Drops;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13159
NEULEPTIL;
01926780;
periciazine 5 mg;
1969-12-31;
Oral;
Capsule;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12653
COVERSYL;
02123274;
perindopril erbumine 2 mg;
1994-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SERVIER CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16880
APO-PERINDOPRIL;
02289261;
perindopril erbumine 2 mg;
2018-03-08;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77465
AURO-PERINDOPRIL;
02459817;
perindopril erbumine 2 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94713
TEVA-PERINDOPRIL;
02464985;
perindopril erbumine 2 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95319
SANDOZ PERINDOPRIL ERBUMINE;
02470225;
perindopril erbumine 2 mg;
2018-03-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95921
PMS-PERINDOPRIL;
02470675;
perindopril erbumine 2 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95968
RIVA-PERINDOPRIL;
02472015;
perindopril erbumine 2 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96126
MAR-PERINDOPRIL;
02474824;
perindopril erbumine 2 mg;
2019-04-11;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96501
MINT-PERINDOPRIL;
02476762;
perindopril erbumine 2 mg;
2019-03-22;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96760
JAMP PERINDOPRIL;
02477009;
perindopril erbumine 2 mg;
2019-02-08;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96775
PERINDOPRIL ERBUMINE;
02479877;
perindopril erbumine 2 mg;
2019-02-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97044
PERINDOPRIL ERBUMINE;
02481634;
perindopril erbumine 2 mg;
2019-03-18;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97209
AG-PERINDOPRIL;
02481677;
perindopril erbumine 2 mg;
2018-12-24;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97216
M-PERINDOPRIL ERBUMINE;
02482924;
perindopril erbumine 2 mg;
2019-07-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97332
PRIVA-PERINDOPRIL ERBUMINE;
02483238;
perindopril erbumine 2 mg;
2019-04-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97367
PERINDOPRIL ERBUMINE;
02488949;
perindopril erbumine 2 mg;
2019-07-09;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97901
NRA-PERINDOPRIL;
02489015;
perindopril erbumine 2 mg;
2019-10-24;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97907
BIO-PERINDOPRIL;
02501309;
perindopril erbumine 2 mg;
2020-07-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99093
COVERSYL;
02123282;
perindopril erbumine 4 mg;
1994-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SERVIER CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16879
APO-PERINDOPRIL;
02289288;
perindopril erbumine 4 mg;
2018-03-08;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77466
AURO-PERINDOPRIL;
02459825;
perindopril erbumine 4 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94714
TEVA-PERINDOPRIL;
02464993;
perindopril erbumine 4 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95320
SANDOZ PERINDOPRIL ERBUMINE;
02470233;
perindopril erbumine 4 mg;
2018-03-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95922
PMS-PERINDOPRIL;
02470683;
perindopril erbumine 4 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95969
RIVA-PERINDOPRIL;
02472023;
perindopril erbumine 4 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96127
MAR-PERINDOPRIL;
02474832;
perindopril erbumine 4 mg;
2019-04-11;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96502
MINT-PERINDOPRIL;
02476770;
perindopril erbumine 4 mg;
2019-01-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96761
JAMP PERINDOPRIL;
02477017;
perindopril erbumine 4 mg;
2019-02-08;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96776
PERINDOPRIL ERBUMINE;
02479885;
perindopril erbumine 4 mg;
2019-02-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97045
PERINDOPRIL ERBUMINE;
02481642;
perindopril erbumine 4 mg;
2019-03-18;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97210
AG-PERINDOPRIL;
02481685;
perindopril erbumine 4 mg;
2018-12-24;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97217
M-PERINDOPRIL ERBUMINE;
02482932;
perindopril erbumine 4 mg;
2019-07-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97333
PRIVA-PERINDOPRIL ERBUMINE;
02483246;
perindopril erbumine 4 mg;
2019-04-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97368
PERINDOPRIL ERBUMINE;
02488957;
perindopril erbumine 4 mg;
2019-07-09;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97902
NRA-PERINDOPRIL;
02489023;
perindopril erbumine 4 mg;
2019-10-24;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97908
BIO-PERINDOPRIL;
02501317;
perindopril erbumine 4 mg;
2020-07-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99094
COVERSYL;
02246624;
perindopril erbumine 8 mg;
2003-09-11;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SERVIER CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70814
APO-PERINDOPRIL;
02289296;
perindopril erbumine 8 mg;
2007-02-02;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77467
AURO-PERINDOPRIL;
02459833;
perindopril erbumine 8 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94715
TEVA-PERINDOPRIL;
02465000;
perindopril erbumine 8 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95321
SANDOZ PERINDOPRIL ERBUMINE;
02470241;
perindopril erbumine 8 mg;
2018-03-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95923
PMS-PERINDOPRIL;
02470691;
perindopril erbumine 8 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95970
RIVA-PERINDOPRIL;
02472031;
perindopril erbumine 8 mg;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96128
MAR-PERINDOPRIL;
02474840;
perindopril erbumine 8 mg;
2019-04-11;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96503
MINT-PERINDOPRIL;
02476789;
perindopril erbumine 8 mg;
2019-01-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96762
JAMP PERINDOPRIL;
02477025;
perindopril erbumine 8 mg;
2019-02-08;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96777
PERINDOPRIL ERBUMINE;
02479893;
perindopril erbumine 8 mg;
2019-02-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97046
PERINDOPRIL ERBUMINE;
02481650;
perindopril erbumine 8 mg;
2019-03-18;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97211
AG-PERINDOPRIL;
02481693;
perindopril erbumine 8 mg;
2018-12-24;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97218
M-PERINDOPRIL ERBUMINE;
02482940;
perindopril erbumine 8 mg;
2019-07-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97334
PRIVA-PERINDOPRIL ERBUMINE;
02483254;
perindopril erbumine 8 mg;
2019-04-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97369
PERINDOPRIL ERBUMINE;
02488965;
perindopril erbumine 8 mg;
2019-07-09;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97903
NRA-PERINDOPRIL;
02489031;
perindopril erbumine 8 mg;
2019-10-24;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97909
BIO-PERINDOPRIL;
02501325;
perindopril erbumine 8 mg;
2020-07-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99095
NIX CREME RINSE;
00771368;
permethrin 1 %;
1988-12-31;
Topical;
Cream;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Otc;
INSIGHT PHARMACEUTICALS, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8964
KWELLADA-P CRÈME RINSE;
02231480;
permethrin 1 %;
1998-11-16;
Topical;
Liquid;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Otc;
MEDTECH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50804
NIX DERMAL CREAM;
02219905;
permethrin 5 %;
1999-07-01;
Topical;
Cream;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37239
KWELLADA-P LOTION;
02231348;
permethrin 5 %;
1997-10-16;
Topical;
Lotion;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Otc;
MEDTECH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50657
PERPHENAZINE;
00335096;
perphenazine 16 mg;
1976-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2365
PERPHENAZINE;
00335134;
perphenazine 2 mg;
1976-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2368
PERPHENAZINE;
00335126;
perphenazine 4 mg;
1976-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2367
PERPHENAZINE;
00335118;
perphenazine 8 mg;
1976-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2366
PERJETA;
02405016;
pertuzumab 420 mg / 14 ml;
2013-05-08;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88984
BÉBÉ HEALING OINTMENT;
02473712;
petrolatum 46.5 %;
2018-06-25;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
CERAVE CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96311
OINTMENT WITH MOISTURIZING VITAMIN E;
02399954;
petrolatum 95.7 % / w/w;
2014-03-06;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
CRLS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88479
PROTECTIVE OINTMENT;
02325578;
petrolatum 98.79 % / w/w;
2010-06-04;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
SMITH & NEPHEW INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81094
PYRIDIUM 100MG;
00476714;
phenazopyridine hydrochloride 100 mg;
1981-12-31;
Oral;
Tablet;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4388
NARDIL;
00476552;
phenelzine (phenelzine sulfate) 15 mg;
1981-12-31;
Oral;
Tablet;
28:16.04.12 – MONOAMINE OXIDASE INHIBITORS;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4309
PHENOBARB;
00178829;
phenobarbital 100 mg;
1957-12-31;
Oral;
Tablet;
28:12.04 – BARBITURATES , 28:24.04 – BARBITURATES;
Schedule G (Cdsa Iv);
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=408
PHENOBARB;
00178799;
phenobarbital 15 mg;
1957-12-31;
Oral;
Tablet;
28:12.04 – BARBITURATES , 28:24.04 – BARBITURATES;
Schedule G (Cdsa Iv);
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=405
PHENOBARB;
00178802;
phenobarbital 30 mg;
1957-12-31;
Oral;
Tablet;
28:12.04 – BARBITURATES , 28:24.04 – BARBITURATES;
Schedule G (Cdsa Iv);
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=406
PHENOBARB ELIXIR;
00645575;
phenobarbital 5 mg / ml;
1965-12-31;
Oral;
Solution;
28:12.04 – BARBITURATES , 28:24.04 – BARBITURATES;
Schedule G (Cdsa Iv);
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6095
PHENOBARB;
00178810;
phenobarbital 60 mg;
1957-12-31;
Oral;
Tablet;
28:12.04 – BARBITURATES , 28:24.04 – BARBITURATES;
Schedule G (Cdsa Iv);
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=407
PHENOBARBITAL SODIUM INJECTION, USP;
02304090;
phenobarbital sodium 120 mg / ml;
2008-02-29;
Intramuscular , Intravenous;
Solution;
28:12.04 – BARBITURATES , 28:24.04 – BARBITURATES;
Schedule G (Cdsa Iv);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78940
PHENOBARBITAL SODIUM INJECTION, USP;
02304082;
phenobarbital sodium 30 mg / ml;
2008-02-29;
Intramuscular , Intravenous;
Solution;
28:12.04 – BARBITURATES , 28:24.04 – BARBITURATES;
Schedule G (Cdsa Iv);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78939
ORAVERSE;
02421666;
phentolamine mesylate 0.4 mg / 1.7 ml;
2014-09-17;
Submucosal;
Solution;
12:16.04.04 – Non-Selective Alfa-Adrenergic Blocking Agents;
Prescription;
SEPTODONT
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90632
PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD;
02243737;
phentolamine mesylate 5 mg / ml;
2001-06-15;
Intramuscular , Intravenous;
Solution;
12:16.04.04 – Non-Selective Alfa-Adrenergic Blocking Agents;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67670
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP;
01953583;
phenylephrine (phenylephrine hydrochloride) 10 mg / ml;
1992-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12889
HEMORRHOIDAL RELIEF OINTMENT;
02230466;
phenylephrine hydrochloride 0.25 %;
1998-08-06;
Topical;
Ointment;
12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49424
MINIMS PHENYLEPHRINE HYDROCHLORIDE;
02148455;
phenylephrine hydrochloride 10 % / w/v;
1995-12-31;
Ophthalmic;
Drops;
52:24.00 – MYDRIATICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18759
NEO-SYNEPHRINE;
02241980;
phenylephrine hydrochloride 10 mg / ml;
2002-11-01;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65650
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP;
02477254;
phenylephrine hydrochloride 10 mg / ml;
2019-03-26;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Ethical;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96812
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1%;
02238400;
phenylephrine hydrochloride 10 mg / 1 ml;
2001-07-30;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61817
MYDFRIN;
00465763;
phenylephrine hydrochloride 2.5 % / w/v;
1979-12-31;
Ophthalmic;
Solution;
52:24.00 – MYDRIATICS;
Otc;
ALCON CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3319
MINIMS PHENYLEPHRINE HYDROCHLORIDE;
02148447;
phenylephrine hydrochloride 2.5 % / w/v;
1995-12-31;
Ophthalmic;
Drops;
52:24.00 – MYDRIATICS;
Ethical;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18860
PHENYLEPHRINE HYDROCHLORIDE INJECTION;
02454599;
phenylephrine hydrochloride 50 mcg / ml;
2016-11-04;
Intravenous;
Solution;
12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Ethical;
BIOSYENT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94130
DILANTIN-125 SUSPENSION;
00023450;
phenytoin 125 mg / 5 ml;
1953-12-31;
Oral;
Suspension;
28:12.12 – HYDANTOINS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=613
TARO-PHENYTOIN;
02250896;
phenytoin 125 mg / 5 ml;
2005-05-03;
Oral;
Suspension;
28:12.12 – HYDANTOINS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73583
DILANTIN-30 SUSPENSION;
00023442;
phenytoin 30 mg / 5 ml;
1968-12-31;
Oral;
Suspension;
28:12.12 – HYDANTOINS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=769
DILANTIN INFATABS;
00023698;
phenytoin 50 mg;
1952-12-31;
Oral;
Tablet;
28:12.12 – HYDANTOINS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1086
DILANTIN;
00022780;
phenytoin sodium 100 mg;
1951-12-31;
Oral;
Capsule;
28:12.12 – HYDANTOINS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1037
PHENYTOIN SODIUM;
02460912;
phenytoin sodium 100 mg;
2017-08-16;
Oral;
Capsule;
28:12.12 – HYDANTOINS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94843
DILANTIN;
00022772;
phenytoin sodium 30 mg;
1951-12-31;
Oral;
Capsule;
28:12.12 – HYDANTOINS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1036
PHENYTOIN SODIUM INJECTION USP;
00780626;
phenytoin sodium 50 mg / ml;
1988-12-31;
Intramuscular , Intravenous;
Liquid;
28:12.12 – HYDANTOINS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9398
PHENYTOIN SODIUM INJECTION, USP;
02431378;
phenytoin sodium 50 mg / ml;
2015-03-12;
Intramuscular , Intravenous;
Solution;
28:12.12 – HYDANTOINS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91579
ISOPTO CARPINE;
00000868;
pilocarpine hydrochloride 2 %;
1959-12-31;
Ophthalmic;
Liquid;
52:40.20 – MIOTICS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2375
ISOPTO CARPINE;
00000884;
pilocarpine hydrochloride 4 %;
1959-12-31;
Ophthalmic;
Liquid;
52:40.20 – MIOTICS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2374
SALAGEN;
02216345;
pilocarpine hydrochloride 5 mg;
1997-04-01;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
AMDIPHARM LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43182
ACCEL-PILOCARPINE;
02496119;
pilocarpine hydrochloride 5 mg;
2020-05-12;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
ACCEL PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98599
MINIMS PILOCARPINE NITRATE;
02148463;
pilocarpine nitrate 2 % / w/v;
1995-12-31;
Ophthalmic;
Drops;
52:40.20 – MIOTICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18744
ELIDEL;
02247238;
pimecrolimus 1 % / w/w;
2003-03-24;
Topical;
Cream;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71480
PIMOZIDE;
02245432;
pimozide 2 mg;
2003-04-01;
Oral;
Tablet;
28:16.08.92 – MISCELLANEOUS ANTIPSYCHOTICS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69484
PIMOZIDE;
02245433;
pimozide 4 mg;
2003-04-01;
Oral;
Tablet;
28:16.08.92 – MISCELLANEOUS ANTIPSYCHOTICS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69485
DICETEL;
02230684;
pinaverium bromide 100 mg;
1999-07-05;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49943
PINAVERIUM;
02469685;
pinaverium bromide 100 mg;
2018-09-13;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95849
DICETEL;
01950592;
pinaverium bromide 50 mg;
1993-12-31;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15176
PINAVERIUM;
02469677;
pinaverium bromide 50 mg;
2018-09-13;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95848
VISKEN;
00443174;
pindolol 10 mg;
1978-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
ARALEZ PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3091
APO-PINDOL TAB 10MG;
00755885;
pindolol 10 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9168
TEVA-PINDOLOL;
00869015;
pindolol 10 mg;
1990-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10950
APO-PINDOL TAB 15MG;
00755893;
pindolol 15 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9169
TEVA-PINDOLOL;
00869023;
pindolol 15 mg;
1990-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10951
VISKEN;
00417270;
pindolol 5 mg;
1978-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
ARALEZ PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3089
APO-PINDOL TAB 5MG;
00755877;
pindolol 5 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9167
TEVA-PINDOLOL;
00869007;
pindolol 5 mg;
1990-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10949
SANDOZ PIOGLITAZONE;
02297906;
pioglitazone (pioglitazone hydrochloride) 15 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78323
ACT PIOGLITAZONE;
02302861;
pioglitazone (pioglitazone hydrochloride) 15 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78818
APO-PIOGLITAZONE;
02302942;
pioglitazone (pioglitazone hydrochloride) 15 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78824
PRO-PIOGLITAZONE;
02312050;
pioglitazone (pioglitazone hydrochloride) 15 mg;
2008-10-27;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79757
ACH-PIOGLITAZONE;
02391600;
pioglitazone (pioglitazone hydrochloride) 15 mg;
2012-10-12;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87693
JAMP PIOGLITAZONE;
02397307;
pioglitazone (pioglitazone hydrochloride) 15 mg;
2014-12-12;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88227
SANDOZ PIOGLITAZONE;
02297914;
pioglitazone (pioglitazone hydrochloride) 30 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78324
ACT PIOGLITAZONE;
02302888;
pioglitazone (pioglitazone hydrochloride) 30 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78819
APO-PIOGLITAZONE;
02302950;
pioglitazone (pioglitazone hydrochloride) 30 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78825
PRO-PIOGLITAZONE;
02312069;
pioglitazone (pioglitazone hydrochloride) 30 mg;
2008-10-27;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79758
ACH-PIOGLITAZONE;
02339587;
pioglitazone (pioglitazone hydrochloride) 30 mg;
2010-06-11;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82518
JAMP PIOGLITAZONE;
02365529;
pioglitazone (pioglitazone hydrochloride) 30 mg;
2011-06-09;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85042
SANDOZ PIOGLITAZONE;
02297922;
pioglitazone (pioglitazone hydrochloride) 45 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78325
ACT PIOGLITAZONE;
02302896;
pioglitazone (pioglitazone hydrochloride) 45 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78820
APO-PIOGLITAZONE;
02302977;
pioglitazone (pioglitazone hydrochloride) 45 mg;
2007-12-05;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78827
PRO-PIOGLITAZONE;
02312077;
pioglitazone (pioglitazone hydrochloride) 45 mg;
2008-10-27;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79759
ACH-PIOGLITAZONE;
02339595;
pioglitazone (pioglitazone hydrochloride) 45 mg;
2010-06-11;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82519
JAMP PIOGLITAZONE;
02365537;
pioglitazone (pioglitazone hydrochloride) 45 mg;
2011-06-09;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85043
ESBRIET;
02393751;
pirfenidone 267 mg;
2013-01-08;
Oral;
Capsule;
48:02.00 – ANTIFIBROTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87895
ESBRIET;
02464489;
pirfenidone 267 mg;
2017-07-26;
Oral;
Tablet;
48:02.00 – ANTIFIBROTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95262
ESBRIET;
02464500;
pirfenidone 801 mg;
2017-07-26;
Oral;
Tablet;
48:02.00 – ANTIFIBROTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95264
APO PIROXICAM CAP 10MG;
00642886;
piroxicam 10 mg;
1986-12-31;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6714
TEVA-PIROXICAM;
00695718;
piroxicam 10 mg;
1986-12-31;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6813
APO PIROXICAM CAP 20MG;
00642894;
piroxicam 20 mg;
1986-12-31;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6715
TEVA-PIROXICAM;
00695696;
piroxicam 20 mg;
1986-12-31;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6812
SANDOMIGRAN DS;
00511552;
pizotifen (pizotifen malate) 1 mg;
1980-12-31;
Oral;
Tablet;
28:32.92 – ANTIMIGRAINE AGENTS, MISCELLANEOUS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4222
MOZOBIL;
02377225;
plerixafor 20 mg / ml;
2012-03-26;
Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86284
CONDYLINE;
01945149;
podophyllotoxin 0.5 %;
1992-12-31;
Topical;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12196
POLIVY;
02499614;
polatuzumab vedotin 140 mg / vial;
2020-11-25;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98934
ALLERGENIC EXTRACT POLLENS;
00299987;
pollen 100000 unit / ml;
1963-12-31;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1914
NON STANDARDIZED ALLERGENIC EXTRACTS – POLLENS;
02372444;
pollen 40000 unit / ml;
2012-02-10;
Intradermal , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85756
CENTER-AL;
00648922;
pollen and non pollen 20000 unit / ml;
1985-12-31;
Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6237
LAX-A-DAY;
02317680;
polyethylene glycol 3350 100 %;
2008-12-10;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80321
CLEARLAX;
02324989;
polyethylene glycol 3350 100 %;
2010-11-05;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81040
RELAXA;
02346672;
polyethylene glycol 3350 100 %;
2010-07-02;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
MEDEXUS PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83209
PEG 3350;
02358034;
polyethylene glycol 3350 100 %;
2012-03-28;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
MEDISCA PHARMACEUTIQUE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84310
LAX-A-DAY MEN;
02455617;
polyethylene glycol 3350 100 %;
2016-08-26;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94243
COMFILAX;
02460297;
polyethylene glycol 3350 100 %;
2017-08-20;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94758
RESTORALAX;
02318164;
polyethylene glycol 3350 100 % / w/w;
2009-10-16;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80366
PEGALAX;
02328232;
polyethylene glycol 3350 100 % / w/w;
2009-09-17;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
ARALEZ PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81376
EMOLAX;
02374137;
polyethylene glycol 3350 100 % / w/w;
2015-10-04;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85934
PURELAX;
02415054;
polyethylene glycol 3350 100 % / w/w;
2014-07-10;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89967
M-PEG 3350;
02450070;
polyethylene glycol 3350 100 % / w/w;
2017-03-13;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93607
LAX-A-DAY PHARMA;
02453193;
polyethylene glycol 3350 100 % / w/w;
2016-08-30;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93973
HYDRALAX;
02473119;
polyethylene glycol 3350 17 g / dose;
2019-04-26;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
JUNO OTC INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96245
TEARS PLUS 1.4%;
00579408;
polyvinyl alcohol 1.4 %;
1982-12-31;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5121
REFRESH;
02138670;
polyvinyl alcohol 1.4 %;
1995-12-31;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18791
POMALYST;
02419580;
pomalidomide 1 mg;
2014-02-24;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90423
POMALYST;
02419599;
pomalidomide 2 mg;
2014-02-24;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90424
POMALYST;
02419602;
pomalidomide 3 mg;
2014-02-24;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90425
POMALYST;
02419610;
pomalidomide 4 mg;
2014-02-24;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90426
ICLUSIG;
02437333;
ponatinib (ponatinib hydrochloride) 15 mg;
2015-08-21;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ARIAD PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92168
ICLUSIG;
02437341;
ponatinib (ponatinib hydrochloride) 45 mg;
2016-01-07;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ARIAD PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92169
CUROSURF;
02241551;
poractant alfa 80 mg / ml;
2016-12-19;
Intratracheal;
Suspension;
48:36.00 – PULMONARY SURFACTANTS;
Prescription;
CHIESI FARMACEUTICI S.P.A.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65204
POSANOL;
02424622;
posaconazole 100 mg;
2014-05-21;
Oral;
Tablet (Delayed-Release);
08:14.08 – AZOLES;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90930
SANDOZ POSACONAZOLE;
02496259;
posaconazole 100 mg;
2020-12-08;
Oral;
Tablet (Delayed-Release);
08:14.08 – AZOLES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98612
POSANOL;
02293404;
posaconazole 200 mg / 5 ml;
2007-06-06;
Oral;
Suspension;
08:14.08 – AZOLES;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77877
POSANOL;
02432676;
posaconazole 300 mg / 16.7 ml;
2014-11-24;
Intravenous;
Solution;
08:14.08 – AZOLES;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91710
POTASSIUM ACETATE INJECTION USP;
02362597;
potassium acetate 39.2 % / w/v;
2016-07-18;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84760
POTASSIUM CHLORIDE INJECTION;
02241677;
potassium chloride 14.9 mg / ml;
2000-08-10;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65337
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP;
00037869;
potassium chloride 149 mg / ml;
1951-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2527
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP;
02485699;
potassium chloride 149 mg / ml;
2020-03-25;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
B. BRAUN MEDICAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97592
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE;
00402206;
potassium chloride 20 meq / 10 ml;
1978-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3394
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE;
02480034;
potassium chloride 200 meq / 100 ml;
2019-08-03;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97058
K + 45;
01905740;
potassium chloride 251.6 g / l;
1990-12-31;
Dialysis;
Liquid;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13833
POTASSIUM CHLORIDE INJECTION;
02241679;
potassium chloride 29.8 mg / ml;
2000-08-10;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65339
POTASSIUM CHLORIDE INJECTION;
02241676;
potassium chloride 7.46 mg / ml;
2000-08-10;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65336
UROCIT-K;
02353997;
potassium citrate 1080 mg;
2011-02-11;
Oral;
Tablet (Extended-Release);
40:12.00 – REPLACEMENT PREPARATIONS;
Prescription;
MISSION PHARMACAL COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83921
UROCIT-K;
01914022;
potassium citrate 540 mg;
1995-01-01;
Oral;
Tablet (Extended-Release);
40:12.00 – REPLACEMENT PREPARATIONS;
Prescription;
MISSION PHARMACAL COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=46885
PHOSPHATE DE POTASSIUM MONOBASIC INJ 176MG/ML;
00711306;
potassium phosphate monobasic 176 mg / ml;
1987-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8119
NUCEIVA;
02480158;
prabotulinumtoxina 100 unit / vial;
2019-10-16;
Intramuscular;
Powder For Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription , Schedule D;
EVOLUS INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97069
FOLOTYN;
02481820;
pralatrexate 20 mg / ml;
2019-01-15;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SERVIER CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97230
MIRAPEX;
02297256;
pramipexole dihydrochloride monohydrate 0.125 mg;
2008-07-09;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78262
MIRAPEX;
02237145;
pramipexole dihydrochloride monohydrate 0.25 mg;
1998-02-26;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60463
APO-PRAMIPEXOLE;
02292378;
pramipexole dihydrochloride monohydrate 0.25 mg;
2007-02-26;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77772
ACT PRAMIPEXOLE;
02297302;
pramipexole dihydrochloride monohydrate 0.25 mg;
2009-04-15;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78267
PRAMIPEXOLE;
02309122;
pramipexole dihydrochloride monohydrate 0.25 mg;
2009-04-09;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79472
SANDOZ PRAMIPEXOLE;
02315262;
pramipexole dihydrochloride monohydrate 0.25 mg;
2008-08-14;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80080
PRAMIPEXOLE;
02325802;
pramipexole dihydrochloride monohydrate 0.25 mg;
2009-06-15;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81116
AURO-PRAMIPEXOLE;
02424061;
pramipexole dihydrochloride monohydrate 0.25 mg;
2014-04-29;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90879
APO-PRAMIPEXOLE;
02292386;
pramipexole dihydrochloride monohydrate 0.5 mg;
2007-02-26;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77773
ACT PRAMIPEXOLE;
02297310;
pramipexole dihydrochloride monohydrate 0.5 mg;
2009-04-15;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78268
PRAMIPEXOLE;
02309130;
pramipexole dihydrochloride monohydrate 0.5 mg;
2009-04-09;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79473
SANDOZ PRAMIPEXOLE;
02315270;
pramipexole dihydrochloride monohydrate 0.5 mg;
2008-08-14;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80081
PRAMIPEXOLE;
02325810;
pramipexole dihydrochloride monohydrate 0.5 mg;
2009-06-15;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81117
AURO-PRAMIPEXOLE;
02424088;
pramipexole dihydrochloride monohydrate 0.5 mg;
2014-04-29;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90880
ACT PRAMIPEXOLE;
02297329;
pramipexole dihydrochloride monohydrate 1 mg;
2009-04-15;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78269
PRAMIPEXOLE;
02309149;
pramipexole dihydrochloride monohydrate 1 mg;
2009-04-09;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79474
SANDOZ PRAMIPEXOLE;
02315289;
pramipexole dihydrochloride monohydrate 1 mg;
2008-08-14;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80082
PRAMIPEXOLE;
02325829;
pramipexole dihydrochloride monohydrate 1 mg;
2009-06-15;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81118
AURO-PRAMIPEXOLE;
02424096;
pramipexole dihydrochloride monohydrate 1 mg;
2014-04-29;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90881
APO-PRAMIPEXOLE;
02292394;
pramipexole dihydrochloride monohydrate 1.0 mg;
2007-02-26;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77774
APO-PRAMIPEXOLE;
02292408;
pramipexole dihydrochloride monohydrate 1.5 mg;
2007-02-26;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77776
ACT PRAMIPEXOLE;
02297337;
pramipexole dihydrochloride monohydrate 1.5 mg;
2009-04-15;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78270
PRAMIPEXOLE;
02309157;
pramipexole dihydrochloride monohydrate 1.5 mg;
2009-04-09;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79475
SANDOZ PRAMIPEXOLE;
02315297;
pramipexole dihydrochloride monohydrate 1.5 mg;
2008-08-14;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80083
PRAMIPEXOLE;
02325837;
pramipexole dihydrochloride monohydrate 1.5 mg;
2009-06-15;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81119
AURO-PRAMIPEXOLE;
02424118;
pramipexole dihydrochloride monohydrate 1.5 mg;
2014-04-29;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90882
ITCH RELIEF BALM;
02486385;
pramoxine hydrochloride 0.5 % / w/w;
2020-07-20;
Topical;
Ointment;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97659
ITCH RELIEF MOISTURIZING LOTION;
02486881;
pramoxine hydrochloride 1 %;
2021-02-01;
Topical;
Lotion;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
CERAVE CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97705
ITCH RELIEF MOISTURIZING CREAM;
02484889;
pramoxine hydrochloride 1 % / w/w;
2021-02-01;
Topical;
Cream;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
CERAVE CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97516
APO-PRAVASTATIN;
02243506;
pravastatin sodium 10 mg;
2001-02-27;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67424
PRAVASTATIN-10;
02243824;
pravastatin sodium 10 mg;
2002-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67763
TEVA-PRAVASTATIN;
02247008;
pravastatin sodium 10 mg;
2003-01-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71241
PMS-PRAVASTATIN;
02247655;
pravastatin sodium 10 mg;
2003-07-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71918
TARO-PRAVASTATIN;
02284421;
pravastatin sodium 10 mg;
2007-05-16;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77000
MINT-PRAVASTATIN;
02317451;
pravastatin sodium 10 mg;
2009-02-06;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80298
JAMP-PRAVASTATIN;
02330954;
pravastatin sodium 10 mg;
2010-04-01;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81669
PRAVASTATIN;
02356546;
pravastatin sodium 10 mg;
2010-11-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84168
PRAVASTATIN;
02389703;
pravastatin sodium 10 mg;
2012-07-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87519
ACH-PRAVASTATIN;
02440644;
pravastatin sodium 10 mg;
2019-12-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92501
PRIVA-PRAVASTATIN;
02445379;
pravastatin sodium 10 mg;
2016-08-17;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93059
BIO-PRAVASTATIN;
02446251;
pravastatin sodium 10 mg;
2016-08-17;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93068
AURO-PRAVASTATIN;
02458977;
pravastatin sodium 10 mg;
2018-05-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94613
SANDOZ PRAVASTATIN TABLETS;
02468700;
pravastatin sodium 10 mg;
2018-06-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95718
AG-PRAVASTATIN;
02476142;
pravastatin sodium 10 mg;
2020-01-13;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96641
M-PRAVASTATIN;
02476274;
pravastatin sodium 10 mg;
2018-12-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96728
APO-PRAVASTATIN;
02243507;
pravastatin sodium 20 mg;
2001-02-27;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67425
PRAVASTATIN-20;
02243825;
pravastatin sodium 20 mg;
2002-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67764
TEVA-PRAVASTATIN;
02247009;
pravastatin sodium 20 mg;
2003-01-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71242
PMS-PRAVASTATIN;
02247656;
pravastatin sodium 20 mg;
2003-07-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71919
TARO-PRAVASTATIN;
02284448;
pravastatin sodium 20 mg;
2007-05-16;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77001
MINT-PRAVASTATIN;
02317478;
pravastatin sodium 20 mg;
2009-02-06;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80299
JAMP-PRAVASTATIN;
02330962;
pravastatin sodium 20 mg;
2010-04-01;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81670
PRAVASTATIN;
02356554;
pravastatin sodium 20 mg;
2010-11-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84169
PRAVASTATIN;
02389738;
pravastatin sodium 20 mg;
2012-07-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87521
ACH-PRAVASTATIN;
02440652;
pravastatin sodium 20 mg;
2020-02-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92502
PRIVA-PRAVASTATIN;
02445395;
pravastatin sodium 20 mg;
2016-08-17;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93060
BIO-PRAVASTATIN;
02446278;
pravastatin sodium 20 mg;
2016-08-17;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93069
AURO-PRAVASTATIN;
02458985;
pravastatin sodium 20 mg;
2018-05-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94614
SANDOZ PRAVASTATIN TABLETS;
02468719;
pravastatin sodium 20 mg;
2018-06-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95719
AG-PRAVASTATIN;
02476150;
pravastatin sodium 20 mg;
2019-12-04;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96642
M-PRAVASTATIN;
02476282;
pravastatin sodium 20 mg;
2018-12-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96729
APO-PRAVASTATIN;
02243508;
pravastatin sodium 40 mg;
2001-02-27;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67426
PRAVASTATIN-40;
02243826;
pravastatin sodium 40 mg;
2002-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67765
TEVA-PRAVASTATIN;
02247010;
pravastatin sodium 40 mg;
2003-01-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71243
PMS-PRAVASTATIN;
02247657;
pravastatin sodium 40 mg;
2003-07-21;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71920
TARO-PRAVASTATIN;
02284456;
pravastatin sodium 40 mg;
2007-05-16;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77002
MINT-PRAVASTATIN;
02317486;
pravastatin sodium 40 mg;
2009-02-06;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80300
JAMP-PRAVASTATIN;
02330970;
pravastatin sodium 40 mg;
2010-04-01;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81671
PRAVASTATIN;
02356562;
pravastatin sodium 40 mg;
2010-12-01;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84170
PRAVASTATIN;
02389746;
pravastatin sodium 40 mg;
2012-07-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87522
ACH-PRAVASTATIN;
02440660;
pravastatin sodium 40 mg;
2020-02-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92503
PRIVA-PRAVASTATIN;
02445409;
pravastatin sodium 40 mg;
2016-08-17;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93061
BIO-PRAVASTATIN;
02446286;
pravastatin sodium 40 mg;
2016-08-17;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93070
AURO-PRAVASTATIN;
02458993;
pravastatin sodium 40 mg;
2018-05-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94615
SANDOZ PRAVASTATIN TABLETS;
02468727;
pravastatin sodium 40 mg;
2018-06-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95720
AG-PRAVASTATIN;
02476169;
pravastatin sodium 40 mg;
2019-12-04;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96643
M-PRAVASTATIN;
02476290;
pravastatin sodium 40 mg;
2018-12-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96730
BILTRICIDE;
02230897;
praziquantel 600 mg;
1997-04-24;
Oral;
Tablet;
08:08.00 – ANTHELMINTICS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50175
APO-PRAZO TAB 1MG;
00882801;
prazosin (prazosin hydrochloride) 1 mg;
1990-12-31;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10828
TEVA-PRAZOSIN;
01934198;
prazosin (prazosin hydrochloride) 1 mg;
1992-12-31;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12451
APO-PRAZO TAB 2MG;
00882828;
prazosin (prazosin hydrochloride) 2 mg;
1990-12-31;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10829
TEVA-PRAZOSIN;
01934201;
prazosin (prazosin hydrochloride) 2 mg;
1992-12-31;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12452
APO-PRAZO TAB 5MG;
00882836;
prazosin (prazosin hydrochloride) 5 mg;
1990-12-31;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10830
TEVA-PRAZOSIN;
01934228;
prazosin (prazosin hydrochloride) 5 mg;
1992-12-31;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12453
DERMATOP OINTMENT;
02227517;
prednicarbate 0.1 % / w/w;
2001-03-21;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43464
DERMATOP EMOLLIENT CREAM;
02230642;
prednicarbate 0.1 % / w/w;
2001-03-21;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49818
PEDIAPRED;
02230619;
prednisolone (prednisolone sodium phosphate) 5 mg / 5 ml;
1998-09-23;
Oral;
Solution;
68:04.00 – ADRENALS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49795
PMS-PREDNISOLONE;
02245532;
prednisolone (prednisolone sodium phosphate) 5 mg / 5 ml;
2002-03-19;
Oral;
Solution;
68:04.00 – ADRENALS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69619
PRED MILD;
00299405;
prednisolone acetate 0.12 %;
1974-12-31;
Ophthalmic;
Drops;
52:08.08 – CORTICOSTEROIDS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1936
PRED FORTE;
00301175;
prednisolone acetate 1 %;
1974-12-31;
Ophthalmic;
Drops;
52:08.08 – CORTICOSTEROIDS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1937
TEVA-PREDNISOLONE;
00700401;
prednisolone acetate 1 %;
1986-12-31;
Ophthalmic;
Suspension;
52:08.08 – CORTICOSTEROIDS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7042
SANDOZ PREDNISOLONE;
01916203;
prednisolone acetate 1 %;
1993-12-31;
Ophthalmic;
Suspension;
52:08.08 – CORTICOSTEROIDS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13946
MINIMS PREDNISOLONE SODIUM PHOSPHATE;
02148498;
prednisolone sodium phosphate 0.5 %;
1995-12-31;
Ophthalmic;
Drops;
52:08.08 – CORTICOSTEROIDS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18750
WINPRED;
00271373;
prednisone 1 mg;
1978-12-31;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3076
TEVA-PREDNISONE;
00021695;
prednisone 5 mg;
1967-12-31;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=507
APO PREDNISONE TAB 5MG;
00312770;
prednisone 5 mg;
1982-12-31;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4732
TEVA-PREDNISONE;
00232378;
prednisone 50 mg;
1972-12-31;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1286
APO PREDNISONE TAB 50MG;
00550957;
prednisone 50 mg;
1982-12-31;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4736
LYRICA;
02268450;
pregabalin 150 mg;
2005-07-18;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75383
PMS-PREGABALIN;
02359634;
pregabalin 150 mg;
2013-02-14;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84463
TEVA-PREGABALIN;
02361205;
pregabalin 150 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84626
RIVA-PREGABALIN;
02377063;
pregabalin 150 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86264
SANDOZ PREGABALIN;
02390841;
pregabalin 150 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87624
TARO-PREGABALIN;
02392844;
pregabalin 150 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87807
APO-PREGABALIN;
02394278;
pregabalin 150 mg;
2013-04-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87942
PREGABALIN;
02396521;
pregabalin 150 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88158
PREGABALIN;
02403722;
pregabalin 150 mg;
2013-03-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88851
PREGABALIN;
02405563;
pregabalin 150 mg;
2013-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89035
MINT-PREGABALIN;
02424207;
pregabalin 150 mg;
2014-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90892
AURO-PREGABALIN;
02433907;
pregabalin 150 mg;
2015-03-02;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91829
JAMP-PREGABALIN;
02436000;
pregabalin 150 mg;
2015-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92034
M-PREGABALIN;
02467321;
pregabalin 150 mg;
2018-04-03;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95571
PREGABALIN;
02474387;
pregabalin 150 mg;
2018-08-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96446
NRA-PREGABALIN;
02479168;
pregabalin 150 mg;
2018-10-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96712
AG-PREGABALIN;
02480751;
pregabalin 150 mg;
2018-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97128
NAT-PREGABALIN;
02494884;
pregabalin 150 mg;
2020-05-07;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98485
LYRICA;
02268477;
pregabalin 225 mg;
2009-11-18;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75385
TEVA-PREGABALIN;
02361221;
pregabalin 225 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84628
TARO-PREGABALIN;
02392852;
pregabalin 225 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87808
APO-PREGABALIN;
02394286;
pregabalin 225 mg;
2013-05-09;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87943
PMS-PREGABALIN;
02398079;
pregabalin 225 mg;
2013-02-19;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88302
NAT-PREGABALIN;
02494892;
pregabalin 225 mg;
2020-05-07;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98486
LYRICA;
02268418;
pregabalin 25 mg;
2005-07-18;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75379
PMS-PREGABALIN;
02359596;
pregabalin 25 mg;
2013-02-14;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84460
TEVA-PREGABALIN;
02361159;
pregabalin 25 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84620
RIVA-PREGABALIN;
02377039;
pregabalin 25 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86261
SANDOZ PREGABALIN;
02390817;
pregabalin 25 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87621
TARO-PREGABALIN;
02392801;
pregabalin 25 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87804
APO-PREGABALIN;
02394235;
pregabalin 25 mg;
2013-06-06;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87939
PREGABALIN;
02396483;
pregabalin 25 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88153
PREGABALIN;
02403692;
pregabalin 25 mg;
2013-03-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88848
PREGABALIN;
02405539;
pregabalin 25 mg;
2013-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89032
MINT-PREGABALIN;
02423804;
pregabalin 25 mg;
2014-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90851
AURO-PREGABALIN;
02433869;
pregabalin 25 mg;
2015-03-02;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91825
JAMP-PREGABALIN;
02435977;
pregabalin 25 mg;
2015-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92031
M-PREGABALIN;
02467291;
pregabalin 25 mg;
2018-04-03;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95568
PREGABALIN;
02474352;
pregabalin 25 mg;
2018-08-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96443
NRA-PREGABALIN;
02479117;
pregabalin 25 mg;
2018-10-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96708
AG-PREGABALIN;
02480727;
pregabalin 25 mg;
2018-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97125
NAT-PREGABALIN;
02494841;
pregabalin 25 mg;
2020-05-07;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98482
LYRICA;
02268485;
pregabalin 300 mg;
2005-07-18;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75386
PMS-PREGABALIN;
02359642;
pregabalin 300 mg;
2013-02-14;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84464
TEVA-PREGABALIN;
02361248;
pregabalin 300 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84629
RIVA-PREGABALIN;
02377071;
pregabalin 300 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86265
SANDOZ PREGABALIN;
02390868;
pregabalin 300 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87625
TARO-PREGABALIN;
02392860;
pregabalin 300 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87809
APO-PREGABALIN;
02394294;
pregabalin 300 mg;
2013-04-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87944
PREGABALIN;
02396548;
pregabalin 300 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88159
PREGABALIN;
02403730;
pregabalin 300 mg;
2013-03-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88852
PREGABALIN;
02405598;
pregabalin 300 mg;
2013-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89037
JAMP-PREGABALIN;
02436019;
pregabalin 300 mg;
2015-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92035
AG-PREGABALIN;
02480778;
pregabalin 300 mg;
2018-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97129
NAT-PREGABALIN;
02494906;
pregabalin 300 mg;
2020-05-07;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98487
LYRICA;
02268426;
pregabalin 50 mg;
2005-07-18;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75380
PMS-PREGABALIN;
02359618;
pregabalin 50 mg;
2013-02-14;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84461
TEVA-PREGABALIN;
02361175;
pregabalin 50 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84623
RIVA-PREGABALIN;
02377047;
pregabalin 50 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86262
SANDOZ PREGABALIN;
02390825;
pregabalin 50 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87622
TARO-PREGABALIN;
02392828;
pregabalin 50 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87805
APO-PREGABALIN;
02394243;
pregabalin 50 mg;
2013-06-06;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87940
PREGABALIN;
02396505;
pregabalin 50 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88156
PREGABALIN;
02403706;
pregabalin 50 mg;
2013-03-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88849
PREGABALIN;
02405547;
pregabalin 50 mg;
2013-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89033
MINT-PREGABALIN;
02423812;
pregabalin 50 mg;
2014-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90852
AURO-PREGABALIN;
02433877;
pregabalin 50 mg;
2015-03-02;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91826
JAMP-PREGABALIN;
02435985;
pregabalin 50 mg;
2015-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92032
M-PREGABALIN;
02467305;
pregabalin 50 mg;
2018-04-03;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95569
PREGABALIN;
02474360;
pregabalin 50 mg;
2018-08-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96444
NRA-PREGABALIN;
02479125;
pregabalin 50 mg;
2018-10-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96709
AG-PREGABALIN;
02480735;
pregabalin 50 mg;
2018-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97126
NAT-PREGABALIN;
02494868;
pregabalin 50 mg;
2020-05-07;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98483
LYRICA;
02268434;
pregabalin 75 mg;
2005-07-18;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75381
PMS-PREGABALIN;
02359626;
pregabalin 75 mg;
2013-02-14;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84462
TEVA-PREGABALIN;
02361183;
pregabalin 75 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84624
RIVA-PREGABALIN;
02377055;
pregabalin 75 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86263
SANDOZ PREGABALIN;
02390833;
pregabalin 75 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87623
TARO-PREGABALIN;
02392836;
pregabalin 75 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87806
APO-PREGABALIN;
02394251;
pregabalin 75 mg;
2013-04-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87941
PREGABALIN;
02396513;
pregabalin 75 mg;
2013-02-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88157
PREGABALIN;
02403714;
pregabalin 75 mg;
2013-03-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88850
PREGABALIN;
02405555;
pregabalin 75 mg;
2013-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89034
MINT-PREGABALIN;
02424185;
pregabalin 75 mg;
2014-06-12;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90890
AURO-PREGABALIN;
02433885;
pregabalin 75 mg;
2015-03-02;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91827
JAMP-PREGABALIN;
02435993;
pregabalin 75 mg;
2015-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92033
M-PREGABALIN;
02467313;
pregabalin 75 mg;
2017-12-14;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95570
PREGABALIN;
02474379;
pregabalin 75 mg;
2018-08-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96445
NRA-PREGABALIN;
02479133;
pregabalin 75 mg;
2018-10-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96710
AG-PREGABALIN;
02480743;
pregabalin 75 mg;
2018-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97127
NAT-PREGABALIN;
02494876;
pregabalin 75 mg;
2020-05-07;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98484
4% CITANEST PLAIN DENTAL;
02435276;
prilocaine hydrochloride 40 mg / ml;
2015-12-23;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
DENTSPLY CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91954
PRIMAQUINE;
02017776;
primaquine phosphate 26.3 mg;
1945-12-31;
Oral;
Tablet;
08:30.08 – ANTIMALARIALS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18330
PRIMIDONE;
00399310;
primidone 125 mg;
1977-12-31;
Oral;
Tablet;
28:12.04 – BARBITURATES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2751
PRIMIDONE;
00396761;
primidone 250 mg;
1977-12-31;
Oral;
Tablet;
28:12.04 – BARBITURATES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2750
PROCAINAMIDE HYDROCHLORIDE INJ. USP;
02184486;
procainamide hydrochloride 100 mg / ml;
1995-12-31;
Intramuscular , Intravenous;
Solution;
24:04.04.04 – CLASS IA ANTIARRYTHMICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19357
MATULANE;
00012750;
procarbazine (procarbazine hydrochloride) 50 mg;
1970-12-31;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
LEADIANT BIOSCIENCES, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=938
PROCHLORAZINE;
00886432;
prochlorperazine (prochlorperazine maleate) 10 mg;
2000-02-09;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES , 56:22.08 – ANTIHISTAMINES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=45324
PROCHLORAZINE;
00886440;
prochlorperazine (prochlorperazine maleate) 5 mg;
2000-02-09;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES , 56:22.08 – ANTIHISTAMINES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=45325
SANDOZ PROCHLORPERAZINE;
00789720;
prochlorperazine 10 mg;
1989-12-31;
Rectal;
Suppository;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9919
PROMETRIUM;
02166704;
progesterone 100 mg;
1995-12-31;
Oral;
Capsule;
68:32.00 – PROGESTINS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18500
ENDOMETRIN;
02334992;
progesterone 100 mg;
2009-11-30;
Vaginal;
Vaginal Tablet, Effervescent;
68:32.00 – PROGESTINS;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82061
TEVA-PROGESTERONE;
02439913;
progesterone 100 mg;
2015-04-16;
Oral;
Capsule;
68:32.00 – PROGESTINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92431
REDDY-PROGESTERONE;
02463113;
progesterone 100 mg;
2018-08-09;
Oral;
Capsule;
68:32.00 – PROGESTINS;
Prescription;
DR REDDY’S LABORATORIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95102
PMS-PROGESTERONE;
02476576;
progesterone 100 mg;
2018-08-08;
Oral;
Capsule;
68:32.00 – PROGESTINS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96745
AURO-PROGESTERONE;
02493578;
progesterone 100 mg;
2020-03-16;
Oral;
Capsule;
68:32.00 – PROGESTINS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98357
PMS-PROGESTERONE;
02480247;
progesterone 200 mg;
2019-02-07;
Oral;
Capsule;
68:32.00 – PROGESTINS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97078
ACT PROGESTERONE INJECTION;
02446820;
progesterone 50 mg / ml;
2016-04-13;
Intramuscular;
Solution;
68:32.00 – PROGESTINS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93234
CRINONE;
02241013;
progesterone 8 %;
2000-05-20;
Vaginal;
Gel;
68:32.00 – PROGESTINS;
Prescription;
EMD SERONO, A DIVISION OF EMD INC., CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64606
HISTANTIL TAB 50MG;
00575186;
promethazine hydrochloride 50 mg;
1983-12-31;
Oral;
Tablet;
04:04.12 – PHENOTHIAZINE DERIVATIVES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5369
RYTHMOL;
00603708;
propafenone hydrochloride 150 mg;
1988-12-31;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8464
APO-PROPAFENONE;
02243324;
propafenone hydrochloride 150 mg;
2001-02-22;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67227
PROPAFENONE;
02343053;
propafenone hydrochloride 150 mg;
2010-02-16;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82854
MYLAN-PROPAFENONE;
02457172;
propafenone hydrochloride 150 mg;
2017-10-31;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94425
RYTHMOL;
00603716;
propafenone hydrochloride 300 mg;
1988-12-31;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8465
APO-PROPAFENONE;
02243325;
propafenone hydrochloride 300 mg;
2001-02-22;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67228
PROPAFENONE;
02343061;
propafenone hydrochloride 300 mg;
2010-02-16;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82855
MYLAN-PROPAFENONE;
02457164;
propafenone hydrochloride 300 mg;
2017-10-31;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94424
ALCAINE;
00035076;
proparacaine hydrochloride 0.5 % / w/v;
1971-12-31;
Ophthalmic;
Drops;
52:16.00 – LOCAL ANESTHETICS;
Ethical;
ALCON CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1172
MICTORYL;
02460262;
propiverine hydrochloride 30 mg;
2017-05-08;
Oral;
Capsule (Controlled-Delivery);
86:12.04 – Antimuscarinics;
Prescription;
DUCHESNAY INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94755
MICTORYL;
02460270;
propiverine hydrochloride 45 mg;
2017-05-08;
Oral;
Capsule (Controlled-Delivery);
86:12.04 – Antimuscarinics;
Prescription;
DUCHESNAY INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94756
MICTORYL PEDIATRIC;
02460289;
propiverine hydrochloride 5 mg;
2017-04-13;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
DUCHESNAY INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94757
DIPRIVAN 1%;
02018950;
propofol 10 mg / ml;
1993-12-31;
Intravenous;
Emulsion;
28:04.92 – MISCELLANEOUS GENERAL ANESTHETICS;
Prescription;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14476
PROPOFOL INJECTION;
02244379;
propofol 10 mg / ml;
2002-03-01;
Intravenous;
Emulsion;
28:04.92 – MISCELLANEOUS GENERAL ANESTHETICS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68347
PROPOFOL INJECTION;
02437643;
propofol 10 mg / ml;
2015-06-01;
Intravenous;
Emulsion;
28:04.92 – MISCELLANEOUS GENERAL ANESTHETICS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92203
TEVA-PROPOFOL;
02437961;
propofol 10 mg / ml;
2015-11-20;
Intravenous;
Emulsion;
28:04.92 – MISCELLANEOUS GENERAL ANESTHETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92233
PROPOFOL;
02468336;
propofol 10 mg / ml;
2018-04-24;
Intravenous;
Emulsion;
28:04.92 – MISCELLANEOUS GENERAL ANESTHETICS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95676
HEMANGIOL;
02457857;
propranolol (propranolol hydrochloride) 3.75 mg / ml;
2017-03-23;
Oral;
Solution;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PIERRE FABRE DERMO-COSMETIQUE CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94488
PROPRANOLOL HYDROCHLORIDE INJECTION USP;
02225883;
propranolol hydrochloride 1 mg / ml;
1996-10-04;
Intravenous;
Solution;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43431
TEVA-PROPRANOLOL;
00496480;
propranolol hydrochloride 10 mg;
1981-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4254
INDERAL-LA;
02042266;
propranolol hydrochloride 120 mg;
1994-12-31;
Oral;
Capsule (Sustained-Release);
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16124
INDERAL-LA;
02042274;
propranolol hydrochloride 160 mg;
1994-12-31;
Oral;
Capsule (Sustained-Release);
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16579
TEVA-PROPRANOLOL;
00740675;
propranolol hydrochloride 20 mg;
1987-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7349
TEVA-PROPRANOLOL;
00496499;
propranolol hydrochloride 40 mg;
1981-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4255
INDERAL-LA;
02042231;
propranolol hydrochloride 60 mg;
1995-12-31;
Oral;
Capsule (Sustained-Release);
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17780
TEVA-PROPRANOLOL;
00496502;
propranolol hydrochloride 80 mg;
1981-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4256
INDERAL-LA;
02042258;
propranolol hydrochloride 80 mg;
1994-12-31;
Oral;
Capsule (Sustained-Release);
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16123
PROTAMINE SULFATE INJECTION, USP;
02139537;
protamine sulfate 10 mg / ml;
1989-12-31;
Intravenous;
Solution;
20:28.08 – ANTIHEPARIN AGENTS;
Ethical;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19443
PROTAMINE SULFATE INJECTION USP;
02231674;
protamine sulfate 10 mg / ml;
1998-03-03;
Intravenous;
Solution;
20:28.08 – ANTIHEPARIN AGENTS;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51049
RESOTRAN;
02377012;
prucalopride (prucalopride succinate) 1 mg;
2012-01-12;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86259
APO-PRUCALOPRIDE;
02491591;
prucalopride (prucalopride succinate) 1 mg;
2020-01-27;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98158
JAMP PRUCALOPRIDE;
02493489;
prucalopride (prucalopride succinate) 1 mg;
2021-02-26;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98349
RESOTRAN;
02377020;
prucalopride (prucalopride succinate) 2 mg;
2012-01-12;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86260
APO-PRUCALOPRIDE;
02491605;
prucalopride (prucalopride succinate) 2 mg;
2020-01-27;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98159
JAMP PRUCALOPRIDE;
02493497;
prucalopride (prucalopride succinate) 2 mg;
2021-02-26;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98350
TUBERSOL;
00317268;
purified protein derivative of tuberculin 5 tub / 0.1 ml;
1975-12-31;
Intradermal;
Solution;
36:84.00 – TUBERCULOSIS;
Schedule D;
SANOFI PASTEUR LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2087
COMBANTRIN TAB 125MG;
01944363;
pyrantel (pyrantel pamoate) 125 mg;
1973-12-31;
Oral;
Tablet;
08:08.00 – ANTHELMINTICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12926
JAMP-PYRANTEL PAMOATE;
02380617;
pyrantel (pyrantel pamoate) 125 mg;
2013-12-13;
Oral;
Tablet;
08:08.00 – ANTHELMINTICS;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86640
JAMP-PYRANTEL PAMOATE SUSPENSION;
02412470;
pyrantel (pyrantel pamoate) 50 mg / ml;
2014-03-25;
Oral;
Suspension;
08:08.00 – ANTHELMINTICS;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89708
PDP-PYRAZINAMIDE;
00618810;
pyrazinamide 500 mg;
1984-12-31;
Oral;
Tablet;
08:16.04 – ANTITUBERCULOSIS AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6130
MESTINON-SR;
00869953;
pyridostigmine bromide 180 mg;
1991-12-31;
Oral;
Tablet (Extended-Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11135
MESTINON;
00869961;
pyridostigmine bromide 60 mg;
1990-12-31;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10567
RIVA-PYRIDOSTIGMINE;
02495643;
pyridostigmine bromide 60 mg;
2020-08-24;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98554
PYRIDOXINE HYDROCHLORIDE INJECTION, USP;
02245215;
pyridoxine hydrochloride 100 mg / ml;
2002-06-01;
Intramuscular , Intravenous;
Solution;
88:08.00 – VITAMIN B COMPLEX;
Ethical;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69230
ZINC ZAP SPRAY;
02242702;
pyrithione zinc 0.2 %;
2000-10-19;
Topical;
Spray;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
NUTRIMMUNE TECHNOLOGIES INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66499
SMOOTH AND SILKY LISSE ET SOYEUX DANDRUFF PYRITHIONE ZINC CONDITIONER;
02494299;
pyrithione zinc 0.3 % / w/w;
2020-01-21;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
APOLLO HEALTH AND BEAUTY CARE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98432
HEAD & SHOULDERS DANDRUFF CONDITIONER;
02244286;
pyrithione zinc 0.5 %;
2008-02-22;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68253
HEAD & SHOULDERS NOURISHING HAIR & SCALP CARE CONDITIONER;
02440911;
pyrithione zinc 0.5 %;
2016-01-04;
Topical;
Shampoo;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92528
HEAD & SHOULDERS INSTANT COOLING RELIEF CONDITIONER;
02429292;
pyrithione zinc 0.5 % / w/w;
2016-01-04;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91372
PYRITHIONE ZINC DANDRUFF CONDITIONER SUPRÊME STRENGTHEN;
02491486;
pyrithione zinc 0.5 % / w/w;
2020-01-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98148
PYRITHIONE ZINC DANDRUFF CONDITIONER SUPRÊME NOURISH;
02491508;
pyrithione zinc 0.5 % / w/w;
2020-01-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98150
PYRITHIONE ZINC DANDRUFF CONDITIONER SUPRÊME PURIFY & HYDRATE;
02491516;
pyrithione zinc 0.5 % / w/w;
2020-01-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98151
PYRITHIONE ZINC DANDRUFF CONDITIONER SUPRÊME COLOUR PROTECT;
02502720;
pyrithione zinc 0.5 % / w/w;
2020-10-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99227
LIFE DANDRUFF SHAMPOO;
02245769;
pyrithione zinc 1 %;
2003-12-06;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LE GROUPE ULTRAPAC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69880
LIFE -SHAMPOOING ET REVITALISANT ANTIPELLICULAIRE CLASSIQUE – 2 EN 1;
02246089;
pyrithione zinc 1 %;
2003-09-15;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LE GROUPE ULTRAPAC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70224
T/GEL DAILY CONTROL 2 IN 1;
02251159;
pyrithione zinc 1 %;
2004-08-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73611
SHAMPOOING 2 EN 1 ANTIPELLICULAIRE;
02255618;
pyrithione zinc 1 %;
2004-12-20;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LE GROUPE ULTRAPAC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74079
LIFE BRAND ITCHY DRY SCALP ANTI-DANDRUFF SHAMPOO;
02382008;
pyrithione zinc 1 %;
2013-02-04;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CRLS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86787
SMOOTH AND SILKY LISSE ET SOYEUX DANDRUFF PYRITHIONE ZINC SHAMPOO;
02479036;
pyrithione zinc 1 %;
2020-01-14;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
APOLLO HEALTH AND BEAUTY CARE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96974
ORIGINAL / ORIGINALE DANDRUFF PYRITHIONE ZINC SHAMPOO & CONDITIONER;
02479044;
pyrithione zinc 1 %;
2020-01-14;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
APOLLO HEALTH AND BEAUTY CARE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96975
GREEN APPLE POMME VERTE DANDRUFF PYRITHIONE ZINC SHAMPOO;
02479052;
pyrithione zinc 1 %;
2020-01-14;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
APOLLO HEALTH AND BEAUTY CARE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96976
CLEANSING NETTOYANT DANDRUFF PYRITHIONE ZINC SHAMPOO;
02479079;
pyrithione zinc 1 %;
2019-11-09;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
APOLLO HEALTH AND BEAUTY CARE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96978
GREEN APPLE POMME VERTE DANDRUFF PYRITHIONE ZINC SHAMPOO & CONDITIONER;
02479095;
pyrithione zinc 1 %;
2019-11-09;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
APOLLO HEALTH AND BEAUTY CARE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96980
PERT ANTI-DANDRUFF;
02297892;
pyrithione zinc 1 % / w/w;
2007-08-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
IDELLE LABS LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78321
SELSUN BLUE ANTI-DANDRUFF SHAMPOO;
02320320;
pyrithione zinc 1 % / w/w;
2009-11-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
SANOFI CONSUMER HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80576
DOVE MEN+CARE FORTIFYING SHAMPOO + CONDITIONER ANTI-DANDRUFF 2 IN 1;
02357739;
pyrithione zinc 1 % / w/w;
2011-01-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84283
HEAD & SHOULDERS DRY SCALP CARE 2IN1;
02399547;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88442
HEAD & SHOULDERS GREEN APPLE;
02399555;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88443
HEAD & SHOULDERS GREEN APPLE 2IN1;
02399563;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88444
HEAD & SHOULDERS OCEAN LIFT 2IN1;
02399601;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88447
HEAD & SHOULDERS OCEAN LIFT;
02399628;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88448
HEAD & SHOULDERS CLASSIC CLEAN 2IN1;
02399636;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88449
HEAD & SHOULDERS CLASSIC CLEAN;
02399644;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88450
HEAD & SHOULDERS CITRUS BREEZE;
02399660;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88452
HEAD & SHOULDERS DRY SCALP CARE;
02399679;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88453
HEAD & SHOULDERS ITCHY SCALP CARE 2IN1;
02399687;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88454
HEAD & SHOULDERS SMOOTH & SILKY;
02399695;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88455
HEAD & SHOULDERS SMOOTH & SILKY 2IN1;
02399709;
pyrithione zinc 1 % / w/w;
2014-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88456
HEAD & SHOULDERS PURELY GENTLE SCALP CARE;
02400634;
pyrithione zinc 1 % / w/w;
2014-02-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88540
HEAD & SHOULDERS INSTANT COOLING RELIEF;
02422077;
pyrithione zinc 1 % / w/w;
2016-01-04;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90679
HEAD & SHOULDERS INSTANT COOLING RELIEF 2IN1;
02422123;
pyrithione zinc 1 % / w/w;
2016-01-04;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90684
SCALPSYNC ANTI-DANDRUFF;
02425580;
pyrithione zinc 1 % / w/w;
2014-07-02;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
MATRIX CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91022
HEAD & SHOULDERS INSTANT OIL CONTROL;
02426080;
pyrithione zinc 1 % / w/w;
2016-01-04;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91069
HEAD & SHOULDERS INSTANT OIL CONTROL 2IN1;
02426099;
pyrithione zinc 1 % / w/w;
2016-01-04;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91070
MEN EXPERT ANTI-DANDRUFF 2 IN 1;
02430436;
pyrithione zinc 1 % / w/w;
2015-02-02;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
L’ OREAL CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91489
NOURISHING CARE;
02432846;
pyrithione zinc 1 % / w/w;
2016-01-04;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91726
NOURISHING CARE 2IN1;
02432862;
pyrithione zinc 1 % / w/w;
2016-01-04;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91727
PYRITHIONE ZINC DANDRUFF SHAMPOO AND CONDITIONER CLASSIC CLEAN 2 IN 1;
02448769;
pyrithione zinc 1 % / w/w;
2016-04-13;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93449
PYRITHIONE ZINC DANDRUFF SHAMPOO CLASSIC CLEAN;
02448912;
pyrithione zinc 1 % / w/w;
2016-04-13;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93469
PYRITHIONE ZINC DANDRUFF SHAMPOO REFRESH;
02449986;
pyrithione zinc 1 % / w/w;
2016-05-17;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93592
PYRITHIONE ZINC DANDRUFF SHAMPOO SCALP CARE;
02449994;
pyrithione zinc 1 % / w/w;
2016-06-13;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93593
PYRITHIONE ZINC DANDRUFF SHAMPOO CITRUS;
02450011;
pyrithione zinc 1 % / w/w;
2016-04-27;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93597
DOVE MEN+CARE DERMA+CARE SCALP ANTI-DANDRUFF DANDRUFF DEFENSE 2 IN 1;
02465515;
pyrithione zinc 1 % / w/w;
2018-02-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95369
DOVE DERMA+CARE SCALP ANTI-DANDRUFF DRYNESS & ITCH RELIEF;
02466090;
pyrithione zinc 1 % / w/w;
2018-02-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95440
DOVE DERMA+CARE SCALP ANTI-DANDRUFF FRESH & CLEAN 2 IN 1;
02466104;
pyrithione zinc 1 % / w/w;
2018-02-18;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95441
DOVE DERMA+CARE SCALP ANTI-DANDRUFF FRESH & CLEAN;
02466112;
pyrithione zinc 1 % / w/w;
2018-03-14;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95442
DOVE MEN+CARE DERMA+CARE SCALP ANTI-DANDRUFF DRYNESS & ITCH RELIEF 2 IN 1;
02467194;
pyrithione zinc 1 % / w/w;
2018-02-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95558
DOVE DERMA+CARE SCALP ANTI-DANDRUFF SMOOTHING MOISTURE;
02467208;
pyrithione zinc 1 % / w/w;
2018-02-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95559
DOVE MEN+CARE DERMA+CARE SCALP ANTI-DANDRUFF GENTLE CLEAN 2 IN 1;
02467216;
pyrithione zinc 1 % / w/w;
2018-02-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95560
2IN1 MEN ADVANCED SERIES CHARCOAL;
02476010;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96691
MEN ADVANCED SERIES CHARCOAL;
02476029;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96697
MEN ADVANCED SERIES FULL & THICK;
02476037;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96698
2IN1 MEN ADVANCED SERIES FULL & THICK;
02476045;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96699
2IN1 MEN ADVANCED SERIES REFRESHING MENTHOL;
02476053;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96700
MEN ADVANCED SERIES REFRESHING MENTHOL;
02476061;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96701
2IN1 MEN ADVANCED SERIES SWAGGER;
02476193;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96721
MEN ADVANCED SERIES SWAGGER;
02476266;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96727
2IN1 MEN ADVANCED SERIES PURE SPORT;
02477211;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96806
MEN ADVANCED SERIES PURE SPORT;
02477238;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96807
2IN1 MEN ADVANCED SERIES FIJI;
02477289;
pyrithione zinc 1 % / w/w;
2019-05-01;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96824
DOVE MEN PLUS CARE DERMA PLUS CARE SCALP ANTI-DANDRUFF DEEP CLEAN 2 IN 1;
02480174;
pyrithione zinc 1 % / w/w;
2019-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97071
DOVE DERMA PLUS CARE SCALP ANTI-DANDRUFF ALOE & RESTORE;
02480182;
pyrithione zinc 1 % / w/w;
2019-12-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97072
DOVE DERMA PLUS CARE SCALP ANTI-DANDRUFF INVIGORATING MINT;
02480190;
pyrithione zinc 1 % / w/w;
2019-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97073
DOVE DERMA PLUS CARE SCALP ANTI-DANDRUFF INVIGORATING MINT 2 IN 1;
02480204;
pyrithione zinc 1 % / w/w;
2019-01-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
UNILEVER CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97074
SCALP RELIEF;
02488132;
pyrithione zinc 1 % / w/w;
2020-05-26;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
REDKEN 5TH AVENUE NYC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97824
PYRITHIONE ZINC DANDRUFF SHAMPOO SUPRÊME NOURISH;
02491443;
pyrithione zinc 1 % / w/w;
2020-01-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98145
PYRITHIONE ZINC DANDRUFF SHAMPOO SUPRÊME STRENGTHEN;
02491451;
pyrithione zinc 1 % / w/w;
2020-01-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98146
PYRITHIONE ZINC DANDRUFF SHAMPOO SUPRÊME PURIFY & HYDRATE;
02491478;
pyrithione zinc 1 % / w/w;
2020-01-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98147
2IN1 MEN ADVANCED SERIES BOURBON;
02492873;
pyrithione zinc 1 % / w/w;
2020-01-15;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98287
2IN1 MEN ADVANCED SERIES SAGE & MINT;
02492881;
pyrithione zinc 1 % / w/w;
2020-01-15;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98288
2IN1 MEN ADVANCED SERIES SANDALWOOD;
02492903;
pyrithione zinc 1 % / w/w;
2020-01-15;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98289
ALOE VERA 2IN1;
02493721;
pyrithione zinc 1 % / w/w;
2020-01-15;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98372
PYRITHIONE ZINC DANDRUFF SHAMPOO SUPRÊME COLOUR PROTECT;
02502763;
pyrithione zinc 1 % / w/w;
2020-11-02;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99231
PYRITHIONE ZINC DANDRUFF SHAMPOO CLASSIC CLEAN;
02258404;
pyrithione zinc 1.0 %;
2004-12-20;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LE GROUPE ULTRAPAC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74361
DANDRUFF;
02318474;
pyrithione zinc 1.0 % / w/w;
2009-04-14;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
BELVEDERE INTERNATIONAL INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80396
HEAD & SHOULDERS ITCHY SCALP CARE;
02399520;
pyrithione zinc 1.0 % / w/w;
2014-02-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88440
HEAD & SHOULDERS PURELY GENTLE SCALP CARE 2IN1;
02400642;
pyrithione zinc 1.0 % / w/w;
2014-02-03;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88542
SHAMPOO CONTROL – 2%;
02207389;
pyrithione zinc 2 %;
1996-06-02;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
AG HAIR LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37795
SEROQUEL;
02236952;
quetiapine (quetiapine fumarate) 100 mg;
1997-12-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60246
TEVA-QUETIAPINE;
02284243;
quetiapine (quetiapine fumarate) 100 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76979
PMS-QUETIAPINE;
02296578;
quetiapine (quetiapine fumarate) 100 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78189
APO-QUETIAPINE;
02313928;
quetiapine (quetiapine fumarate) 100 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79944
SANDOZ QUETIAPINE;
02314002;
quetiapine (quetiapine fumarate) 100 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79952
ACT QUETIAPINE;
02316099;
quetiapine (quetiapine fumarate) 100 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80162
RIVA-QUETIAPINE;
02316706;
quetiapine (quetiapine fumarate) 100 mg;
2008-09-24;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80221
PRO-QUETIAPINE;
02317354;
quetiapine (quetiapine fumarate) 100 mg;
2008-10-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80288
QUETIAPINE;
02317907;
quetiapine (quetiapine fumarate) 100 mg;
2009-02-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80342
JAMP-QUETIAPINE;
02330423;
quetiapine (quetiapine fumarate) 100 mg;
2010-04-02;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81616
QUETIAPINE;
02353172;
quetiapine (quetiapine fumarate) 100 mg;
2010-07-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83839
QUETIAPINE TABLETS;
02387808;
quetiapine (quetiapine fumarate) 100 mg;
2012-06-20;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87338
AURO-QUETIAPINE;
02390213;
quetiapine (quetiapine fumarate) 100 mg;
2012-10-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87567
RAN-QUETIAPINE;
02397102;
quetiapine (quetiapine fumarate) 100 mg;
2013-01-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88210
MINT-QUETIAPINE;
02438011;
quetiapine (quetiapine fumarate) 100 mg;
2015-03-19;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92238
NAT-QUETIAPINE;
02439166;
quetiapine (quetiapine fumarate) 100 mg;
2015-07-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92354
BIO-QUETIAPINE;
02447207;
quetiapine (quetiapine fumarate) 100 mg;
2016-09-07;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93277
AG-QUETIAPINE;
02475987;
quetiapine (quetiapine fumarate) 100 mg;
2018-09-25;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96638
TEVA-QUETIAPINE;
02284251;
quetiapine (quetiapine fumarate) 150 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76980
SEROQUEL XR;
02321513;
quetiapine (quetiapine fumarate) 150 mg;
2009-04-14;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80692
QUETIAPINE TABLETS;
02387816;
quetiapine (quetiapine fumarate) 150 mg;
2012-06-20;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87339
TEVA-QUETIAPINE XR;
02395452;
quetiapine (quetiapine fumarate) 150 mg;
2013-03-08;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88054
SANDOZ QUETIAPINE XRT;
02407698;
quetiapine (quetiapine fumarate) 150 mg;
2013-06-14;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89244
QUETIAPINE XR;
02417367;
quetiapine (quetiapine fumarate) 150 mg;
2014-01-16;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90199
QUETIAPINE XR;
02417790;
quetiapine (quetiapine fumarate) 150 mg;
2014-01-09;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90241
NAT-QUETIAPINE;
02439174;
quetiapine (quetiapine fumarate) 150 mg;
2015-07-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92355
ACH-QUETIAPINE FUMARATE XR;
02450879;
quetiapine (quetiapine fumarate) 150 mg;
2020-10-21;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93700
APO-QUETIAPINE XR;
02457237;
quetiapine (quetiapine fumarate) 150 mg;
2018-06-15;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94431
SEROQUEL;
02236953;
quetiapine (quetiapine fumarate) 200 mg;
1997-12-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60247
TEVA-QUETIAPINE;
02284278;
quetiapine (quetiapine fumarate) 200 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76981
PMS-QUETIAPINE;
02296594;
quetiapine (quetiapine fumarate) 200 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78191
SEROQUEL XR;
02300192;
quetiapine (quetiapine fumarate) 200 mg;
2007-09-27;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78551
APO-QUETIAPINE;
02313936;
quetiapine (quetiapine fumarate) 200 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79945
SANDOZ QUETIAPINE;
02314010;
quetiapine (quetiapine fumarate) 200 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79953
ACT QUETIAPINE;
02316110;
quetiapine (quetiapine fumarate) 200 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80164
RIVA-QUETIAPINE;
02316722;
quetiapine (quetiapine fumarate) 200 mg;
2008-09-24;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80223
PRO-QUETIAPINE;
02317362;
quetiapine (quetiapine fumarate) 200 mg;
2008-10-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80289
QUETIAPINE;
02317923;
quetiapine (quetiapine fumarate) 200 mg;
2009-02-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80344
JAMP-QUETIAPINE;
02330458;
quetiapine (quetiapine fumarate) 200 mg;
2010-04-02;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81618
QUETIAPINE;
02353199;
quetiapine (quetiapine fumarate) 200 mg;
2010-07-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83841
QUETIAPINE TABLETS;
02387824;
quetiapine (quetiapine fumarate) 200 mg;
2012-06-20;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87340
AURO-QUETIAPINE;
02390248;
quetiapine (quetiapine fumarate) 200 mg;
2012-10-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87569
TEVA-QUETIAPINE XR;
02395460;
quetiapine (quetiapine fumarate) 200 mg;
2013-03-08;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88055
RAN-QUETIAPINE;
02397110;
quetiapine (quetiapine fumarate) 200 mg;
2013-01-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88211
SANDOZ QUETIAPINE XRT;
02407701;
quetiapine (quetiapine fumarate) 200 mg;
2013-06-14;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89241
QUETIAPINE XR;
02417375;
quetiapine (quetiapine fumarate) 200 mg;
2014-01-16;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90200
QUETIAPINE XR;
02417804;
quetiapine (quetiapine fumarate) 200 mg;
2014-01-09;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90242
MINT-QUETIAPINE;
02438046;
quetiapine (quetiapine fumarate) 200 mg;
2015-03-19;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92240
NAT-QUETIAPINE;
02439182;
quetiapine (quetiapine fumarate) 200 mg;
2015-07-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92356
BIO-QUETIAPINE;
02447223;
quetiapine (quetiapine fumarate) 200 mg;
2016-09-07;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93279
ACH-QUETIAPINE FUMARATE XR;
02450887;
quetiapine (quetiapine fumarate) 200 mg;
2020-10-21;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93701
APO-QUETIAPINE XR;
02457245;
quetiapine (quetiapine fumarate) 200 mg;
2018-06-15;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94432
AG-QUETIAPINE;
02475995;
quetiapine (quetiapine fumarate) 200 mg;
2018-09-26;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96639
SEROQUEL;
02236951;
quetiapine (quetiapine fumarate) 25 mg;
1997-12-10;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60245
TEVA-QUETIAPINE;
02284235;
quetiapine (quetiapine fumarate) 25 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76978
PMS-QUETIAPINE;
02296551;
quetiapine (quetiapine fumarate) 25 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78188
APO-QUETIAPINE;
02313901;
quetiapine (quetiapine fumarate) 25 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79943
SANDOZ QUETIAPINE;
02313995;
quetiapine (quetiapine fumarate) 25 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79951
ACT QUETIAPINE;
02316080;
quetiapine (quetiapine fumarate) 25 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80161
RIVA-QUETIAPINE;
02316692;
quetiapine (quetiapine fumarate) 25 mg;
2008-09-24;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80220
PRO-QUETIAPINE;
02317346;
quetiapine (quetiapine fumarate) 25 mg;
2008-10-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80287
QUETIAPINE;
02317893;
quetiapine (quetiapine fumarate) 25 mg;
2009-02-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80341
JAMP-QUETIAPINE;
02330415;
quetiapine (quetiapine fumarate) 25 mg;
2010-04-02;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81615
QUETIAPINE;
02353164;
quetiapine (quetiapine fumarate) 25 mg;
2010-07-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83838
QUETIAPINE TABLETS;
02387794;
quetiapine (quetiapine fumarate) 25 mg;
2012-06-20;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87337
AURO-QUETIAPINE;
02390205;
quetiapine (quetiapine fumarate) 25 mg;
2012-10-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87566
RAN-QUETIAPINE;
02397099;
quetiapine (quetiapine fumarate) 25 mg;
2013-01-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88209
MINT-QUETIAPINE;
02438003;
quetiapine (quetiapine fumarate) 25 mg;
2015-03-19;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92237
NAT-QUETIAPINE;
02439158;
quetiapine (quetiapine fumarate) 25 mg;
2015-07-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92353
PRIVA-QUETIAPINE;
02447088;
quetiapine (quetiapine fumarate) 25 mg;
2016-09-07;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93265
BIO-QUETIAPINE;
02447193;
quetiapine (quetiapine fumarate) 25 mg;
2016-09-07;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93276
AG-QUETIAPINE;
02475979;
quetiapine (quetiapine fumarate) 25 mg;
2018-09-25;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96637
NRA-QUETIAPINE;
02486237;
quetiapine (quetiapine fumarate) 25 mg;
2019-09-23;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97646
SEROQUEL;
02244107;
quetiapine (quetiapine fumarate) 300 mg;
2001-08-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68066
TEVA-QUETIAPINE;
02284286;
quetiapine (quetiapine fumarate) 300 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76982
PMS-QUETIAPINE;
02296608;
quetiapine (quetiapine fumarate) 300 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78192
SEROQUEL XR;
02300206;
quetiapine (quetiapine fumarate) 300 mg;
2007-09-27;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78552
APO-QUETIAPINE;
02313944;
quetiapine (quetiapine fumarate) 300 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79946
SANDOZ QUETIAPINE;
02314029;
quetiapine (quetiapine fumarate) 300 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79954
ACT QUETIAPINE;
02316129;
quetiapine (quetiapine fumarate) 300 mg;
2008-09-04;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80165
RIVA-QUETIAPINE;
02316730;
quetiapine (quetiapine fumarate) 300 mg;
2008-09-24;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80224
PRO-QUETIAPINE;
02317370;
quetiapine (quetiapine fumarate) 300 mg;
2008-10-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80290
QUETIAPINE;
02317931;
quetiapine (quetiapine fumarate) 300 mg;
2009-02-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80345
JAMP-QUETIAPINE;
02330466;
quetiapine (quetiapine fumarate) 300 mg;
2010-06-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81619
QUETIAPINE;
02353202;
quetiapine (quetiapine fumarate) 300 mg;
2010-07-26;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83842
QUETIAPINE TABLETS;
02387832;
quetiapine (quetiapine fumarate) 300 mg;
2012-06-20;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87341
AURO-QUETIAPINE;
02390256;
quetiapine (quetiapine fumarate) 300 mg;
2012-10-18;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87570
TEVA-QUETIAPINE XR;
02395479;
quetiapine (quetiapine fumarate) 300 mg;
2013-03-08;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88056
RAN-QUETIAPINE;
02397129;
quetiapine (quetiapine fumarate) 300 mg;
2013-01-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88212
SANDOZ QUETIAPINE XRT;
02407728;
quetiapine (quetiapine fumarate) 300 mg;
2013-06-14;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89242
QUETIAPINE XR;
02417383;
quetiapine (quetiapine fumarate) 300 mg;
2014-01-16;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90201
QUETIAPINE XR;
02417812;
quetiapine (quetiapine fumarate) 300 mg;
2014-01-09;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90243
MINT-QUETIAPINE;
02438054;
quetiapine (quetiapine fumarate) 300 mg;
2015-03-19;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92241
NAT-QUETIAPINE;
02439190;
quetiapine (quetiapine fumarate) 300 mg;
2015-07-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92357
BIO-QUETIAPINE;
02447258;
quetiapine (quetiapine fumarate) 300 mg;
2016-09-07;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93280
ACH-QUETIAPINE FUMARATE XR;
02450895;
quetiapine (quetiapine fumarate) 300 mg;
2021-01-21;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93702
APO-QUETIAPINE XR;
02457253;
quetiapine (quetiapine fumarate) 300 mg;
2018-06-15;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94433
AG-QUETIAPINE;
02476002;
quetiapine (quetiapine fumarate) 300 mg;
2018-09-26;
Oral;
Tablet (Immediate Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96640
SEROQUEL XR;
02300214;
quetiapine (quetiapine fumarate) 400 mg;
2007-09-27;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78553
TEVA-QUETIAPINE XR;
02395487;
quetiapine (quetiapine fumarate) 400 mg;
2013-03-08;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88057
SANDOZ QUETIAPINE XRT;
02407736;
quetiapine (quetiapine fumarate) 400 mg;
2013-06-14;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89243
QUETIAPINE XR;
02417391;
quetiapine (quetiapine fumarate) 400 mg;
2014-01-16;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90202
QUETIAPINE XR;
02417820;
quetiapine (quetiapine fumarate) 400 mg;
2014-01-09;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90244
ACH-QUETIAPINE FUMARATE XR;
02450909;
quetiapine (quetiapine fumarate) 400 mg;
2020-10-29;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93703
APO-QUETIAPINE XR;
02457261;
quetiapine (quetiapine fumarate) 400 mg;
2018-06-15;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94434
SEROQUEL XR;
02300184;
quetiapine (quetiapine fumarate) 50 mg;
2007-09-27;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78550
PMS-QUETIAPINE;
02361892;
quetiapine (quetiapine fumarate) 50 mg;
2011-01-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84693
TEVA-QUETIAPINE XR;
02395444;
quetiapine (quetiapine fumarate) 50 mg;
2013-03-08;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88053
SANDOZ QUETIAPINE XRT;
02407671;
quetiapine (quetiapine fumarate) 50 mg;
2013-06-14;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89240
QUETIAPINE XR;
02417359;
quetiapine (quetiapine fumarate) 50 mg;
2014-01-01;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90198
QUETIAPINE XR;
02417782;
quetiapine (quetiapine fumarate) 50 mg;
2014-01-09;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90240
ACH-QUETIAPINE FUMARATE XR;
02450860;
quetiapine (quetiapine fumarate) 50 mg;
2020-10-21;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93699
APO-QUETIAPINE XR;
02457229;
quetiapine (quetiapine fumarate) 50 mg;
2018-06-15;
Oral;
Tablet (Extended-Release);
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94430
NORPROLAC;
02223740;
quinagolide (quinagolide hydrochloride) 0.025 mg;
2004-12-29;
Oral;
Tablet;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43389
NORPROLAC;
02223759;
quinagolide (quinagolide hydrochloride) 0.05 mg;
2004-12-29;
Oral;
Tablet;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43390
NORPROLAC;
02223767;
quinagolide (quinagolide hydrochloride) 0.075 mg;
2004-12-29;
Oral;
Tablet;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43391
NORPROLAC;
02223775;
quinagolide (quinagolide hydrochloride) 0.15 mg;
2004-12-29;
Oral;
Tablet;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43392
ACCUPRIL TAB 10MG;
01947672;
quinapril (quinapril hydrochloride) 10 mg;
1992-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12332
APO-QUINAPRIL;
02248500;
quinapril (quinapril hydrochloride) 10 mg;
2013-07-02;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72852
PMS-QUINAPRIL;
02340569;
quinapril (quinapril hydrochloride) 10 mg;
2013-11-18;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82614
ACCUPRIL TAB 20MG;
01947680;
quinapril (quinapril hydrochloride) 20 mg;
1992-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12333
APO-QUINAPRIL;
02248501;
quinapril (quinapril hydrochloride) 20 mg;
2013-07-02;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72853
PMS-QUINAPRIL;
02340577;
quinapril (quinapril hydrochloride) 20 mg;
2013-11-18;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82615
ACCUPRIL TAB 40MG;
01947699;
quinapril (quinapril hydrochloride) 40 mg;
1992-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12334
APO-QUINAPRIL;
02248502;
quinapril (quinapril hydrochloride) 40 mg;
2013-07-02;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72854
PMS-QUINAPRIL;
02340585;
quinapril (quinapril hydrochloride) 40 mg;
2013-11-18;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82616
ACCUPRIL 5MG TAB;
01947664;
quinapril (quinapril hydrochloride) 5 mg;
1992-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12331
APO-QUINAPRIL;
02248499;
quinapril (quinapril hydrochloride) 5 mg;
2013-07-02;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72851
PMS-QUINAPRIL;
02340550;
quinapril (quinapril hydrochloride) 5 mg;
2013-11-18;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82613
TEVA-QUININE;
00021008;
quinine sulfate 200 mg;
1966-12-31;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=651
QUININE – ODAN;
00695440;
quinine sulfate 200 mg;
1999-05-01;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=38055
APO-QUININE;
02254514;
quinine sulfate 200 mg;
2004-06-08;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73941
PRO-QUININE – 200;
02311216;
quinine sulfate 200 mg;
2008-07-03;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79680
JAMP-QUININE;
02445190;
quinine sulfate 200 mg;
2015-09-16;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93042
TEVA-QUININE;
00021016;
quinine sulfate 300 mg;
1966-12-31;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=290
QUININE – ODAN;
00695459;
quinine sulfate 300 mg;
1999-05-01;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=38056
APO-QUININE;
02254522;
quinine sulfate 300 mg;
2004-06-08;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73942
PRO-QUININE – 300;
02311224;
quinine sulfate 300 mg;
2008-07-03;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79681
JAMP-QUININE;
02445204;
quinine sulfate 300 mg;
2015-09-16;
Oral;
Capsule;
08:30.08 – ANTIMALARIALS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93043
PARIET, ENTERIC-COATED TABLET 10MG;
02243796;
rabeprazole sodium 10 mg;
2002-04-02;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67734
TEVA-RABEPRAZOLE EC;
02296632;
rabeprazole sodium 10 mg;
2007-11-13;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78199
TARO-RABEPRAZOLE;
02298074;
rabeprazole sodium 10 mg;
2007-11-09;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78338
PMS-RABEPRAZOLE EC;
02310805;
rabeprazole sodium 10 mg;
2008-06-03;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79643
SANDOZ RABEPRAZOLE;
02314177;
rabeprazole sodium 10 mg;
2008-07-29;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79974
PRO-RABEPRAZOLE;
02315181;
rabeprazole sodium 10 mg;
2009-02-10;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80074
RABEPRAZOLE EC;
02356511;
rabeprazole sodium 10 mg;
2010-11-23;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84166
RABEPRAZOLE;
02385449;
rabeprazole sodium 10 mg;
2012-06-10;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87107
PARIET, ENTERIC-COATED TABLET 20MG;
02243797;
rabeprazole sodium 20 mg;
2002-04-02;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67735
TEVA-RABEPRAZOLE EC;
02296640;
rabeprazole sodium 20 mg;
2007-11-13;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78200
TARO-RABEPRAZOLE;
02298082;
rabeprazole sodium 20 mg;
2007-11-09;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78339
PMS-RABEPRAZOLE EC;
02310813;
rabeprazole sodium 20 mg;
2008-06-03;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79644
SANDOZ RABEPRAZOLE;
02314185;
rabeprazole sodium 20 mg;
2008-07-29;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79975
RABEPRAZOLE EC;
02356538;
rabeprazole sodium 20 mg;
2010-11-23;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84167
RABEPRAZOLE;
02385457;
rabeprazole sodium 20 mg;
2012-06-10;
Oral;
Tablet (Enteric-Coated);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87108
IMOGAM RABIES PASTEURIZED;
02237328;
rabies immunoglobulin (human) 150 unit / ml;
1999-04-30;
Intramuscular;
Solution;
80:04.00 – SERUMS;
Schedule D;
SANOFI PASTEUR LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60651
KAMRAB;
02482436;
rabies immunoglobulin (human) 150 unit / ml;
2020-04-06;
Intramuscular;
Solution;
80:04.00 – SERUMS;
Schedule D;
KAMADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97288
HYPERRAB;
02486571;
rabies immunoglobulin (human) 300 unit / ml;
2019-07-02;
Intramuscular;
Solution;
80:04.00 – SERUMS;
Schedule D;
GRIFOLS THERAPEUTICS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97677
IMOVAX RABIES RABIES VACCINE INACTIVATED (DCO);
01908286;
rabies vaccine inactivated (human diploid-cell culture) 2.5 unit / vial;
1999-08-13;
Intramuscular;
Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=46832
RABAVERT;
02267667;
rabies vaccine inactivated (purified chick embryo cell culture) 2.5 unit / dose;
2005-05-16;
Intramuscular;
Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
BAVARIAN NORDIC AS
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75308
EVISTA (60MG);
02239028;
raloxifene hydrochloride 60 mg;
1998-11-20;
Oral;
Tablet;
68:16.12 – ESTROGEN AGONIST-ANTAGONISTS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62480
APO-RALOXIFENE;
02279215;
raloxifene hydrochloride 60 mg;
2009-03-31;
Oral;
Tablet;
68:16.12 – ESTROGEN AGONIST-ANTAGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76475
ACT RALOXIFENE;
02358840;
raloxifene hydrochloride 60 mg;
2012-06-19;
Oral;
Tablet;
68:16.12 – ESTROGEN AGONIST-ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84388
ISENTRESS;
02392437;
raltegravir (raltegravir potassium) 100 mg;
2013-02-11;
Oral;
Tablet (Chewable);
08:18.08.12 – HIV INTEGRASE INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87771
ISENTRESS;
02392429;
raltegravir (raltegravir potassium) 25 mg;
2013-02-11;
Oral;
Tablet (Chewable);
08:18.08.12 – HIV INTEGRASE INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87770
ISENTRESS;
02301881;
raltegravir (raltegravir potassium) 400 mg;
2007-11-28;
Oral;
Tablet;
08:18.08.12 – HIV INTEGRASE INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78722
ISENTRESS HD;
02465337;
raltegravir (raltegravir potassium) 600 mg;
2017-09-11;
Oral;
Tablet;
08:18.08.12 – HIV INTEGRASE INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95353
TOMUDEX;
02229566;
raltitrexed (raltitrexed disodium) 2 mg / vial;
1996-11-18;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47482
ALTACE;
02221829;
ramipril 1.25 mg;
1997-05-28;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43308
APO-RAMIPRIL;
02251515;
ramipril 1.25 mg;
2006-12-12;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73644
RAMIPRIL;
02308363;
ramipril 1.25 mg;
2010-03-01;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79402
PRO-RAMIPRIL – 1.25;
02310023;
ramipril 1.25 mg;
2011-11-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79569
TARO-RAMIPRIL;
02310503;
ramipril 1.25 mg;
2008-06-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79613
AURO-RAMIPRIL;
02387387;
ramipril 1.25 mg;
2012-09-13;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87297
PHARMA-RAMIPRIL;
02469057;
ramipril 1.25 mg;
2018-04-16;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95770
ALTACE;
02221853;
ramipril 10 mg;
1997-03-24;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43311
TEVA-RAMIPRIL;
02247947;
ramipril 10 mg;
2007-05-02;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72257
APO-RAMIPRIL;
02251582;
ramipril 10 mg;
2006-12-12;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73650
RAMIPRIL;
02255332;
ramipril 10 mg;
2008-03-14;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74051
RAMIPRIL;
02287943;
ramipril 10 mg;
2010-03-01;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77335
PRO-RAMIPRIL – 10;
02310104;
ramipril 10 mg;
2011-11-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79575
TARO-RAMIPRIL;
02310546;
ramipril 10 mg;
2008-06-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79616
JAMP-RAMIPRIL;
02331144;
ramipril 10 mg;
2010-03-10;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81686
RAMIPRIL;
02374862;
ramipril 10 mg;
2011-11-24;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86021
AURO-RAMIPRIL;
02387417;
ramipril 10 mg;
2012-09-13;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87300
PHARMA-RAMIPRIL;
02469081;
ramipril 10 mg;
2018-04-16;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95773
AG-RAMIPRIL;
02477599;
ramipril 10 mg;
2018-09-06;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96786
PRIVA-RAMIPRIL;
02483432;
ramipril 10 mg;
2019-02-06;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97259
NRA-RAMIPRIL;
02486199;
ramipril 10 mg;
2019-09-20;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97642
RAMIPRIL;
02486539;
ramipril 10 mg;
2020-02-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97673
MAR-RAMIPRIL;
02420481;
ramipril 10.0 mg;
2015-01-09;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90507
MINT-RAMIPRIL;
02421321;
ramipril 10.0 mg;
2014-03-17;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90596
ALTACE;
02281112;
ramipril 15 mg;
2006-08-14;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76678
APO-RAMIPRIL;
02325381;
ramipril 15 mg;
2009-05-01;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81078
JAMP-RAMIPRIL;
02440334;
ramipril 15 mg;
2015-09-08;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92469
MAR-RAMIPRIL;
02420503;
ramipril 15.0 mg;
2014-09-10;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90508
MINT-RAMIPRIL;
02421348;
ramipril 15.0 mg;
2014-03-17;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90597
ALTACE;
02221837;
ramipril 2.5 mg;
1997-04-21;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43309
TEVA-RAMIPRIL;
02247945;
ramipril 2.5 mg;
2007-05-02;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72255
APO-RAMIPRIL;
02251531;
ramipril 2.5 mg;
2006-12-12;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73646
RAMIPRIL;
02255316;
ramipril 2.5 mg;
2008-03-14;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74047
RAMIPRIL;
02287927;
ramipril 2.5 mg;
2010-03-01;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77332
PRO-RAMIPRIL – 2.5;
02310066;
ramipril 2.5 mg;
2011-11-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79571
TARO-RAMIPRIL;
02310511;
ramipril 2.5 mg;
2008-06-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79614
JAMP-RAMIPRIL;
02331128;
ramipril 2.5 mg;
2010-03-10;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81684
RAMIPRIL;
02374846;
ramipril 2.5 mg;
2011-11-24;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86019
AURO-RAMIPRIL;
02387395;
ramipril 2.5 mg;
2012-09-13;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87298
MAR-RAMIPRIL;
02420465;
ramipril 2.5 mg;
2015-01-09;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90505
MINT-RAMIPRIL;
02421305;
ramipril 2.5 mg;
2014-03-17;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90594
PHARMA-RAMIPRIL;
02469065;
ramipril 2.5 mg;
2018-04-16;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95771
AG-RAMIPRIL;
02477572;
ramipril 2.5 mg;
2018-09-06;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96784
PRIVA-RAMIPRIL;
02483416;
ramipril 2.5 mg;
2019-02-06;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97257
NRA-RAMIPRIL;
02486172;
ramipril 2.5 mg;
2019-09-20;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97640
RAMIPRIL;
02486512;
ramipril 2.5 mg;
2020-03-19;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97671
ALTACE;
02221845;
ramipril 5 mg;
1997-04-21;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43310
TEVA-RAMIPRIL;
02247946;
ramipril 5 mg;
2007-05-02;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72256
APO-RAMIPRIL;
02251574;
ramipril 5 mg;
2006-12-12;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73648
RAMIPRIL;
02255324;
ramipril 5 mg;
2008-03-14;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74048
RAMIPRIL;
02287935;
ramipril 5 mg;
2010-03-01;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77334
PRO-RAMIPRIL – 5;
02310074;
ramipril 5 mg;
2011-11-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79574
TARO-RAMIPRIL;
02310538;
ramipril 5 mg;
2008-06-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79615
JAMP-RAMIPRIL;
02331136;
ramipril 5 mg;
2010-03-10;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81685
RAMIPRIL;
02374854;
ramipril 5 mg;
2011-11-24;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86020
AURO-RAMIPRIL;
02387409;
ramipril 5 mg;
2012-09-13;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87299
PHARMA-RAMIPRIL;
02469073;
ramipril 5 mg;
2018-04-16;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95772
AG-RAMIPRIL;
02477580;
ramipril 5 mg;
2018-09-06;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96785
PRIVA-RAMIPRIL;
02483424;
ramipril 5 mg;
2019-02-06;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97258
NRA-RAMIPRIL;
02486180;
ramipril 5 mg;
2019-09-20;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97641
RAMIPRIL;
02486520;
ramipril 5 mg;
2020-02-25;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97672
MAR-RAMIPRIL;
02420473;
ramipril 5.0 mg;
2015-01-09;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90506
MINT-RAMIPRIL;
02421313;
ramipril 5.0 mg;
2014-03-17;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90595
CYRAMZA;
02443805;
ramucirumab 10 mg / ml;
2015-09-10;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92855
LUCENTIS;
02296810;
ranibizumab 10 mg / ml;
2007-07-26;
Intravitreal;
Solution;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78217
LUCENTIS;
02425629;
ranibizumab 10 mg / ml;
2014-09-18;
Intravitreal;
Solution;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91026
PMS-RANITIDINE 150 MG;
02242453;
ranitidine (ranitidine hydrochloride) 150 mg;
2000-08-25;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66172
ZANTAC MAXIMUM STRENGTH NON-PRESCRIPTION;
02277301;
ranitidine (ranitidine hydrochloride) 150 mg;
2007-03-09;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Otc;
SANOFI CONSUMER HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76295
MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION;
02293471;
ranitidine (ranitidine hydrochloride) 150 mg;
2007-07-18;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77884
MAXIMUM STRENGTH ACID REDUCER;
02298902;
ranitidine (ranitidine hydrochloride) 150 mg;
2007-10-12;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78429
RAN-RANITIDINE;
02336480;
ranitidine (ranitidine hydrochloride) 150 mg;
2009-11-02;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82205
RANITIDINE;
02353016;
ranitidine (ranitidine hydrochloride) 150 mg;
2010-07-26;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83824
MAR-RANITIDINE;
02443708;
ranitidine (ranitidine hydrochloride) 150 mg;
2018-11-09;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92844
JAMP-RANITIDINE;
02463717;
ranitidine (ranitidine hydrochloride) 150 mg;
2018-10-24;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95181
M-RANITIDINE;
02473534;
ranitidine (ranitidine hydrochloride) 150 mg;
2018-12-11;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96292
AG-RANITIDINE;
02484501;
ranitidine (ranitidine hydrochloride) 150 mg;
2019-08-14;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97481
PMS-RANITIDINE 300 MG;
02242454;
ranitidine (ranitidine hydrochloride) 300 mg;
2000-08-25;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66173
RAN-RANITIDINE;
02336502;
ranitidine (ranitidine hydrochloride) 300 mg;
2009-11-02;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82207
RANITIDINE;
02353024;
ranitidine (ranitidine hydrochloride) 300 mg;
2010-07-26;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83825
MAR-RANITIDINE;
02443716;
ranitidine (ranitidine hydrochloride) 300 mg;
2018-11-09;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92845
JAMP-RANITIDINE;
02463725;
ranitidine (ranitidine hydrochloride) 300 mg;
2018-10-24;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95182
M-RANITIDINE;
02473542;
ranitidine (ranitidine hydrochloride) 300 mg;
2018-12-11;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96293
ZANTAC;
02230287;
ranitidine (ranitidine hydrochloride) 75 mg;
1997-09-26;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Otc;
SANOFI CONSUMER HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49044
ACID REDUCER;
02247551;
ranitidine (ranitidine hydrochloride) 75 mg;
2004-07-13;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71801
ACID REDUCER;
02298740;
ranitidine (ranitidine hydrochloride) 75 mg;
2008-01-31;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78405
AZILECT;
02284642;
rasagiline (rasagiline mesylate) 0.5 mg;
2006-09-14;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
TEVA PHARMACEUTICAL INDUSTRIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77019
APO-RASAGILINE;
02404680;
rasagiline (rasagiline mesylate) 0.5 mg;
2016-01-12;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88948
TEVA-RASAGILINE;
02418436;
rasagiline (rasagiline mesylate) 0.5 mg;
2016-05-30;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90300
JAMP RASAGILINE;
02491974;
rasagiline (rasagiline mesylate) 0.5 mg;
2020-09-04;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98198
APO-RASAGILINE;
02404699;
rasagiline (rasagiline mesylate) 1 mg;
2016-01-12;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88949
TEVA-RASAGILINE;
02418444;
rasagiline (rasagiline mesylate) 1 mg;
2016-05-30;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90301
JAMP RASAGILINE;
02491982;
rasagiline (rasagiline mesylate) 1 mg;
2020-09-04;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98199
AZILECT;
02284650;
rasagiline (rasagiline mesylate) 1.0 mg;
2006-09-14;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
TEVA PHARMACEUTICAL INDUSTRIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77020
FASTURTEC;
02248416;
rasburicase 1.5 mg / vial;
2004-09-21;
Intravenous;
Powder For Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72766
ALPROLIX;
02422921;
recombinant human coagulation factor ix – fc fusion protein 1000 unit / vial;
2016-01-15;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90758
ALPROLIX;
02422948;
recombinant human coagulation factor ix – fc fusion protein 2000 unit / vial;
2015-12-11;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90759
ALPROLIX;
02422956;
recombinant human coagulation factor ix – fc fusion protein 3000 unit / vial;
2016-01-15;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90760
ALPROLIX;
02422913;
recombinant human coagulation factor ix – fc fusion protein 500 unit / vial;
2015-12-11;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90757
STIVARGA;
02403390;
regorafenib 40 mg;
2013-04-02;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88820
VEKLURY;
02502143;
remdesivir 100 mg / vial;
2020-10-16;
Intravenous;
Powder For Solution;
08:18.92 – MISCELLANEOUS ANTIVIRALS;
Prescription;
GILEAD SCIENCES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99173
REMIFENTANIL FOR INJECTION;
02344424;
remifentanil (remifentanil hydrochloride) 1 mg / vial;
2014-06-05;
Intravenous;
Powder For Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82993
REMIFENTANIL HYDROCHLORIDE FOR INJECTION;
02366460;
remifentanil (remifentanil hydrochloride) 1 mg / vial;
2011-09-27;
Intravenous;
Powder For Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85131
REMIFENTANIL FOR INJECTION;
02344432;
remifentanil (remifentanil hydrochloride) 2 mg / vial;
2014-06-05;
Intravenous;
Powder For Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82994
REMIFENTANIL HYDROCHLORIDE FOR INJECTION;
02366479;
remifentanil (remifentanil hydrochloride) 2 mg / vial;
2011-09-29;
Intravenous;
Powder For Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85132
GLUCONORM 0.5MG;
02239924;
repaglinide 0.5 mg;
1999-06-21;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63424
ACT REPAGLINIDE;
02321475;
repaglinide 0.5 mg;
2010-10-18;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80688
SANDOZ REPAGLINIDE;
02357453;
repaglinide 0.5 mg;
2011-02-17;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84259
REPAGLINIDE;
02415968;
repaglinide 0.5 mg;
2013-11-28;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90056
AURO-REPAGLINIDE;
02424258;
repaglinide 0.5 mg;
2014-04-30;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90896
ACT REPAGLINIDE;
02321483;
repaglinide 1 mg;
2010-10-18;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80689
SANDOZ REPAGLINIDE;
02357461;
repaglinide 1 mg;
2011-02-17;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84260
REPAGLINIDE;
02415976;
repaglinide 1 mg;
2013-11-28;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90057
AURO-REPAGLINIDE;
02424266;
repaglinide 1 mg;
2014-04-30;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90897
GLUCONORM 1.0MG;
02239925;
repaglinide 1.0 mg;
1999-06-21;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63425
ACT REPAGLINIDE;
02321491;
repaglinide 2 mg;
2010-10-18;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80690
SANDOZ REPAGLINIDE;
02357488;
repaglinide 2 mg;
2011-02-17;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84261
REPAGLINIDE;
02415984;
repaglinide 2 mg;
2013-11-28;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90058
AURO-REPAGLINIDE;
02424274;
repaglinide 2 mg;
2014-04-30;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90898
GLUCONORM 2.0MG;
02239926;
repaglinide 2.0 mg;
1999-06-21;
Oral;
Tablet;
68:20.16 – MEGLITINIDES;
Prescription;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63426
CINQAIR;
02456419;
reslizumab 10 mg / ml;
2016-12-19;
Intravenous;
Solution;
48:10.20 – INTERLEUKIN ANTAGONISTS;
Prescription , Schedule D;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94330
IBAVYR;
02439212;
ribavirin 200 mg;
2015-05-01;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92360
IBAVYR;
02425890;
ribavirin 400 mg;
2014-07-14;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91049
VIRAZOLE;
02170140;
ribavirin 6 g / vial;
1996-12-05;
Inhalation;
Aerosol , Powder For Solution;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=34574
IBAVYR;
02425904;
ribavirin 600 mg;
2014-07-14;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91050
KISQALI;
02473569;
ribociclib (ribociclib succinate) 200 mg;
2018-04-27;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96295
MYCOBUTIN;
02063786;
rifabutin 150 mg;
1995-12-31;
Oral;
Capsule;
08:16.04 – ANTITUBERCULOSIS AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18081
ROFACT;
00393444;
rifampin 150 mg;
1977-12-31;
Oral;
Capsule;
08:16.04 – ANTITUBERCULOSIS AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2866
ROFACT;
00343617;
rifampin 300 mg;
1977-12-31;
Oral;
Capsule;
08:16.04 – ANTITUBERCULOSIS AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2863
ZAXINE;
02410702;
rifaximin 550 mg;
2013-11-07;
Oral;
Tablet;
08:12.28.30 – RIFAMYCINS;
Prescription;
SALIX PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89537
EDURANT;
02370603;
rilpivirine (rilpivirine hydrochloride) 25 mg;
2011-08-31;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85574
RILUTEK;
02242763;
riluzole 50 mg;
2000-10-26;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66576
APO-RILUZOLE;
02352583;
riluzole 50 mg;
2012-09-25;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83784
MYLAN-RILUZOLE;
02390299;
riluzole 50 mg;
2012-10-23;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87574
ADEMPAS;
02412764;
riociguat 0.5 mg;
2013-09-25;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89742
ADEMPAS;
02412772;
riociguat 1 mg;
2013-09-25;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89743
ADEMPAS;
02412799;
riociguat 1.5 mg;
2013-09-25;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89745
ADEMPAS;
02412802;
riociguat 2 mg;
2013-09-25;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89746
ADEMPAS;
02412810;
riociguat 2.5 mg;
2013-09-25;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89747
QINLOCK;
02500833;
ripretinib 50 mg;
2020-12-10;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
DECIPHERA PHARMACEUTICALS. LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99049
SKYRIZI;
02487454;
risankizumab 90 mg / 1 ml;
2019-05-13;
Subcutaneous;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription , Schedule D;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97761
ACTONEL;
02316838;
risedronate sodium (risedronate sodium hemipentahydrate) 150 mg;
2008-12-01;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80233
APO-RISEDRONATE;
02377721;
risedronate sodium (risedronate sodium hemipentahydrate) 150 mg;
2012-05-17;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86354
PMS-RISEDRONATE;
02424177;
risedronate sodium (risedronate sodium hemipentahydrate) 150 mg;
2014-05-28;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90889
ACTONEL;
02246896;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2002-12-10;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71123
PMS-RISEDRONATE;
02302209;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2010-07-27;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78754
SANDOZ RISEDRONATE;
02327295;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2010-07-28;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81259
RIVA-RISEDRONATE;
02341077;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2010-07-28;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82662
RISEDRONATE;
02347474;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2010-10-15;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83286
APO-RISEDRONATE;
02353687;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2010-11-10;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83888
JAMP-RISEDRONATE;
02368552;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2011-10-04;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85353
ACTONEL DR;
02370417;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2011-08-10;
Oral;
Tablet (Delayed-Release);
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85557
AURO-RISEDRONATE;
02406306;
risedronate sodium (risedronate sodium hemipentahydrate) 35 mg;
2013-07-08;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89102
TEVA-RISEDRONATE;
02413809;
risedronate sodium (risedronate sodium monohydrate) 150 mg;
2013-10-10;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89845
TEVA-RISEDRONATE;
02298384;
risedronate sodium (risedronate sodium monohydrate) 30 mg;
2010-01-27;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78368
TEVA-RISEDRONATE;
02298392;
risedronate sodium (risedronate sodium monohydrate) 35 mg;
2010-01-27;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78369
RISEDRONATE;
02370255;
risedronate sodium (risedronate sodium monohydrate) 35 mg;
2011-10-18;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85541
RISEDRONATE-35;
02411407;
risedronate sodium (risedronate sodium monohydrate) 35 mg;
2013-10-23;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89602
TEVA-RISEDRONATE;
02298376;
risedronate sodium (risedronate sodium monohydrate) 5 mg;
2010-01-27;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78367
RISPERDAL ORAL SOLUTION;
02236950;
risperidone (risperidone tartrate) 1 mg / ml;
1998-03-04;
Oral;
Solution;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60243
PMS-RISPERIDONE;
02279266;
risperidone (risperidone tartrate) 1 mg / ml;
2006-07-05;
Oral;
Solution;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76481
APO-RISPERIDONE;
02280396;
risperidone (risperidone tartrate) 1 mg / ml;
2006-07-05;
Oral;
Solution;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76606
JAMP-RISPERIDONE;
02454319;
risperidone (risperidone tartrate) 1 mg / ml;
2018-08-22;
Oral;
Solution;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94083
PMS-RISPERIDONE;
02252007;
risperidone 0.25 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73690
APO-RISPERIDONE;
02282119;
risperidone 0.25 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76778
TEVA-RISPERIDONE;
02282690;
risperidone 0.25 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76833
RIVA-RISPERIDONE;
02283565;
risperidone 0.25 mg;
2006-07-31;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76916
SANDOZ RISPERIDONE;
02303655;
risperidone 0.25 mg;
2007-12-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78897
PRO-RISPERIDONE;
02312700;
risperidone 0.25 mg;
2008-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79823
RAN-RISPERIDONE;
02328305;
risperidone 0.25 mg;
2009-10-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81383
RISPERIDONE;
02356880;
risperidone 0.25 mg;
2010-10-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84200
JAMP-RISPERIDONE;
02359529;
risperidone 0.25 mg;
2010-12-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84454
MINT-RISPERIDON;
02359790;
risperidone 0.25 mg;
2011-01-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84478
AG-RISPERIDONE;
02369079;
risperidone 0.25 mg;
2018-09-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85402
MAR-RISPERIDONE;
02371766;
risperidone 0.25 mg;
2013-04-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85689
PMS-RISPERIDONE;
02252015;
risperidone 0.5 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73691
RIVA-RISPERIDONE;
02283573;
risperidone 0.5 mg;
2006-07-31;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76917
SANDOZ RISPERIDONE;
02303663;
risperidone 0.5 mg;
2007-12-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78898
PRO-RISPERIDONE;
02312719;
risperidone 0.5 mg;
2008-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79824
RAN-RISPERIDONE;
02328313;
risperidone 0.5 mg;
2009-10-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81384
RISPERIDONE;
02356899;
risperidone 0.5 mg;
2010-10-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84201
AG-RISPERIDONE;
02369087;
risperidone 0.5 mg;
2018-09-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85403
APO-RISPERIDONE;
02282127;
risperidone 0.50 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76779
JAMP-RISPERIDONE;
02359537;
risperidone 0.50 mg;
2010-12-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84455
MINT-RISPERIDON;
02359804;
risperidone 0.50 mg;
2011-01-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84479
MAR-RISPERIDONE;
02371774;
risperidone 0.50 mg;
2013-04-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85690
RIVA-RISPERIDONE;
02283581;
risperidone 1 mg;
2006-07-31;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76918
RISPERIDONE;
02356902;
risperidone 1 mg;
2010-10-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84202
AG-RISPERIDONE;
02369095;
risperidone 1 mg;
2018-09-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85404
PMS-RISPERIDONE;
02252023;
risperidone 1.0 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73692
TEVA-RISPERIDONE;
02264196;
risperidone 1.0 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74963
SANDOZ RISPERIDONE;
02279800;
risperidone 1.0 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76539
APO-RISPERIDONE;
02282135;
risperidone 1.0 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76780
PRO-RISPERIDONE;
02312727;
risperidone 1.0 mg;
2008-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79825
RAN-RISPERIDONE;
02328321;
risperidone 1.0 mg;
2009-10-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81385
JAMP-RISPERIDONE;
02359545;
risperidone 1.0 mg;
2010-12-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84456
MINT-RISPERIDON;
02359812;
risperidone 1.0 mg;
2011-01-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84480
MAR-RISPERIDONE;
02371782;
risperidone 1.0 mg;
2013-04-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85691
RISPERDAL CONSTA;
02298465;
risperidone 12.5 mg / vial;
2007-10-24;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78377
RIVA-RISPERIDONE;
02283603;
risperidone 2 mg;
2006-07-31;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76919
RISPERIDONE;
02356910;
risperidone 2 mg;
2010-10-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84203
AG-RISPERIDONE;
02369117;
risperidone 2 mg;
2018-09-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85406
PMS-RISPERIDONE;
02252031;
risperidone 2.0 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73693
TEVA-RISPERIDONE;
02264218;
risperidone 2.0 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74964
SANDOZ RISPERIDONE;
02279819;
risperidone 2.0 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76540
APO-RISPERIDONE;
02282143;
risperidone 2.0 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76781
PRO-RISPERIDONE;
02312735;
risperidone 2.0 mg;
2008-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79826
RAN-RISPERIDONE;
02328348;
risperidone 2.0 mg;
2009-10-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81386
JAMP-RISPERIDONE;
02359553;
risperidone 2.0 mg;
2010-12-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84457
MINT-RISPERIDON;
02359820;
risperidone 2.0 mg;
2011-01-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84481
MAR-RISPERIDONE;
02371790;
risperidone 2.0 mg;
2013-04-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85692
RISPERDAL CONSTA;
02255707;
risperidone 25 mg / vial;
2004-09-08;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74089
RIVA-RISPERIDONE;
02283611;
risperidone 3 mg;
2006-07-31;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76920
RISPERIDONE;
02356929;
risperidone 3 mg;
2010-10-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84204
AG-RISPERIDONE;
02369125;
risperidone 3 mg;
2018-09-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85407
PMS-RISPERIDONE;
02252058;
risperidone 3.0 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73694
TEVA-RISPERIDONE;
02264226;
risperidone 3.0 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74965
SANDOZ RISPERIDONE;
02279827;
risperidone 3.0 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76541
APO-RISPERIDONE;
02282151;
risperidone 3.0 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76782
PRO-RISPERIDONE;
02312743;
risperidone 3.0 mg;
2008-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79827
RAN-RISPERIDONE;
02328364;
risperidone 3.0 mg;
2009-10-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81388
JAMP-RISPERIDONE;
02359561;
risperidone 3.0 mg;
2010-12-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84458
MINT-RISPERIDON;
02359839;
risperidone 3.0 mg;
2011-01-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84482
MAR-RISPERIDONE;
02371804;
risperidone 3.0 mg;
2013-04-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85693
RISPERDAL CONSTA;
02255723;
risperidone 37.5 mg / vial;
2004-09-08;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74091
RIVA-RISPERIDONE;
02283638;
risperidone 4 mg;
2006-07-31;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76921
RISPERIDONE;
02356937;
risperidone 4 mg;
2010-10-21;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84205
AG-RISPERIDONE;
02369133;
risperidone 4 mg;
2018-09-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85408
MAR-RISPERIDONE;
02371812;
risperidone 4 mg;
2013-04-17;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85694
PMS-RISPERIDONE;
02252066;
risperidone 4.0 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73695
TEVA-RISPERIDONE;
02264234;
risperidone 4.0 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74966
SANDOZ RISPERIDONE;
02279835;
risperidone 4.0 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76542
APO-RISPERIDONE;
02282178;
risperidone 4.0 mg;
2006-07-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76783
PRO-RISPERIDONE;
02312751;
risperidone 4.0 mg;
2008-07-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79828
RAN-RISPERIDONE;
02328372;
risperidone 4.0 mg;
2009-10-22;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81389
JAMP-RISPERIDONE;
02359588;
risperidone 4.0 mg;
2010-12-23;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84459
MINT-RISPERIDON;
02359847;
risperidone 4.0 mg;
2011-01-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84483
RISPERDAL CONSTA;
02255758;
risperidone 50 mg / vial;
2004-09-08;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74093
NORVIR;
02357593;
ritonavir 100 mg;
2010-12-17;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84270
RITUXAN;
02241927;
rituximab 10 mg / ml;
2000-03-20;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65597
RUXIENCE;
02495724;
rituximab 10 mg / ml;
2020-05-26;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98562
RIXIMYO;
02498316;
rituximab 10 mg / ml;
2020-05-22;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Schedule D;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98809
RIABNI;
02513447;
rituximab 10 mg / ml;
2021-04-21;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100265
TRUXIMA;
02478382;
rituximab 100 mg / 10 ml;
2019-12-11;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
CELLTRION HEALTHCARE CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96914
RITUXAN SC;
02457350;
rituximab 1400 mg / 11.7 ml;
2016-11-22;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94441
RITUXAN SC;
02473976;
rituximab 1600 mg / 13.4 ml;
2018-04-24;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96398
TRUXIMA;
02478390;
rituximab 500 mg / 50 ml;
2019-12-11;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
CELLTRION HEALTHCARE CO LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96915
XARELTO;
02316986;
rivaroxaban 10 mg;
2008-09-16;
Oral;
Tablet;
20:12.04.14 – Direct Factor Xa Inhibitors;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80247
XARELTO;
02378604;
rivaroxaban 15 mg;
2012-01-17;
Oral;
Tablet;
20:12.04.14 – Direct Factor Xa Inhibitors;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86439
XARELTO;
02480808;
rivaroxaban 2.5 mg;
2018-09-28;
Oral;
Tablet;
20:12.04.14 – Direct Factor Xa Inhibitors;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97146
XARELTO;
02378612;
rivaroxaban 20 mg;
2012-01-17;
Oral;
Tablet;
20:12.04.14 – Direct Factor Xa Inhibitors;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86440
EXELON 1.5 MG;
02242115;
rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg;
2000-05-15;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65791
SANDOZ RIVASTIGMINE;
02324563;
rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg;
2009-07-21;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81001
APO-RIVASTIGMINE;
02336715;
rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg;
2010-04-07;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82234
MED-RIVASTIGMINE;
02401614;
rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg;
2013-11-27;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
GENERIC MEDICAL PARTNERS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88650
RIVASTIGMINE;
02416999;
rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg;
2013-12-05;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90163
JAMP RIVASTIGMINE;
02485362;
rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg;
2020-02-10;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97561
EXELON;
02245240;
rivastigmine (rivastigmine hydrogen tartrate) 2 mg / ml;
2002-12-05;
Oral;
Solution;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69257
EXELON;
02242116;
rivastigmine (rivastigmine hydrogen tartrate) 3 mg;
2000-05-15;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65792
SANDOZ RIVASTIGMINE;
02324571;
rivastigmine (rivastigmine hydrogen tartrate) 3 mg;
2009-07-21;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81002
APO-RIVASTIGMINE;
02336723;
rivastigmine (rivastigmine hydrogen tartrate) 3 mg;
2010-04-07;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82235
MED-RIVASTIGMINE;
02401622;
rivastigmine (rivastigmine hydrogen tartrate) 3 mg;
2013-11-27;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
GENERIC MEDICAL PARTNERS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88651
RIVASTIGMINE;
02417006;
rivastigmine (rivastigmine hydrogen tartrate) 3 mg;
2013-12-05;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90164
JAMP RIVASTIGMINE;
02485370;
rivastigmine (rivastigmine hydrogen tartrate) 3 mg;
2020-02-10;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97562
EXELON;
02242117;
rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg;
2000-05-15;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65793
SANDOZ RIVASTIGMINE;
02324598;
rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg;
2009-07-21;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81003
APO-RIVASTIGMINE;
02336731;
rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg;
2010-04-07;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82236
MED-RIVASTIGMINE;
02401630;
rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg;
2014-11-12;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
GENERIC MEDICAL PARTNERS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88652
RIVASTIGMINE;
02417014;
rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg;
2013-12-05;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90165
JAMP RIVASTIGMINE;
02485389;
rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg;
2020-02-10;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97563
EXELON;
02242118;
rivastigmine (rivastigmine hydrogen tartrate) 6 mg;
2000-05-15;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65794
SANDOZ RIVASTIGMINE;
02324601;
rivastigmine (rivastigmine hydrogen tartrate) 6 mg;
2009-07-21;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81004
APO-RIVASTIGMINE;
02336758;
rivastigmine (rivastigmine hydrogen tartrate) 6 mg;
2010-04-07;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82237
MED-RIVASTIGMINE;
02401649;
rivastigmine (rivastigmine hydrogen tartrate) 6 mg;
2013-11-27;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
GENERIC MEDICAL PARTNERS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88653
RIVASTIGMINE;
02417022;
rivastigmine (rivastigmine hydrogen tartrate) 6 mg;
2013-12-05;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90166
JAMP RIVASTIGMINE;
02485397;
rivastigmine (rivastigmine hydrogen tartrate) 6 mg;
2020-02-10;
Oral;
Capsule;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97564
EXELON PATCH 15;
02432803;
rivastigmine 13.3 mg / 24 hour;
2015-04-17;
Transdermal;
Patch;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91722
EXELON PATCH 5;
02302845;
rivastigmine 4.6 mg / 24 hour;
2007-12-12;
Transdermal;
Patch;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78816
MYLAN-RIVASTIGMINE PATCH 5;
02423413;
rivastigmine 4.6 mg / 24 hour;
2016-12-05;
Transdermal;
Patch;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90814
SANDOZ RIVASTIGMINE PATCH 5;
02426293;
rivastigmine 4.6 mg / 24 hour;
2016-11-30;
Transdermal;
Patch;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91089
EXELON PATCH 10;
02302853;
rivastigmine 9.5 mg / 24 hour;
2007-12-12;
Transdermal;
Patch;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78817
MYLAN-RIVASTIGMINE PATCH 10;
02423421;
rivastigmine 9.5 mg / 24 hour;
2016-12-05;
Transdermal;
Patch;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90815
SANDOZ RIVASTIGMINE PATCH 10;
02426307;
rivastigmine 9.5 mg / 24 hour;
2016-11-30;
Transdermal;
Patch;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91090
MAXALT RPD;
02240519;
rizatriptan (rizatriptan benzoate) 10 mg;
1999-08-31;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64090
MAXALT;
02240521;
rizatriptan (rizatriptan benzoate) 10 mg;
1999-08-31;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64092
SANDOZ RIZATRIPTAN ODT;
02351889;
rizatriptan (rizatriptan benzoate) 10 mg;
2012-01-30;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83712
MYLAN-RIZATRIPTAN ODT;
02379201;
rizatriptan (rizatriptan benzoate) 10 mg;
2012-01-31;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86509
MAR-RIZATRIPTAN;
02379678;
rizatriptan (rizatriptan benzoate) 10 mg;
2012-05-03;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86554
ACT RIZATRIPTAN;
02381702;
rizatriptan (rizatriptan benzoate) 10 mg;
2012-06-14;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86756
PMS-RIZATRIPTAN RDT;
02393379;
rizatriptan (rizatriptan benzoate) 10 mg;
2012-10-30;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87860
APO-RIZATRIPTAN;
02393476;
rizatriptan (rizatriptan benzoate) 10 mg;
2012-09-27;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87869
TEVA-RIZATRIPTAN ODT;
02396688;
rizatriptan (rizatriptan benzoate) 10 mg;
2014-11-04;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88171
RIZATRIPTAN RDT;
02415801;
rizatriptan (rizatriptan benzoate) 10 mg;
2013-11-28;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90040
JAMP-RIZATRIPTAN IR;
02429241;
rizatriptan (rizatriptan benzoate) 10 mg;
2014-09-25;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91368
NAT-RIZATRIPTAN ODT;
02436612;
rizatriptan (rizatriptan benzoate) 10 mg;
2015-02-17;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92094
RIZATRIPTAN ODT;
02442914;
rizatriptan (rizatriptan benzoate) 10 mg;
2015-07-23;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92742
RIZATRIPTAN ODT;
02446138;
rizatriptan (rizatriptan benzoate) 10 mg;
2015-10-07;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93139
CCP-RIZATRIPTAN ODT;
02458772;
rizatriptan (rizatriptan benzoate) 10 mg;
2019-01-04;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94592
MAR-RIZATRIPTAN ODT;
02462796;
rizatriptan (rizatriptan benzoate) 10 mg;
2018-02-15;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95063
JAMP-RIZATRIPTAN ODT;
02465094;
rizatriptan (rizatriptan benzoate) 10 mg;
2018-02-12;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95328
ACCEL-RIZATRIPTAN ODT;
02483289;
rizatriptan (rizatriptan benzoate) 10 mg;
2019-10-07;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ACCEL PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97372
NRA-RIZATRIPTAN ODT;
02489384;
rizatriptan (rizatriptan benzoate) 10 mg;
2020-01-17;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97947
AG-RIZATRIPTAN ODT;
02492490;
rizatriptan (rizatriptan benzoate) 10 mg;
2020-01-27;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98250
MAXALT RPD;
02240518;
rizatriptan (rizatriptan benzoate) 5 mg;
2000-05-05;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64089
SANDOZ RIZATRIPTAN ODT;
02351870;
rizatriptan (rizatriptan benzoate) 5 mg;
2012-01-30;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83711
MYLAN-RIZATRIPTAN ODT;
02379198;
rizatriptan (rizatriptan benzoate) 5 mg;
2012-01-31;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86508
PMS-RIZATRIPTAN RDT;
02393360;
rizatriptan (rizatriptan benzoate) 5 mg;
2012-10-30;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87859
APO-RIZATRIPTAN;
02393468;
rizatriptan (rizatriptan benzoate) 5 mg;
2013-03-06;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87868
TEVA-RIZATRIPTAN ODT;
02396661;
rizatriptan (rizatriptan benzoate) 5 mg;
2014-11-04;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88170
RIZATRIPTAN RDT;
02415798;
rizatriptan (rizatriptan benzoate) 5 mg;
2013-11-28;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90039
JAMP-RIZATRIPTAN IR;
02429233;
rizatriptan (rizatriptan benzoate) 5 mg;
2014-09-25;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91367
NAT-RIZATRIPTAN ODT;
02436604;
rizatriptan (rizatriptan benzoate) 5 mg;
2015-02-17;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92093
RIZATRIPTAN ODT;
02442906;
rizatriptan (rizatriptan benzoate) 5 mg;
2015-07-23;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92741
RIZATRIPTAN ODT;
02446111;
rizatriptan (rizatriptan benzoate) 5 mg;
2015-10-07;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93138
CCP-RIZATRIPTAN ODT;
02458764;
rizatriptan (rizatriptan benzoate) 5 mg;
2019-01-04;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
CELLCHEM PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94591
MAR-RIZATRIPTAN ODT;
02462788;
rizatriptan (rizatriptan benzoate) 5 mg;
2018-02-15;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95062
JAMP-RIZATRIPTAN ODT;
02465086;
rizatriptan (rizatriptan benzoate) 5 mg;
2018-02-12;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95327
ACCEL-RIZATRIPTAN ODT;
02483270;
rizatriptan (rizatriptan benzoate) 5 mg;
2019-10-07;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ACCEL PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97371
ROCURONIUM BROMIDE INJECTION;
02318121;
rocuronium bromide 10 mg / ml;
2009-02-10;
Intravenous;
Solution;
12:20.20 – NEUROMUSCULAR BLOCKING AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80363
ROCURONIUM BROMIDE INJECTION;
02318415;
rocuronium bromide 10 mg / ml;
2008-10-24;
Intravenous;
Solution;
12:20.20 – NEUROMUSCULAR BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80390
ROCURONIUM BROMIDE INJECTION;
02469774;
rocuronium bromide 10 mg / ml;
2019-01-17;
Intravenous;
Solution;
12:20.20 – NEUROMUSCULAR BLOCKING AGENTS;
Prescription;
JUNO PHARMACEUTICALS CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95863
ROCURONIUM BROMIDE INJECTION;
02498820;
rocuronium bromide 10 mg / ml;
2020-11-24;
Intravenous;
Solution;
12:20.20 – NEUROMUSCULAR BLOCKING AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98856
DAXAS;
02359456;
roflumilast 500 mcg;
2010-12-30;
Oral;
Tablet;
48:32.00 – Phosphodiesterase Type 4 Inhibitors;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84447
ISTODAX;
02414295;
romidepsin 10 mg / vial;
2014-02-05;
Intravenous;
Kit , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89895
NPLATE;
02322854;
romiplostim 250 mcg / vial;
2009-04-15;
Subcutaneous;
Powder For Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80832
NPLATE;
02322862;
romiplostim 500 mcg / vial;
2009-04-15;
Subcutaneous;
Powder For Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80833
EVENITY;
02489597;
romosozumab 105 mg / 1.17 ml;
2019-08-12;
Subcutaneous;
Solution;
92:22.00 – BONE ANABOLIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97967
RAN-ROPINIROLE;
02314037;
ropinirole (ropinirole hydrochloride) 0.25 mg;
2009-07-22;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79955
TEVA-ROPINIROLE;
02316846;
ropinirole (ropinirole hydrochloride) 0.25 mg;
2009-07-22;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80234
JAMP-ROPINIROLE;
02352338;
ropinirole (ropinirole hydrochloride) 0.25 mg;
2010-06-16;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83760
ROPINIROLE;
02353040;
ropinirole (ropinirole hydrochloride) 0.25 mg;
2010-07-26;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83827
TEVA-ROPINIROLE;
02316854;
ropinirole (ropinirole hydrochloride) 1 mg;
2009-07-22;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80235
ROPINIROLE;
02353059;
ropinirole (ropinirole hydrochloride) 1 mg;
2010-07-26;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83828
RAN-ROPINIROLE;
02314053;
ropinirole (ropinirole hydrochloride) 1.0 mg;
2009-07-22;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79957
JAMP-ROPINIROLE;
02352346;
ropinirole (ropinirole hydrochloride) 1.0 mg;
2010-06-16;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83761
TEVA-ROPINIROLE;
02316862;
ropinirole (ropinirole hydrochloride) 2 mg;
2009-07-22;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80236
RAN-ROPINIROLE;
02314061;
ropinirole (ropinirole hydrochloride) 2.0 mg;
2009-07-22;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79958
JAMP-ROPINIROLE;
02352354;
ropinirole (ropinirole hydrochloride) 2.0 mg;
2010-06-16;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83762
TEVA-ROPINIROLE;
02316870;
ropinirole (ropinirole hydrochloride) 5 mg;
2009-07-22;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80237
RAN-ROPINIROLE;
02314088;
ropinirole (ropinirole hydrochloride) 5.0 mg;
2009-07-22;
Oral;
Tablet;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79959
NAROPIN;
02229418;
ropivacaine hydrochloride 10 mg / ml;
1997-04-30;
Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47225
ROPIVACAINE HYDROCHLORIDE INJECTION USP;
02347830;
ropivacaine hydrochloride 10 mg / ml;
2010-12-14;
Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83320
ROPIVACAINE HYDROCHLORIDE INJECTION, USP;
02439409;
ropivacaine hydrochloride 10 mg / ml;
2019-02-26;
Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92377
NAROPIN;
02229411;
ropivacaine hydrochloride 2 mg / ml;
1997-04-30;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47216
ROPIVACAINE HYDROCHLORIDE INJECTION, USP;
02439379;
ropivacaine hydrochloride 2 mg / ml;
2018-09-28;
Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92374
NAROPIN;
02229415;
ropivacaine hydrochloride 5 mg / ml;
1997-04-30;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47220
ROPIVACAINE HYDROCHLORIDE INJECTION USP;
02347822;
ropivacaine hydrochloride 5 mg / ml;
2010-12-14;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83319
ROPIVACAINE HYDROCHLORIDE INJECTION, USP;
02439387;
ropivacaine hydrochloride 5 mg / ml;
2019-09-13;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92375
ROSIGLITAZONE;
02403366;
rosiglitazone (rosiglitazone maleate) 2 mg;
2017-02-21;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88817
ROSIGLITAZONE;
02403374;
rosiglitazone (rosiglitazone maleate) 4 mg;
2017-02-21;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88818
ROSIGLITAZONE;
02403382;
rosiglitazone (rosiglitazone maleate) 8 mg;
2017-02-21;
Oral;
Tablet;
68:20.28 – THIAZOLIDINEDIONES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88819
CRESTOR – 10MG;
02247162;
rosuvastatin (rosuvastatin calcium) 10 mg;
2003-02-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71404
APO-ROSUVASTATIN;
02337983;
rosuvastatin (rosuvastatin calcium) 10 mg;
2012-04-02;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82363
SANDOZ ROSUVASTATIN;
02338734;
rosuvastatin (rosuvastatin calcium) 10 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82438
TEVA-ROSUVASTATIN;
02354616;
rosuvastatin (rosuvastatin calcium) 10 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83978
PMS-ROSUVASTATIN;
02378531;
rosuvastatin (rosuvastatin calcium) 10 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86433
RIVA-ROSUVASTATIN;
02380056;
rosuvastatin (rosuvastatin calcium) 10 mg;
2012-06-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86589
ROSUVASTATIN;
02381184;
rosuvastatin (rosuvastatin calcium) 10 mg;
2012-07-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86696
TARO-ROSUVASTATIN;
02382652;
rosuvastatin (rosuvastatin calcium) 10 mg;
2012-04-02;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86847
JAMP-ROSUVASTATIN;
02391260;
rosuvastatin (rosuvastatin calcium) 10 mg;
2012-09-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87661
ROSUVASTATIN;
02405636;
rosuvastatin (rosuvastatin calcium) 10 mg;
2013-06-12;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89040
ROSUVASTATIN;
02411636;
rosuvastatin (rosuvastatin calcium) 10 mg;
2013-10-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89623
ACH-ROSUVASTATIN;
02438925;
rosuvastatin (rosuvastatin calcium) 10 mg;
2019-05-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92330
AURO-ROSUVASTATIN;
02442582;
rosuvastatin (rosuvastatin calcium) 10 mg;
2015-11-30;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92692
BIO-ROSUVASTATIN;
02444976;
rosuvastatin (rosuvastatin calcium) 10 mg;
2016-06-30;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93019
PRIVA-ROSUVASTATIN;
02445425;
rosuvastatin (rosuvastatin calcium) 10 mg;
2016-06-30;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93065
AG-ROSUVASTATIN;
02477041;
rosuvastatin (rosuvastatin calcium) 10 mg;
2018-12-28;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96734
NRA-ROSUVASTATIN;
02477491;
rosuvastatin (rosuvastatin calcium) 10 mg;
2019-04-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96855
M-ROSUVASTATIN;
02496542;
rosuvastatin (rosuvastatin calcium) 10 mg;
2020-08-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98640
JAMP ROSUVASTATIN CALCIUM;
02498340;
rosuvastatin (rosuvastatin calcium) 10 mg;
2021-02-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98812
CRESTOR – 20MG;
02247163;
rosuvastatin (rosuvastatin calcium) 20 mg;
2003-02-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71405
APO-ROSUVASTATIN;
02337991;
rosuvastatin (rosuvastatin calcium) 20 mg;
2012-04-02;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82364
SANDOZ ROSUVASTATIN;
02338742;
rosuvastatin (rosuvastatin calcium) 20 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82439
TEVA-ROSUVASTATIN;
02354624;
rosuvastatin (rosuvastatin calcium) 20 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83979
PMS-ROSUVASTATIN;
02378558;
rosuvastatin (rosuvastatin calcium) 20 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86434
RIVA-ROSUVASTATIN;
02380064;
rosuvastatin (rosuvastatin calcium) 20 mg;
2012-06-13;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86590
ROSUVASTATIN;
02381192;
rosuvastatin (rosuvastatin calcium) 20 mg;
2012-07-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86697
TARO-ROSUVASTATIN;
02382660;
rosuvastatin (rosuvastatin calcium) 20 mg;
2012-04-02;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86848
JAMP-ROSUVASTATIN;
02391279;
rosuvastatin (rosuvastatin calcium) 20 mg;
2012-09-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87662
ROSUVASTATIN;
02405644;
rosuvastatin (rosuvastatin calcium) 20 mg;
2013-06-12;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89041
ROSUVASTATIN;
02411644;
rosuvastatin (rosuvastatin calcium) 20 mg;
2013-10-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89624
ACH-ROSUVASTATIN;
02438933;
rosuvastatin (rosuvastatin calcium) 20 mg;
2019-05-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92331
AURO-ROSUVASTATIN;
02442590;
rosuvastatin (rosuvastatin calcium) 20 mg;
2015-11-30;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92693
BIO-ROSUVASTATIN;
02444984;
rosuvastatin (rosuvastatin calcium) 20 mg;
2016-06-30;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93020
PRIVA-ROSUVASTATIN;
02445433;
rosuvastatin (rosuvastatin calcium) 20 mg;
2016-06-30;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93066
AG-ROSUVASTATIN;
02477068;
rosuvastatin (rosuvastatin calcium) 20 mg;
2018-12-28;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96735
NRA-ROSUVASTATIN;
02477505;
rosuvastatin (rosuvastatin calcium) 20 mg;
2019-04-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96856
M-ROSUVASTATIN;
02496550;
rosuvastatin (rosuvastatin calcium) 20 mg;
2020-08-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98641
JAMP ROSUVASTATIN CALCIUM;
02498359;
rosuvastatin (rosuvastatin calcium) 20 mg;
2021-02-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98813
CRESTOR – 40MG;
02247164;
rosuvastatin (rosuvastatin calcium) 40 mg;
2003-02-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71406
APO-ROSUVASTATIN;
02338009;
rosuvastatin (rosuvastatin calcium) 40 mg;
2012-04-02;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82365
SANDOZ ROSUVASTATIN;
02338750;
rosuvastatin (rosuvastatin calcium) 40 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82440
TEVA-ROSUVASTATIN;
02354632;
rosuvastatin (rosuvastatin calcium) 40 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83980
PMS-ROSUVASTATIN;
02378566;
rosuvastatin (rosuvastatin calcium) 40 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86435
RIVA-ROSUVASTATIN;
02380102;
rosuvastatin (rosuvastatin calcium) 40 mg;
2012-06-13;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86594
ROSUVASTATIN;
02381206;
rosuvastatin (rosuvastatin calcium) 40 mg;
2012-07-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86698
TARO-ROSUVASTATIN;
02382679;
rosuvastatin (rosuvastatin calcium) 40 mg;
2012-04-02;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86849
JAMP-ROSUVASTATIN;
02391287;
rosuvastatin (rosuvastatin calcium) 40 mg;
2012-09-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87663
ROSUVASTATIN;
02405652;
rosuvastatin (rosuvastatin calcium) 40 mg;
2013-06-12;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89042
ROSUVASTATIN;
02411652;
rosuvastatin (rosuvastatin calcium) 40 mg;
2013-10-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89625
ACH-ROSUVASTATIN;
02438941;
rosuvastatin (rosuvastatin calcium) 40 mg;
2019-05-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92332
AURO-ROSUVASTATIN;
02442604;
rosuvastatin (rosuvastatin calcium) 40 mg;
2015-11-30;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92694
BIO-ROSUVASTATIN;
02444992;
rosuvastatin (rosuvastatin calcium) 40 mg;
2016-06-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93021
AG-ROSUVASTATIN;
02477076;
rosuvastatin (rosuvastatin calcium) 40 mg;
2018-12-28;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96736
M-ROSUVASTATIN;
02496569;
rosuvastatin (rosuvastatin calcium) 40 mg;
2020-08-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98642
JAMP ROSUVASTATIN CALCIUM;
02498367;
rosuvastatin (rosuvastatin calcium) 40 mg;
2021-02-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98814
CRESTOR – 5MG;
02265540;
rosuvastatin (rosuvastatin calcium) 5 mg;
2005-03-18;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75100
APO-ROSUVASTATIN;
02337975;
rosuvastatin (rosuvastatin calcium) 5 mg;
2012-04-02;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82362
SANDOZ ROSUVASTATIN;
02338726;
rosuvastatin (rosuvastatin calcium) 5 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82437
TEVA-ROSUVASTATIN;
02354608;
rosuvastatin (rosuvastatin calcium) 5 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83977
PMS-ROSUVASTATIN;
02378523;
rosuvastatin (rosuvastatin calcium) 5 mg;
2012-03-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86432
RIVA-ROSUVASTATIN;
02380013;
rosuvastatin (rosuvastatin calcium) 5 mg;
2012-06-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86586
ROSUVASTATIN;
02381176;
rosuvastatin (rosuvastatin calcium) 5 mg;
2012-07-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86695
TARO-ROSUVASTATIN;
02382644;
rosuvastatin (rosuvastatin calcium) 5 mg;
2012-04-02;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86846
JAMP-ROSUVASTATIN;
02391252;
rosuvastatin (rosuvastatin calcium) 5 mg;
2012-09-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87660
ROSUVASTATIN;
02405628;
rosuvastatin (rosuvastatin calcium) 5 mg;
2013-06-12;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89039
ROSUVASTATIN;
02411628;
rosuvastatin (rosuvastatin calcium) 5 mg;
2013-10-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89622
ACH-ROSUVASTATIN;
02438917;
rosuvastatin (rosuvastatin calcium) 5 mg;
2019-05-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92329
AURO-ROSUVASTATIN;
02442574;
rosuvastatin (rosuvastatin calcium) 5 mg;
2015-11-30;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92691
BIO-ROSUVASTATIN;
02444968;
rosuvastatin (rosuvastatin calcium) 5 mg;
2016-06-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93018
PRIVA-ROSUVASTATIN;
02445417;
rosuvastatin (rosuvastatin calcium) 5 mg;
2016-06-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93064
AG-ROSUVASTATIN;
02477033;
rosuvastatin (rosuvastatin calcium) 5 mg;
2018-12-28;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96733
NRA-ROSUVASTATIN;
02477483;
rosuvastatin (rosuvastatin calcium) 5 mg;
2019-04-24;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96854
M-ROSUVASTATIN;
02496534;
rosuvastatin (rosuvastatin calcium) 5 mg;
2020-08-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98639
JAMP ROSUVASTATIN CALCIUM;
02498332;
rosuvastatin (rosuvastatin calcium) 5 mg;
2021-02-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98811
NEUPRO;
02403897;
rotigotine 1 mg / 24 hour;
2013-12-19;
Transdermal;
Patch;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
UCB CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88866
NEUPRO;
02403900;
rotigotine 2 mg / 24 hour;
2013-06-27;
Transdermal;
Patch;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
UCB CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88867
NEUPRO;
02403919;
rotigotine 3 mg / 24 hour;
2013-12-19;
Transdermal;
Patch;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
UCB CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88868
NEUPRO;
02403927;
rotigotine 4 mg / 24 hour;
2013-06-27;
Transdermal;
Patch;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
UCB CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88869
NEUPRO;
02403935;
rotigotine 6 mg / 24 hour;
2013-06-27;
Transdermal;
Patch;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
UCB CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88870
NEUPRO;
02403943;
rotigotine 8 mg / 24 hour;
2013-06-27;
Transdermal;
Patch;
28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
Prescription;
UCB CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88871
BANZEL;
02369613;
rufinamide 100 mg;
2011-10-20;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85454
BANZEL;
02369621;
rufinamide 200 mg;
2011-08-29;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85455
BANZEL;
02369648;
rufinamide 400 mg;
2011-09-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
EISAI LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85456
RUPALL;
02456478;
rupatadine (rupatadine fumarate) 1 mg / ml;
2017-01-20;
Oral;
Solution;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Prescription;
MEDEXUS PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94336
RUPALL;
02456451;
rupatadine (rupatadine fumarate) 10 mg;
2017-01-16;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Prescription;
MEDEXUS PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94335
JAKAVI;
02434814;
ruxolitinib (ruxolitinib phosphate) 10 mg;
2015-04-15;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91911
JAKAVI;
02388014;
ruxolitinib (ruxolitinib phosphate) 15 mg;
2012-07-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87358
JAKAVI;
02388022;
ruxolitinib (ruxolitinib phosphate) 20 mg;
2012-07-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87359
JAKAVI;
02388006;
ruxolitinib (ruxolitinib phosphate) 5 mg;
2012-07-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87357

NOTICE

This page contains a copy of information from Health Canada’s Drug Product Database.
The author of this website is not responsible for any incomplete or erroneous information that may be found in the Health Canada database and / or on this page.

The AHFS class of active ingredients is regularly reassigned. The information on this page doesn’t always reflect these changes.

© All rights reserved. Pharmaceuticals database and data extracts.
Health Canada. Adapted and reproduced with permission from the Minister of Health, 2019.

⇡ Return to top

AVIS

Cette page contient une copie des informations de la base de données sur les produits pharmaceutiques de Santé Canada.
L’auteure de ce site web n’est pas responsable des informations incomplètes ou erronées qui pourraient être trouvées dans la base de données de Santé Canada et/ou sur cette page.


La classe AHFS des ingrédients actifs fait régulièrement l’objet de réaffectations.
Les informations sur cette page ne reflète pas toujours ces changements;

© Tous droits réservés. Base de données sur les produits pharmaceutiques et extraits de données.
Santé Canada. Adapté et reproduit avec la permission du ministre de la Santé, 2019.

⇡ Retour en haut